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Cryptosporidium is a protozoan parasite responsible for causing diarrhoeal disease in
humans. Cryptosporidiosis is spread by contact with contaminated municipal water sup-
plies or swimming pools, and can pose a serious health risk for individuals with weakened
immune systems. This disease takes a massive toll on global public health, with over
200,000 deaths in children of less than two years old in Asia and Sub-Saharan Africa
being attributed to it annually. Genomics can be a valuable asset in helping combat
this parasite and the disease it causes. The primary focus of this project was to iden-
tify novel biomarkers around the genome of Cryptosporidium, using novel bioinformatics
software, which can be used to furnish epidemiological surveys with high resolution data.
This work necessitates generating high quality, reliable genome assemblies. Consequently,
over 40 new Cryptosporidium genomes were sequenced and assembled. The biomarkers
identified using these genomes provide a strong foundation upon which multiplicity of
infection can be elucidated, using a novel in silico pipeline. The tools developed were
designed with computational efficiency in mind, with the intention that they can be used
by the Public Health Wales Cryptosporidium Reference Unit. This kind of computational
efficiency was achieved, in part, by using alignment-free sequence analysis techniques to
analyse raw read sets generated by Next-Generation sequencing projects, obviating the
computationally intensive task of genome assembly. The results presented here shed light
on the complex way this parasite is transmitted, and will facilitate the development of
novel prevention strategies in the battle against Cryptosporidiosis.
Keywords: Cryptosporidium, Genomics, NGS, bioinformatics, alignment-free sequence
analysis
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The salient points of this project are as follows:
 Cryptosporidium suffers from low DNA yield from clinical samples. This lack of
DNA often results in WGS attempts producing genomes with very uneven depth
of coverage. Due to the Cryptosporidium genome being small and repeat rich,
misassembly was common using conventional and popular de novo assemblers, such
as SPAdes and velvet, wherein highly uneven coverage over low complexity regions
resulted in translocation of large chromosomal fragments. Consequently IDBA-UD,
an assembler designed to assemble genomes with highly uneven depth of coverage,
was used. This dramatically decreased the number of in silico translocation events
that were observed during assembly. A novel pipeline utilising this assembler was
developed to assemble and annotate 58 Cryptosporidium genomes.
 The Gini coefficient, along with a novel metric, Gini-granularity curves, can be
used to characterise the distribution of reads across a genome assembly. These
Gini-granularity curves demonstrate that WGA selectively amplifies regions of the
Cryptosporidium genome in a biased manner.
 Cryptosporidium diagnostics is constrained by the convention of defining subtypes
by variation in the highly repetitive region within the gene coding for a 60 kD surface
glycoprotein on chromosome 6 (gp60). The single locus nature of this convention
lacks the resolution of a multi locus approach. Furthermore, Cryptosporidium ex-
hibits a sexual lifecyle, and has been reported to recombine at the gp60 locus. These
observations may confound epidemiological research, which is reliant on subtyping
using the gp60 locus. There is currently no consensus on which loci to interrogate
for a MLST approach.
 Using a novel VNTR discovery and analysis pipeline (VaNTA), over 3000 polymor-
phic tandem repeats (VNTR’s) have been identified. Around 300 of these compare
favourably to gp60 in both their capacity to resolve subtype populations of Cryp-
tosporidium, and the conservation of regions flanking the repeat locus, a feature
essential for primer design.
 The advent of next generation sequencing has lead to an explosion in the amount
of genomic data that can be produced by sequencing projects. However, this has
lead to a significant bottle neck in the analysis of these data. Consequently, quick
and reliable methods of analysing these data are critically important.
 BlooMine is a novel raw read mining tool developed to facilitate quick and compu-
tationally efficient local analysis of sequences captured within raw reads generated
by whole or partial genome sequencing projects. It utilises Bloomfilters, a highly
space efficient probabilistic data structure, to perform set membership queries and
infer sequence homogeneity. Using this approach allows for analysis of genomic
sequence without the need to carry out the memory and time consuming task of
genome assembly.
 Using BlooMine, extensive multiplicity of infection was demonstrated within single-
host clinical isolates of Cryptosporidium parvum across a number of VNTR loci
identified using VaNTA. MOI-signature typing, a typing scheme utilising the rel-
ative abundance of alleles at a single locus within a host, appears to demonstrate
superior typing resolution to conventional dominant allele schemes.
x
Thus, from the war of nature, from famine and death, the most exalted object which we
are capable of conceiving, namely, the production of the higher animals, directly follows.
There is grandeur in this view of life, with its several powers, having been originally
breathed into a few forms or into one; and that, whilst this planet has gone cycling on
according to the fixed law of gravity, from so simple a beginning endless forms most beau-
tiful and most wonderful have been, and are being, evolved.
— Charles R. Darwin, On the Origin of Species, 1859
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5.1 A simplified schematic of genetic recombination in Cryptosporidium, po-
tentially generating variation between sporozoites within oocysts. In a
mixed infection population, different fertilization scenarios potentially oc-
cur - between the same genotypes (resulting in identical daughter sporo-
zoites) or between different genotypes, as in the example shown, that re-
sult in a variety of outcomes depending on the random genetic exchange,
or lack of, that occurs during meiosis. For simplicity only two example
chromosomes are shown with DNA from different genotypes represented
by blue and red. The diploid zygote contains duplicate pairs of chromo-
somes, one set from each parent cell; during interphase (In) the DNA in
each chromosome is replicated to produce two identical sister chromatids
held together with a centromere; in prophase I (Pr I) the chromosomes
start to condense and pair up with the homologous chromosome from the
other parent cell, and cross-over can occur resulting in an genetic exchange;
during metaphase I (Me I) the paired chromosomes line up along the cen-
ter of the cell and microtubules connect the centromeres to the centro-
somes (shown in green); during anaphase I (An I) each complete set of
chromosomes (still paired as sister chromatids) are pulled towards each
centrosome. The chromosomes from either parent are randomly combined
at this phase introducing a further opportunity for recombination (a blue
and a red chromosome are drawn to each centrosome in this example); in
telophase I (Te I) the chromosomes start to unravel and cytokinesis starts
to split the cell into two, resulting in two haploid cells; in prophase II
(Pr II) the chromosomes condense again; during metaphase II (Me II) the
chromosomes line up along the center of the cells and microtubules connect
the centromeres to the centrosomes; this time during anaphase II (An II)
the sister chromatids are separated and pulled apart towards the centro-
somes, creating new daughter chromosomes; finally in telophase II (Te II)
the chromosomes unravel and cytokinesis starts to split the cells, which in
the case of this example due to the crossover event in prophase I, results
in four genetically different haploid sporozoites. Depending upon whether
random genetic exchanges take place between chromosomes from different
genotype parents (either in prophase I or anaphase I) the resulting haploid
sporozoites can either be all different, two pairs of identical sporozoites
that are different from each parent, or two pairs of identical sporozoites
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Chapter 1
Introduction
Protozoans belonging to the phylum Apicomplexa are of significant importance to med-
ical and veterinary health worldwide, containing medically important genera such as
Toxoplasma, Babesia, Cryptosporidium, and the Malaria causing parasite, Plasmodium.
The global burden of parasitoses caused by Apicomplexans is considerable, with roughly
500,000 deaths caused by members of genus Plasmodium annually, between 20-50% of
the world’s population testing seropositive for Toxoplasma gondii, and over 200,000 infant
deaths being attributed to Cryptosporidium in Asia and Sub-Saharan Africa alone each
year. The huge toll on human life these parasites take necessitates the urgent develop-
ment of preventative and therapeutic strategies to combat this important issue in global
public health. High-throughput generation of parasite genomes has allowed for the most
thorough analysis of the biology of these parasites currently possible, leading to huge ad-
vancements in our understanding of the parasites, the diseases they cause, and facilitates
the development of novel therapeutics, and biomarkers for highly sensitive and reliable
species and genotype identification. However, there lies a significant bottle neck in this
process, wherein the generation of data has progressed at a quicker rate than methods to
analyse it. In 2010, Elaine Mardis, the co-executive director of the Institute for Genomic
Medicine at Nationwide Children’s Hospital in Columbus Ohio, quipped on the human
genome: ”it’s $1000 genome and a $100,000 analysis” [Mardis, 2010]. It is essential
that this bottle neck is alleviated by using modern computing techniques and systems
to develop methods which allow for high-throughput analysis of the enormous amount of
genomic information which can be generated during genome sequencing projects.
This project aims to utilise computational genome mining techniques on next gen-
eration sequencing data to generate novel diagnostic and genotyping methods for Cryp-
tosporidium spp. The data produced using the methods and tools developed during this
project will aid analysis of transmission of cryptosporidiosis by furnishing epidemiolog-
ical investigations carried out by the national Cryptosporidium Reference Unit, hosted
by Public Health Wales.
1
2 CHAPTER 1. INTRODUCTION
Genome analysis will necessitate the assembly and annotation of genomes using the
most recent tools and pipelines in bioinformatics. The primary aims of this project are:
 Expand the current database of assembled and annotated Cryptosporidium genomes
available to facilitate genome analysis. This will be detailed in Chapter 2.
 Develop novel approaches to identify conserved regions within the genome of Cryp-
tosporidium species and subtypes to direct species identification within clinical sam-
ples or metagenomic datasets, and new genotyping paradigms, to be used by the
Cryptosporidium Reference Unit. This will be detailed in Chapter 3.
 Utilise alignment-free sequence analysis techniques which can be applied to reads to
increase the speed and reduce the computational power required to analyse genomes
for these genomic marker sequences. This will allow such genome mining techniques
to be carried out on laptops and workstation computers, rather than HPC (High
Performance Computing) clusters necessary for genome assembly. This will be
detailed in Chapters 4 and 5.
This project will attempt to use comparative genomics using the methodologies de-
veloped and the NGS data generated to expand our understanding of the population
genomics of genus Cryptosporidium, which will in turn elucidate transmission patterns,
allowing for more accurate tracking of the parasite within a population. The data will
be used to establish mutagenicity of loci within the genome of Cryptosporidium which
can be used to follow transmission of the parasite back to its source, directing prevention
strategies.
This chapter is split into five sections, evaluating and discussing the literature and
examining the cutting edge in each section:
1. The biology, history, clinical importance, and methods of diagnosis of genus Cryp-
tosporidium, with particular focus on genetic differentiation of discrete genotypes
and subtypes.
2. Genome sequencing, with particular emphasis on methods employed to generate
high quality complete genomes from Next Generation Sequencing (NGS) data.
3. Multiplicity of infection (MOI), approaches used to identify in-host pathogen pop-
ulations and the impact it has on public health.
4. Alignment-free sequence analysis, different approaches and how the can be applied
to alleviate the data analysis bottle neck.
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5. Data-structures which can be used in tandem with Alignment-free sequence analy-
sis.
1.1 Genus: Cryptosporidium
Genus Cryptosporidium is a group of parasitic protozoans within the Apicomplexa be-
longing to the novel clade Cryptogregorina. They can most accurately be described as
facultative epicellular Apicomplexans. They are pathogens of a wide range of vertebrates,
causing a mild to significant gastrointestinal condition referred to as cryptosporidiosis.
The parasite has been detected in humans worldwide, but is generally more common in
areas where sanitation is poor, with improper treatment of sewage and drinking water or
where human faeces is used as a fertiliser (’nightsoil’). Cryptosporidiosis is exacerbated in
many developing countries by the lack of available health care and malnutrition; factors
which are known to effect the severity of the disease. However, the problems associated
with treating water for the presence of Cryptosporidium oocysts as well as the prolifera-
tion of C. parvum in ruminants, allowing them to act as a reservoir host, means countries
such as the UK, Ireland, Turkey and Mexico have ongoing problems with local infection.
1.1.1 The Life Cycle of Cryptosporidium
Figure 1.1: The life cycle of C. parvum with hypothesised roles and orgins of the gamont-
like stages. Taken from Clode et al. [Clode et al., 2015].
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Transmission of Cryptosporidium and its status as a parasite with outbreak potential
is due almost entirely to its life cycle, and peculiarities that allow it to persist outside of
a host. These observations are of paramount importance in the development of strate-
gies to tackle cryptosporidiosis. The life cycle of Cryptosporidium (detailed in Figure 1.1)
remains consistent with the standard characteristics of an apicomplexan life cycle; i.e. in-
volves an infective sporozoite stage, merogony, and formation of a zygote by sexual union
between gamete cells. Members of genus Cryptosporidium complete their full life cycle
in one host. However, there are two putative life cycles, accounting for the extracellular,
and epicellular observations of Cryptosporidium.
Figure 1.2: Cryptosporidium parvum oocysts visualised by light microscopy. Image taken
from the Public Health Wales Cryptosporidium information page.
After ingestion of the oocyst (see Figure 1.2) by a suitable host, the oocyst adheres
to the mucous lining of the ileum via surface lectins, whereupon excystation occurs to
release four sporozoites. These sporozoites then discharge their apicle and adhere to the
ileal mucous lining, mediated by mucin-like surface receptors expressed on the apical
organelle (such as gp900 and gp60). The sporozoites release enzymes, breaking down the
mucous lining and allowing for contact with, and infiltration of, the ileal epithelial cells
mediated by receptor-ligand interaction (including Cpa135, TRAP-C1, CS, CP47 and
CP12) facilitating gliding motility [Wetzel et al., 2005]. This interaction induces host-cell
membrane protrusion, encapsulating the sporozoite in a parasitophorous vacuole (PV)
underneath the apical membrane of the host-cell [Valigurová et al., 2008]. Within this
PV, the sporozoites mature into trophozoites; the feeding form. Ultrastructural studies
have shown that the PV forms radial folds at the parasite-cell interface [Valigurová et al.,
2007], generating a feeder organelle referred to as an epimerete. It is this organelle that
allows for extraction of nutrients from the host cell via Myzocytosis. These trophozoites
subsequently undergo merogony to form type I meronts, bearing many type I merozoites.
The type I merozoites are then released, forming into type II merozoites containing a
number of type II merozoites, which in turn are released to undergo transformation into
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the sexual cells; the microgamete (male) and the macrogamete (female). The fertilisation
of a macrogamete by a microgamete forms a single thick walled oocyst, which is passed out
of the host. The extracellular stages involve formation of a vacuoles around the sporozoite
in the ileal lumen, facilitating transformation into the trophozoite stage. During this
extracellular life cycle, trophozoites may undergo syzygy; a pairing of two trophozoite
stages necessary in the formation of the enigmatic gamont-like stages (although this is
a hypothetical origin), a characteristic of gregarines (in which these stages are referred
to as gametocysts). The function of Cryptosporidium syzygy has not been conclusively
elucidated, though it has been hypothesised that it it has a role in the generation of more
trophozoites or merozoites, facilitating oocyst production in host-cell free environments,
such as in aquatic biofilms [Borowski et al., 2008, Clode et al., 2015, Koh et al., 2013, Koh
et al., 2014].
1.1.2 A Historical Perspective on Cryptosporidium
Cryptosporidium was first described by Tyzzer in 1907, whereupon the atypical nature
of this coccidian was noted. The attachment organelles, lack of sporocysts and presumed
life-cycle were of particular note and value in its taxonomic classification. The genus
name was given to signify the presence of naked sporocysts (Cryptosporidium: literally
’hidden spores’). The morphology of the oocyst, presence of attachment organelles, the
extracytoplasmic nature of the parasite, the observation that unshed oocysts can elicit
autoinfection within the host and (later noted) their complete insensitivity to anticoccidial
drugs made Cryptosporidium an atypical example of a coccidian. It was consequently
placed in family Asporocystidae [Tyzzer, 1907]. Traditionally the characteristics used to
identify and name novel species belonging to the Apicomplexa has been host specificity,
location of endogenous life stages and morphology of the various life stages. Tyzzer
applied these in forming the species nomenclature of Cryptosporidium, which lead to
him describing C. muris, representing its identification within the gastric glands of mice.
The study of Cryptosporidium following its description was considered that of curious
endeavour rather than being driven by medical necessity. As is so common in classical
protozoology, the convention of describing and naming new species based on the host in
which they were found persisted, leading to the description of C. agni in sheep [Barker
and Carbonell, 1974], C. bovis in cattle and C. garnhami or C. enteritidis in humans
[Fayer, 2010]. However, because of the lack of taxonomic data, many of these novel
species could not be clearly distinguished from others leading to their names becoming
invalid. It became quickly clear that morphological characterisation alone was not enough
to distinguish the species within genus Cryptosporidium, beyond observations on oocyst
size, due to their extreme similarity. Because of this, from the 1970’s through much of the
1990’s, species distinction was based entirely on their bearing ’large’ or ’small’ oocysts,
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and consequently only two species were consistently described; C. muris and C. parvum,
bearing large and small oocysts respectively. It was generally considered that a single
species could be found in the gastric glands of mice, as described by Tyzzer (C. muris),
and that all other mammals exhibited C. parvum. It was not until the emergence of
HIV/AIDS that Cryptosporidium became of medical importance, due to its pathogenicity
among immunosuppressed individuals. A review by Casemore et al. reported 71 cases of
Cryptosporidium in immunosuppressed individuals, and an association was established
between bovine and human infection for the first time [Casemore et al., 1985]. Casemore
and Jackson also proposed a hypothesis in which human cryptosporidiosis is not entirely a
zoonosis, which lead to the elucidation of two distinct transmission cycles [Casemore and
Jackson, 1984]. This was confirmed using molecular methodologies which eventually lead
to the description of the human species; C. hominis as distinct from C. parvum [Morgan-
Ryan et al., 2002]. The advent of the use of genetic and molecular data in species
identification lead to the reinterpretation of the genus and its constituents, leading to C.
parvum being split into a number of different distinct species [Nader et al., 2019].
Figure 1.3: Phylogenetic relationships of the alveolates inferred from concatenated protien
sequences containing 10,753 amino acid positions. Tree taken from Templeton et al.
[Templeton et al., 2010]
Reservations in the placement of Cryptosporidium amongst the coccidians began to
show when Bull & Chalmers et al. observed cross-reactivity of anti-Cryptosporidium
monoclonal antibodies with sporocysts of the gregarine Monocystis from faecal speci-
mens of small mammals in the UK [Bull et al., 1998]. Further evidence that all was not
as previously thought with the membership of Cryptosporidium as a coccidian arose when
advances in our understanding of its life cycle and morphology suggested that the may
bear closer ancestry with the gregarines. Support for this was presented when molecular
studies consistently illustrated a separation between the coccidia and Cryptosporidium
[Morrison and Ellis, 1997, Carreno et al., 1998] and their position within a clade populated
by the gregarines [Carreno et al., 1999, Leander et al., 2003]. Gregarine-like gamonts,
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syzygy and spores bearing eight sprozoites which closely resembled those in gregarines
were demonstrated in Cryptosporidium using ultrastructural analysis of the extracellular
stages [Rosales et al., 2005]. Genetic studies have contributed a great deal of data in the
elucidation of the confusing world of Cryptosporidium taxonomy, illustrating a disparity
between codon usage in C. parvum and the Eimeriorines; Toxoplasma gondii and Eme-
ria tenella, but a surprisingly high parity between that and other members of phylum
Apicomplexa; Plasmodium falciparum, Babesia bovis and Theileria parva, as well as to
the amoeba; Entamoeba histolytica [Char et al., 1996]. The largely intronless structure
of the C. parvum genome also provided support for the evolutionary distinction between
this genus and other members of the coccidia clade [Spano and Crisanti, 2000]. In 2014,
a large scale revision of the Sporozoans by 18S rDNA analysis by Cavalier-Smith placed
Cryptosporidium in a novel subclass; Orthogregarina, along with protozoans which are
closely related to this genus (see Figure 1.3) [Cavalier-Smith, 2014]. In 2016 Ryan et al.
discussed the re-appraisal of Cryptosporidium as a gregarine and the supporting evidence
and its implications on the water industry [Ryan et al., 2016].
1.1.3 Cryptosporidiosis
Cryptosporidiosis is a disease of humans affecting the small intestine, leading to acute
gastroenteritis. There are approximately 6000 new cases of human cryptosporidiosis re-
ported every year in the UK, with focal points of outbreaks clustering around April and
August for C. parvum and C. hominis respectively. It is a significant cause of diarrhoeal
disease globally, with potentially dire consequences for young children in the third-world,
where access to healthcare is poor and malnourishment rife, and immunosuppressed in-
dividuals. At least ten of the currently identified Cryptosporidium species have been
detected in humans, with 7 species (C. hominis, C. parvum, C. meleagridis, C. felis,
C. viatorum and C. cuniculus) being capable of causing disease in humans. It bears a
faecal-oral route of infection which necessitates contact with the infectious agent, includ-
ing an infected animal, waters (such as swimming pools and freshwater lakes or rivers),
and ingestion of contaminated food or water. Contaminated water supplies constitute
a major infective risk, leading to the potential for epidemics to arise. Koh et al. have
documented the potential for Cryptosporidium to reside suspended in biofilms, whereby
oocysts may be trapped and reintroduced into a water supply as well as acting as a nu-
trient rich medium within which the parasites may undergo an extracellular lifecycle and
proliferate [Koh et al., 2013, Koh et al., 2014], though this has yet to be demonstrated in
natural water pipes. This potential for large scale outbreaks of cryptosporidiosis makes
it a public health risk of significance outweighing that implied by the small number of
cases relative to other gastroenteritis’ such as Salmonella, Campylobacter and E. coli.
This is illustrated by the Milwaukee outbreak of 1994, where 403,000 people fell ill with
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cryptosporidiosis, with 19 mortalities. The source was tracked to a contaminated water
supply [Eisenberg et al., 2005]. Person to person infection remains a significant risk in
areas where sanitation and hygiene are lacking.
The clinical presentation of cryptosporidiosis varies depending on the hosts immuno-
competence and nutrition. In both cases there is diarrhoea, with the majority of immuno-
competent people experiencing abdominal pain and vomiting and around half suffering
from a fever. In otherwise healthy individuals, cryptosporidiosis is self limiting, usually
resolving within two weeks. In immunocompromised individuals the disease is often se-
vere, with morbidity and mortality greatly increased. Sufferers of T-cell deficiency are
in the highest risk category, such as those with haematological cancers, T-cell deficien-
cies such as CD40 ligand deficiency and severe combined immunodeficiency (SCID), and
late stage HIV patients with low CD4 lymphocyte counts. In these cases the diarrhoea
is more severe, often transient and chronic in a similar fashion to cholera resulting in
severe weight loss. The disease may involve the biliary tract and respiratory system,
which is potentially intractable and of devastating consequence. Damage to the gas-
trointestinal system and bronchial tree may be extensive, with dilation of the bile duct
and gall bladder, and generalised inflammation presenting as pancreatitis, cholecystitis
and sclerosing cholangitis. Recrudescence of cryptosporidiosis is a possibility in these
cases, as the parasite may inhabit the billiary ducts through treatment and re-emerge
to cause clinical disease. With this in mind, correct treatment regimes is of paramount
importance of effective clearance of the parasite. A rare complication of cryptosporidiosis
in late stage HIV patients is pneumatosis cystoides intestinalise, in which gas containing
cysts form within the gut wall and subsequently rupture, causing pneumoretroperitonium
and pneumomediastinum [Hunter and Nichols, 2002, Sivarajah et al., 2013]. In severely
affected immunocompromised individuals, standard drug treatment in the US (Nitazox-
onide administration) has been shown to lack effective efficacy, which limits the clinician
to attempting to improve the hosts immune condition to combat infection, an approach
which has seen success. In late stage HIV patients, this takes the form of aggressive
antiretroviral therapy [Chalmers and Davies, 2010]. Due to the problems associated with
the treatment of the most severe cases of cryptosporidiosis, emphasis has been put on
prevention, which necessitates close monitoring of incidents and data collection on the
spread of the disease, as well as consistent monitoring of drinking water sources for the
presence of Cryptosporidium oocysts.
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1.1.4 Cryptosporidium Genomics: the Journey to the Genome
1.1.4.1 Sequencing the Cryptosporidium Genome
In the late nineties, the importance of C. parvum and C. hominis in public health lead
the National Institute of Allergy and Infectious Diseases (NIAID) to fund a consortium
comprising of the University of Minnesota, Virginia Commonwealth University and Tufts
University to sequence the genome of these human-infective species. Molecular tools
(Restriction Fragment Length Polymorphism and other genotyping methods) illustrated
that human infection was caused primarily by two genotypes [Widmer and Sullivan,
2012]. Since then, the generation of whole genome sequences of members of genus Cryp-
tosporidium has become more streamlined and faster due to a significant progression in
the development of DNA sequencing tools and methodologies.
Attempts to sequence the genome of Cryptosporidium began in the early 2000’s. Initial
attempts involved cloning sheared fragments into plasmid vectors and Sanger sequenc-
ing. This approach resulted in > 9x coverage of the genome and yielded a fragmented
assembly of 221 contigs of length > 5kbp. A more advanced sequencing project was
undertaken to resolve gaps, using large C. parvum fragments contained within lambda
DASH II libraries, and sequence missing DNA using a primer walk strategy [Widmer
et al., 2002]. The completed genome of C. parvum (IowaII) along with a preliminary an-
notation was first published in 2004 by Abrahamsen et al. by passaging oocysts through
an animal donor to produce enough parasitic material for the extraction and purification
of sufficient amounts of DNA. A random shotgun sequencing approach was used, which
yielded a complete genome with coverage of 13x over 18 large contigs [Abrahamsen et al.,
2004]. This was shortly followed by the publication of the first draft genome of C. ho-
minis (TU502) in late 2004. However, this genome proved to be much more fragmented
than that of C. parvum, resulting in a sequence consisting of 1422 contigs [Xu et al.,
2004]. In 2015, the C. parvum (IowaII) reference genome was reannotated, and a new C.
hominis reference genome (UdeA01) published. This reannotation effort increased the
number of putative genes from 3807 to 3865 for C. parvum IowaII, and predicted the
presence of 3819 genes in C. hominis UdeA01 [Isaza et al., 2015]. In 2016, Ifeonu et
al. reassembled and reannotated the C. hominis TU502 genome, along with producing
new draft genomes of human isolated C. hominis (UKH1) and C. meliagridis (UKMEL1)
along with the avian species C. baileyi (TAMU-09Q1). The C. hominis TU502 genome
proved to be a considerable improvement on the previous 2004 version, being much more
complete, and reducing the number of contigs down to 119. Annotation was facilitated
by the RNAseq data generated from the oocyst stage of both C. hominis & C. baileyi,
predicting the presence of 3745 protein coding genes in C. hominis TU502 and 3765 in
C. hominis UKH1 [Ifeonu et al., 2016].









sion no or Reference)
C. alticolis 5.4× 4.9 Voles No No
C. apodemi 4.2× 4.0 Mice No No
C. andersoni 7.4× 5.5 Cattle Yes (rarely) PRJNA354069
C. avium 6.3× 4.9 Birds No No
C. baileyi 6.2× 4.6 Birds No PRJNA222835
C. bovis 4.9× 4.6 Cattle Yes (rarely) No
C. canis 5.0× 4.7 Canids Yes (occasionally) No
C. cuniculus 5.6× 5.4 Lagomorphs, Hu-
mans
Yes (occasionally) PRJNA315496
C. ditrichi 4.7× 4.2 Mice Yes (rarely) No
C. ducismarci 5.0× 4.8 Tortoises No No
C. erinacei 4.9× 4.4 Hedgehogs Yes (rarely) No
C. fayeri 4.9× 4.3 Marsupials Yes (rarely) No
C. felis 4.6× 4.0 Felids Yes (occasionally) No
C. fragile 6.2× 5.5 Toads No No
C. galli 8.3× 6.3 Birds No No
C. homai Data not available Guinea Pigs No No





C. huwi 4.6× 4.4 Fish No No
C. macropodum 5.4× 4.9 Marsupials No No
C. meleagridis 5.2× 4.6 Birds, mammals Yes (occasionally) PRJNA222838 PRJNA315503
PRJNA315502
C. microti 4.3× 4.1 Voles No No
C. molnari 4.7× 4.5 Fish No No
C. muris 7.0× 5.0 Rodents Yes (rarely) PRJNA32283 PRJNA19553
C. occultus 5.2× 4.9 Rodents Yes (rarely) No









C. proliferans 7.7× 5.3 Rodents, maybe
Equids
No No
C. proventriculi 7.4× 5.7 Birds No No
C. rubeyi 4.7× 4.3 Squirrels No No
C. ryanae 3.7× 3.2 Cattle No No
C. scrofarum 5.2× 4.8 Pigs Yes (rarely) No
C. serpentis 6.2× 5.3 Reptiles No No
C. suis 4.6× 4.2 Pigs Yes (rarely) No
C. testudinis 6.4× 5.9 Tortoises No No
C. tyzzeri 4.6× 4.2 Rodents Yes (rarely) No
Table 1.1: The currently discovered and documented human and animal Cryptosporidium
species [Morris et al., 2019c].
1.1. GENUS: CRYPTOSPORIDIUM 11
The extraction of DNA from Cryptosporidium has long been a confounding issue for
biologists, since the DNA yield from oocysts is low. Consequently, in order to obtain
sufficient amounts of genomic DNA, a great number of oocysts must be extracted and
cleaned prior to DNA extraction, or the DNA enriched. This has lead to attempts to
culture oocysts in vitro, obviating the need for a host, which has seen little success. In
addition, it was not until 2018 that a method for storing Cryptosporidium infective mate-
rial in cryostatic conditions was developed. This method involved vitrification (ultra-fast
cooling) of Cryptosporidium oocysts in a microcapillary, which exhibit high viability, and
infectivity to interferon-γ-mice after several weeks [Jaskiewicz et al., 2018]. However, this
has not been verified for longer periods of storage, and has only been demonstrated as
applicable in very small quantities of oocysts, making it currently unviable for large-scale
application. There are consequently no methods which allow for indefinite storage of
large quantities of oocysts, which means there is a requirement for the serial passaging
of isolates through host animals to propagate the parasite. Due to the sexual nature
of the Cryptosporidium life cycle and a known propensity for certain loci (notably the
gp60/cgd6 1080 locus) to recombine, this may lead to a destabilisation and variation of
the subtype, a potential confounding variable if these isolates are to be used for genomic
study. Hijjawi et al. reported success in long-term culturing (up to 25 days) of Cryp-
tosporidium in cell culture using pH modification sub-culturing and gamma irradiation
[Hijjawi et al., 2001]. Complete development of Cryptosporidium in vitro was reported by
Hijjawi et al. in 2004, where new oocysts were reportedly present after 8 days after being
inoculated into a culture devoid of host cells. This represents the first reported case in
which Cryptosporidium has been shown to multiply, develop and complete its life cycles
without the need to infiltrate and infect host cells [Hijjawi et al., 2004]. However, these
results have yet to be verified independently or applied on any significant scale to aid re-
search in this area. In 2018, a new method of culturing Cryptosporidium oocysts in vitro
was detailed by Miller et al. This method involved the infection of COLO-680N cells,
which proved a sufficient method to yield enough oocysts to inoculate further COLO-
680N cell lines. The authors reported an increase in the number of oocysts from the
initial inoculation, verified by microscopy and molecular techniques [Miller et al., 2018].
Despite these results, this method has also resisted attempts at independent verification.
The development of a verified, scalable, and entirely in vitro technique for the culture
of Cryptosporidium oocysts would represent a major step in Cryptosporidium research.
Such a method would allow for the application of modern molecular and cell-biology tech-
niques, accelerating research into host-parasite interaction, virulence, and the develop-
ment of novel therapeutic agents, laying the foundation for a new era of Cryptosporidium
research.
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The problem associated with DNA extraction of Cryptosporidium was addressed by
Hawash (2014) who observed this problem in comparison to DNA recovery of cysts of
other parasitic protozoans (Entamoeba histolytica and Giardia sp.) isolated from stool
samples. He modified the QIAmp DNA Stool Mini Kit (Qiagen) protocol, leading to
an increased sensitivity and specificity from 60% to 100% of samples testing positive for
the presence of Cryptosporidium DNA [Hawash, 2014]. In 2015, Hadfield et al. devel-
oped a novel method of Immunomagnetic Seperation (IMS) of oocysts obtained from
faecal samples which dramatically increased the quality of Cryptosporidium DNA ob-
tained from stool samples, reducing the amount of contaminant DNA [Hadfield et al.,
2015]. This allowed for extensive comparative genomic analysis of clinical isolates, which
was not previously possible. The problems associated with poor DNA yield from clin-
ical samples were tackled in 2015 by Guo et al., who used whole genome amplification
(WGA) to enrich Cryptosporidium DNA from 6 discrete species/genotypes extracted
from 24 faecal samples from humans and animals. The results were encouraging, showing
that Cryptosporidium DNA was significantly enriched, allowing for coverage of > 94% of
the Cryptosporidium genome [Guo et al., 2015a].
Recently, there have been attempts to generate sequences using long read technology,
such as MinION by Oxford Nanopore, and Pacific Biosciences. There exist a few draft
genomes (published and unpublished) from long reads generated by PacBio. In 2018,
Gilchrist et al. explored the genetic diversity of C. hominis using long reads generated
by PacBio sequencing [Gilchrist et al., 2018]. The Kissinger Research group at Geor-
gia university are also attempting to produce a high quality PacBio assembly, and the
Welcome Trust, Sanger Institute generated a set of PacBio reads which are as yet un-
published. Currently, there have been no successful attempts at sequencing the genome
using the MinIon platform. This is likely due to the large amount of DNA required to
generate such reads using this technology, which is a known difficulty associated with
Cryptosporidium genome sequencing.
With the advent of these novel methodologies to generate high quality genomes from
clinical samples, there comes an opportunity to greatly expand the number of genomes
available. The online Cryptosporidium genomics resource http://cryptodb.org/cryptodb/,
provdes access and analytical tools to C. hominis TU502 and UdeA01 and other C. homi-
nis genomes, C. parvum Iowa II and human-adapted C. parvum, other zoonotic species
including C. meleagridis, and host-adapted species rarely found in humans (C. muris, C.
andersoni, C. baileyi, and C. tyzzeri). To date, genome assemblies from 39 isolates of
human and animal Cryptosporidium and are available on GenBank in various states of
assembly and annotation (see Table 1.1). 68 paired end read libraries are also available
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with 62 of these having been produced by The Welcome Trust Sanger Institute during a
pilot study sequencing Giardia and Cryptosporidium (Accession: PRJEB3213).
1.1.4.2 The Cryptosporidium Genome
C. parvum Iowa II C. hominis UdeA01
Number of genes 3865 3819
Mean gene length (bp) excluding introns 1783 1784
Percent coding 75.7 75.4
Genes with introns (%) 10.8 10.9
exons
Number 4553 4503
Mean length (bp) 1514 1514
Mean number per gene* 2.6 2.6
G + C content (%) 32 32
introns
Number 688 684
Mean length (bp) 99 100
G + C content (%) 22 22
Intergenic regions
G + C content (%) 25 25.2
Mean length (bp) 552 563
tRNAs 45 45
Annotation
Genes with EC code 502 498
Number of unique EC code 207 206
Genes with GO terms 2030 2026
Number pf unique GO terms 967 968
Numner of unique PFAM domains 1969 1982
Number of unique SCOP superfamilies 1667 1677
Table 1.2: Summary of general statistics for the C. parvum Iowa II and C. hominis
UdeA01 reference genomes taken from Isaza et al. 2015. C. parvum and C. hominis
comprise the vast majority of cases of human cryptosporidiosis, and therefore are consid-
ered the most important species in global public health.
The genome of Cryptosporidium parvum (according to the Iowa II reference genome
[Abrahamsen et al., 2004]) and Cryptosporidium hominis (according to the UdeA01 ref-
erence genome [Xu et al., 2004]) are approximately 9.1 mbp in size, arranged into 8
chromosomes, and with a genomic GC content of roughly 30%. C. parvum Iowa II ex-
hibits 3,865 genes with a mean length of 1783 (excluding introns), of which 75% are
coding. C. hominis UdeA01 exhibits 3,819 genes with a mean length of 1784 (excluding
introns) of which 75.7% are coding. The dramatic absence of introns within the genome
of Cryptosporidium is of particular note, with only 10.9% of genes bearing introns in the
Iowa II C. parvum reference genome, and 10.9% in C. hominis UdeA01 [Isaza et al., 2015].
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As can be seen in Table 1.2, there is little difference between the genomes of C.
parvum and C. hominis. They exhibit 95-97% DNA sequence identity; with 11 protein-
coding sequences identified only in C. hominis and 5 in C. parvum, and no large indels
or rearrangements apparent [Widmer and Sullivan, 2012]. Cryptosporidium has, like
the other gregarines, lost its apicoplast. C. parvum and C. hominis both exhibit a
degenerate ’mitosome’ in place of mitochondrion and consequently lack a mitochondrial
genome and nuclear genes for many mitochondrial proteins, including but not limited
to those required for the tricarboxylic acid (TCA) cycle, oxidative phosphorylation and
fatty acid oxidation [Ryan and Hijjawi, 2015]. Genomes released by Abrahamson et
al. and Xu et al. indicate that the genes for de novo biosynthesis of amino acids,
nucleotides, sugars and mechanisms for gene silencing and RNA splicing are all absent
[Abrahamsen et al., 2004, Xu et al., 2004]. It appears to be this loss of genes associated
with metabolic biosynthesis that influences the parasitic nature of C. parvum and C.
hominis, necessitating their reliance on acquiring nutrients from the host. The high
conservation in the C. hominis genomes generated from European samples compared
to the much more polymorphic C. parvum does not appear to be expressed in general
observations on structure and base representation as illustrated in Table 1.2, suggesting
that the variation is primarily exhibited within the sequence itself. This further illustrates
the importance of large scale sequence comparison of Cryptosporidium species to elucidate
potentially exploitable variation. Widmer et al. identified a number of highly divergent
genes by comparison of the genomes of C. parvum gp60 subtype IIc and the Iowa reference.
Furthermore they reported that within this set of genes, transporters were highly over-
represented, which lead them to conclude that these transporters may have a significant
role in the ability to establish infection in the host species, potentially due to their
importance in controlling the movement of metabolites between the parasite and the
host cell during the epicellular developmental stages [Widmer and Sullivan, 2012, Widmer
et al., 2012].
1.1.4.3 Mining the Cryptosporidium Genome for Diagnostic Purposes
The differentiation of Cryptosporidium spp. isolates has been attempted using a vari-
ety of methodologies, including single locus sequence typing, single nucleotide polymor-
phism, restriction fragment length polymorphism, amplification of random loci within
the genome, conformational polymorphism, simple sequence repeats and DNA polymor-
phism. Using the data provided by these genomic methodologies, a great deal of informa-
tion was yielded pertaining to the taxonomy of the genus, leading to the characterisation
of two separate species within populations of anthropopathogenic isolates: Cryptosporid-
ium parvum and Cryptosporidium hominis.
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Gp60 typing is the most widely accepted and applied method with which to identify
discrete Cryptosporidium spp. subtypes. This typing approach involves the interrogation
of the partial sequence of a polymorphic sporozoite surface glycoprotein gene (the gp60
locus). Specifically it is based on the number of ’TCA’ repeat units within the gp60
locus and the sequence downstream of this tandem repeat region. The naming conven-
tion involves differentiating species by a roman numeral (I for C. hominis and II for
C. parvum), a lower case letter denoting a discrete genotype within the species, upper
case alphanumeric strings denoting the number of copies of the repeated sub-sequence
within the gp60 tandem repeat locus [Widmer and Lee, 2010]. For example, the subtype
IIaA15G2R1, refers to a C. hominis subtype (II), belonging to genotype ’a’, and bearing
15 TCA sequences (A15), 2 TCG sequences (G2), and 1 further non TCA/TCG sequence
denoted by ’R1’.
Thus far, gp60 subtyping has been the most effective and productive approach to
subtyping in C. parvum and has lead to the characterisation of new species, reevaluation
and resolution of phylogenetic relationships and elucidation of cryptosporidiosis epidemi-
ology. However, it is known that C. hominis does not effectively segregate according
to gp60 locus sequence typing, and is therefore not viable as an alternative subtyping
methology to multi-locus subtyping (MLST) (Widmer & Lee, 2010). Despite these ad-
vances, this approach remains a single locus genotyping methodology which is made less
reliable in light of fact that Cryptosporidium populations of distinct subtypes are known
to recombine, particularly around the gp60 region, which may be related to its relevance
as a virulence factor [Guo et al., 2015b]. In 2018, Gilchrist et al. carried out a study of
the genetic diversity of C. hominis in slum dwelling infants in Dhaka, Bangladesh, over
a two year period. They found that C. hominis was more abundant during the monsoon
periods, and exhibited very high levels of diversity at 7 discrete loci, including the gp60
locus. They also detected high levels of recombination, evidenced by linkage disequilib-
rium decay. The genetic diversity of C. hominis encountered in this study was found
to be far greater than that seen in Europe, where the C. hominis genome is conserved.
This study reveals both the capacity of C. hominis to recombine at the gp60 locus, and
the importance of high-throughput, wide scale genomic sequencing and analysis in eluci-
dating the complex population structure of this parasite worldwide [Gilchrist et al., 2018].
These weaknesses highlight the need to develop a multilocus subtyping methodology
for the genus. However, attempts to do so have not lead to a consensus on which target
loci to use for interrogation [Widmer and Lee, 2010]. The shortfallings of gp60 locus
variation as a subtyping paradigm highlight the need for further analysis of the genome
of multiple species and isolates of Cryptosporidium to identify novel genomic biomarkers.
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Multi-locus typing approaches are acknowledged to improve resolution over single
locus subtyping, particularly in the case of Cryptosporidium, where potentially confound-
ing genetic recombination due to sexual reproduction is commonplace [Guo et al., 2015b].
A meta-analysis by Robinson & Chalmers (2012) investigated published literature to iden-
tify the most informative markers as candidates for the development of a standardised
multi locus fragment size-based typing (MLFT) scheme for the purpose of augmenting
epidemiological analysis. They collated 31 MLFT studies which reported 55 markers, of
which 45 were applied to both C. parvum and C. hominis. Within the identified studies,
the critical number of markers to identify 95% of all MLFTs was elucidated, illustrating
that in both species, there was some marker redundancy (C. hominis : 40%, C. parvum:
27%). The authors then investigated the most informative theoretical combinations by
ranking the markers. Two sets of markers were developed (one for each species), which
would be evaluated for viability as MLFT schemes [Robinson and Chalmers, 2012].
In 2010, Widmer & Lee investigated whether multi-locus genotypes of C. parvum and
C. hominis cluster according to the gp60 subtype. It was found that interrogation of the
gp60 locus alone (gp60 subtyping) was not a suitable replacement for a MLST approach
in all cases for C. hominis and the majority of cases for C. parvum [Widmer and Lee,
2010]. However, since the gp60 locus is associated with host cell invasion, and therefore
can be considered a virulence factor, it may still be an appropriate target for interrogation
as a phenotype determining biomarker.
During outbreaks of C. hominis in Europe, isolates bearing the gp60 allele IbA10G2
predominate cases of clinical infection [Hadfield et al., 2015]. MLST has been shown to
be, as yet, entirely ineffective due to a lack of suitable polymorphism in loci between
isolates. In contrast, there appears to be a great deal of variation between European
isolates of C. parvum, supporting the use of a Multi-locus genotyping scheme. Conse-
quently, much more importance has been put on C. parvum genotyping, driving research
into genetic diversity of this species and its role in transmission.
In 2015 Widmer & Caccio investigated the relationship between sequence and length
polymorphism within a set of biomarkers in the Cryptosporidium genome. They com-
pared genetic distances of sequence and length polymorphism, finding that there was a
weak correlation between the two distance measures. Their results also indicated that
the resolution of Cryptosporidium population structure was dependant on the genotyping
method used [Widmer and Cacciò, 2015].
The state of Cryptosporidium genotyping is far from resolved, and these publications
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indicate that there is still a large amount of work to be done regarding the discovery,
assessment, and selection of suitable biomarkers and genotyping conventions.
1.2 Multiplicity of Infection: An Extra Dimension in
Epidemiology
Multiple populations of pathogen species within a single host is a well documented ob-
servation within the natural world. It has been reported that the majority of infections
consist of multiple parasite species or discrete genetic lineages. In 1999, Lord et al.
reported that the majority of adults infected with Plasmodium falciparum were host to
more than five distinct strains [Lord et al., 1999]. Grinberg et al. reported the presence of
a number of sub-populations within single isolates of Cryptosporidium parvum by cloning
PCR amplicons of two loci which are known to be highly polymorphic (gp60 & HSP70),
and utilising Next Generation Sequencing (NGS). They demonstrated the presence of
two HSP70 and 10 gp60 alleles within their two isolate dataset [Grinberg et al., 2013].
Similarly, Troell et al. attempted to elucidate these putative intra-isolate sub-populations
by using a combination of single-cell sequencing and DNA enrichment by whole genome
amplification. Using this protocol they sequenced 10 single oocysts, resulting in assem-
blies of 49.4 - 91.8% of the size of the C. parvum IowaII reference genome [Abrahamsen
et al., 2004]. Using these genomes, the authors detected variation at multiple loci be-
tween the assembled genomes, verifying the presence of discrete populations within the
isolate [Troell et al., 2016]. It is worth noting, however, that each oocyst contains 4
sporozoites, and therefore 4 copies of the genome. In oocyst genetic heterogeneity has
been suspected [Grinberg et al., 2013], and adds another layer of ambiguity to the results
of whole genome analysis and epidemiological surveys.
Multiple infections have a significant impact on the incidence and spread of parasites,
along with their virulence. These factors have been acknowledged to be of enormous im-
portance to public health. An incomplete understanding of the subtypes and genotypes
of a parasite within a host leads to potentially inaccurate assumptions about the clin-
ical presentation and outlook of the infection. Efforts have been made which illustrate
that there exist general patterns when ecological and evolutionary theory are applied to
within-host dynamics, leading to the generalization that ”basic ecological rules govern
the outcome of co-infection across a broad spectrum of parasite taxa” [Graham, 2008].
Graham et al. carried out a meta-analysis of helmith-microparasite coinfections, which
demonstrated that, as in ecology, the abundance or limitation of key resources (nutri-
ents) were a key factor governing in-host population size, as did host immune response
[Graham, 2008].
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The virulence (defined here as ’the capacity of the parasite to reduce host fitness’)
experienced by a host infected by multiple subtypes/genotypes of a parasite (often re-
ferred to as ’overall virulence’) is a result of the interactions between the different sub-
populations within the host, resulting in an overall virulence of anywhere from greater
than the most virulence to less than the least virulent, depending on various biological
factors [Seppälä et al., 2009, Seppälä et al., 2012]. It has been argued, by Alizon et
al., that overall virulence cannot be used to predict virulence evolution. Instead, they
suggest that detailing how the presence of multiple sub-populations affects the duration
of infection, and transmission of the genetically discrete sub-populations is far more of
a driving factor in virulence evolution. The evolution of virulence is a complex issue,
governed by a wide array of host-parasite and in-host parasite-parasite interactions, and
between-host transmission of discrete parasite populations [Alizon et al., 2013].
Because of a lack of scalable, high-throughput techniques to investigate and charac-
terise Multiplicity of Infection (MOI), our understanding of the evolutionary consequences
of this phenomenon is poor. Previously, this has lead to many public & animal health
policies underestimating, or failing to take into account the impact of MOI [Read and
Taylor, 2001, Balmer and Tanner, 2011].
1.3 Genome Analysis
1.3.1 Whole Genome Sequencing, Assembly, Improvement and
Annotation
Sequence assembly can be split into two major categories: de novo assembly, and mapped
assembly.
1.3.1.1 De novo Assembly
De novo assembly is a manner by which a sequence is assembled from NGS reads by the
application of an algorithm, without a reference genome. Two of the most widely used
assembly algorithms are the de Bruijn graph (DBG), and overlap layout consensus (OLC).
De Bruijn graph assembly involves a graph algorithm based on leveraging the kmer
content of each read. Using overlapping kmers, a walk can be carried out to find overlap-
ping reads, which in turn can be used to assembly longer contiguous sequences (contigs).
This approach of digesting reads into smaller sequences (kmers) solves problems intro-
duced by differing read lengths.
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Overlap Layout Consensus is another graph based algorithm which utilises, as
the name suggests, three major phases: overlap, layout and consensus. The initial phase
involves calculation of sequence overlap between each read. These are then arranged ac-
cording to these calculations to form contiguous sequences. During the consensus phase,
each base within a read is assigned a quality score dependant on the depth of coverage
for that base in the read library, i.e. if that base is sequenced 60 times (x60 depth) and
59 of those times the base is sequenced as Adenine, we can say that this base is Adenine
with a high degree of certainty. Using this logic, OLC assembly algorithms form contigs
by calculating the consensus for each base at each position of the genome.
There are a multitude of other assembly algorithms, such as the Greedy algorithm,
which finds optimally overlapped reads to produce contigs, and Hybrid techniques, which
utilise a mixture of other algorithms.
The unbiased nature of de novo assembly may pose a problem if the objective is to
assemble the genome of a single organism, since contaminant DNA will also be assem-
bled into contigs in an identical manner. It is therefore necessary either that ’cleaning’
should be done on either the samples pre DNA extraction (in vitro using processes like
immunomagnetic separation and bleaching, which has been used by Hadfield et al (2015)
to clean Cryptosporidium oocysts extracted from stool samples [Hadfield et al., 2015])
or the reads prior to assembly (in silico using tools such as Kontaminant [Leggett et al.,
2013, Daly et al., 2015]) to reduce the amount of contaminant sequence. Popular de novo
assemblers include SPAdes [Bankevich et al., 2012], Velvet [Zerbino and Birney, 2008],
MaSuRCA [Zimin et al., 2013], SOAPdenovo [Li et al., 2010] and ABySS [Simpson et al.,
2009].
1.3.1.2 Mapped Assembly
Mapped assembly involves an alignment-consensus algorithm, whereby WGS reads are
initially aligned to a (putatively similar) reference genome. This alignment is used to
guide the assembly of the new genome. It is much faster than de novo assembly due to
it obviating the need to carry out the intensive overlap step. Scaffolding also becomes
unnecessary due to the reference guiding the structure of the new genome. However,
problems arise when the reference genome is divergent from, or there is recombination or
restructuring of, the genome being assembled.
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Figure 1.4: The workflow of genome improvement in the PAGIT pipeline, illustrating
the function of the four components: ABACAS, IMAGE, ICORN & RATT [Swain et al.,
2012].
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1.3.1.3 Genome Improvement
Genome improvement is a fundamental aspect of assembly. In the past, curation of
genomes of great importance (such as the human genome, Escherichia coli or Saccha-
romyces cerevisiae) has been undertaken manually by dedicated teams of researchers,
involving a great deal of time and effort. However, this is an intensive, costly and time
consuming process that is not viable for the majority of genome projects. Consequently
automated improvement has become of great importance to attempt to improve the
quality of assemblies in an attempt to bring it up to the standard of manually curated
genomes. The main objectives of genome improvement involve gap closure, error cor-
rection and utilising reference guided assemblers and highly similar genomes to improve
scaffolding and annotation. The Post-Assembly Genome-Improvement Toolkit (PAGIT)
[Swain et al., 2012], developed by The Welcome Trust Sanger Institute, utilises a num-
ber of tools to improve the quality of and annotate assemblies. PAGIT consists of four
components: ABACAS, IMAGE, ICORN and RATT. The function of these components
are genome reference based genome structuring, gap closure, error (indel) correction, and
annotation respectively (see Figure 1.4). ABACAS is used to map the contigs produced
by de novo assembly to a reference genome of high similarity (95-99%), where it will
exploit the structure and conformation of the reference assembly to produce a similarly
structured assembly, whilst plugging gaps within the new assembly with ’N’-spaces. The
fastq paired end reads are then used to attempt to close these gaps by aligning them in
such a fashion that they overhang and extend into the N-space. ICORN utilises iterative
mapping of reads onto the consensus sequence to identify putative errors (SNP’s or indels
of up to 3bp). It then measures the change in read coverage that would result from the
correction, and if there is no reduction it is presumed that the new sequence is correct
and the correction is incorporated into the assembly. ICORN utilises SSAHA to perform
read mappings and the SSAHA pileup pipeline to identify SNP’s and indels <=3bp [Ning
et al., 2001]. Provisional corrections are then evaluated using SNP-o-matic [Manske and
Kwiatkowski, 2009]. In 2016, they updated PAGIT and made it available as a web server
for the pseudochromosome contiguation (using ABACAS2: an updated version of the
previously described ABACAS), annotation and analysis of parasite genomes [Steinbiss
et al., 2016].
1.3.1.4 Genome Annotation
Gene annotation takes place using two major approaches: ab initio annotation, which
detects open reading frames (ORF’s) by identifying regions which are flanked by start and
stop codons; and reference guided annotation transfer, which uses gene orthology infer-
ence between an assembly and a similar annotated reference assembly. Rapid Annotation
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Figure 1.5: Workflow of RATT. Taken from Otto et al [Otto et al., 2011].
Transfer Tool [Otto et al., 2011] (RATT) is a reference based annotator which utilises
this approach of orthology inference. In RATT, NUCmer (a tool from the MUMmer
tookit [Kurtz et al., 2004]) is used to identify regions of sequence synteny (with a 40%
nucleotide sequence identity threshold). RATT was designed to transfer annotations in
three scenarios: between successive versions of the same assembly, between the genomes
of closely related species, and between the genomes of closely related strains (see Figure
1.5. RATT employs various techniques of gene inference that are common in de novo
annotation, such as ORF distinction; whereby start and stop codons are detected and
allowed to influence annotation, allowing for gene variability between the reference anno-
tation and the assembly to be annotated. Annotation of genomes has played a large part
in VNTR discovery during this project, since it allows for the quick recovery of genes for
comparison and analysis. However it may be necessary to attempt de novo annotation
on the more phylogenetically distant species due to the polymorphic nature of the C.
parvum genome leading to incomplete annotation transfer.
1.4 Alignment-free Sequence Analysis
Sequence comparison by alignment is subject to a major assumption that there is con-
servation of contiguity between nucleotide or protein sequences which are functionally
and/or evolutionarily related (i.e. significant rearrangement is rare and often results in
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functional change). This is not always the case due to genetic recombination and restruc-
turing. Because of this, alternative approaches where developed due to the necessity of
analysing the similarity of DNA sequences whilst attempting to avoid these principles
of genetic rearrangement that confound alignment based sequence analysis approaches
[Vinga and Almeida, 2003, Zielezinski et al., 2017]. These approaches have garnered
greater interest due to the increase in the size of datasets to analyse [Vinga and Almeida,
2003]. In general, these approaches are split into two major categories: genetic ’word’
(or ’k-mer’) frequency approaches, and information theory based approaches [Zielezin-
ski et al., 2017]. These approaches have been extensively developed, and therefore have
rigorous mathematical foundations.
1.4.1 K-mer Analysis and Applications
Because of the dramatic increase in genomic data being produced in next generation
sequencing studies in recent years, there is an elevated requirement for these genomic
data to be analysed. Analysis of genomic data generally necessitates de novo assembly,
homology searches from raw reads or mapping of data to a reference genome, which
are all time consuming and have the potential of introducing internal errors. Genome
analysis methods involving interpretation of the spectra of k-mers have attracted interest
over recent years due to fact that they do not necessitate the genome to be assembled,
analysis can be performed directly on sequencing reads. This dramatically speeds up the
process of analysis for a genome [Zielezinski et al., 2017].
1.4.1.1 K-mer Counting
The first stage of k-mer spectrum (also referred to as a k-mer list) analysis involves the
formation of a k-mer database from the query genome and counting the frequency (in-
cidence) of each k-mer within the database. This database is then generally ordered by
frequency to facilitate further analysis [Kurtz et al., 2008].
If we consider a sequence, X, of length n, as a string of n elements from a finite,
defined alphabet, A, of size r. A k-mer (wk) is defined as a substring of k elements of
X where k ≤ n, and can be generated using a sliding frame approach over X (detailed
in Eq. 1.1). rk possible k-mers can be generated from A. The set Wk contains all (S)
k-mers that may be generated from sequence X:
Wk = {wk,1, ..., wk,S} (1.1)
S = n− k + 1 (1.2)
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The k-mers within X can then be counted computationally. Word frequency (fXk,i)
can be calculated in a similar manner. A vector of k-mer probabilities can be generated
by calculating the probability (pXk,i) of encountering each k-mer within X:
pXk = {pXk,1, pXk,2, ..., pXk,S} (1.3)











There are many k-mer counting tools available, many of which function as part of
larger programs. One of the most efficient and widely used is Jellyfish [Marçais and
Kingsford, 2011], which is optimised for counting <=31bp k-mers based on a multi-
threaded, lock-free hash table. Jellyfish is commonly used as a fast k-mer counting tool
in higher level software or pipelines, due to it’s flexible and robust nature. However, in
some use-cases, a more bespoke tool may be necessary. Tallymer is a tool built specifi-
cally for the purpose of counting k-mers from large eukaryotic genomes containing large
proportions of low complexity repetitive sequence [Kurtz et al., 2008]. This is of great
benefit when working with plant genomes, which are both extremely large, often poly-
ploid, and highly repetitive. Assumptions of particular genome characteristics may be
vital to downstream analysis when counting k-mers within a dataset. Counting k-mers
in large datasets may be an extremely computationally intensive task, requiring large
amounts of memory and disk space. A rough calculation demonstrates that, given a
genome (a string of elements from an alphabet of size 4) of size s (the number of nu-
cleotides), the theoretical upper bound of required memory to store a k-mer array would
be k(s − k + 1) bytes, where 4k ≥ s − k + 1, else 4k bytes. In real terms, this means
that the theoretical upper bound of required memory for storing a 15-mer array from a
1Gb genome would be 15Gb, assuming optimal uncompressed storage. In an attempt to
alleviate such requirements, DSK uses a defined amount of memory and disk space by
writing temporary k-mer tables onto disk storage, allowing it to run on systems with low
memory [Rizk et al., 2013]. The application of probabilistic data structures has also been
used to reduce the memory consumption of k-mer counting methods, since they are much
more memory efficient than k-mer counting algorithms that use exact data structures.
Such is the case with Khmer: a k-mer counting tool which uses a simple probabilistic
data structure, called a Count-Min Sketch, which permits online retrieval and updating
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of k-mer counts in memory [Zhang et al., 2014].
1.4.1.2 K-mer Spectrum Analysis
In the last 10 years, there has been interest in analysis of the distribution of k-mers across
a genome. Particular interest has been directed towards the extremes of this spectrum,
that is, k-mers that are poorly represented (low frequency k-mers) and k-mers that are
abundant (high frequency k-mers). This has lead to various hypotheses attempting to
understand the purpose of these over and under represented k-mers.
After a k-mer count has been undertaken on a genome, analysis of this spectrum
must be carried out. Analysis of k-mer spectra has been used applied to tasks such as
genome size estimation, de novo repeat detection, measurement of gene expression [Patro
et al., 2014], read matching between metagenomic data sets, and identification of organ-
isms within metagenomic data sets using DNA species specific DNA motifs [Wood and
Salzberg, 2014].
It has been postulated that high frequency k-mers are due to their appearance in
structural, mobile and regulatory elements, although it has also been suggested that the
high frequency of these motifs represent unrecognised or little understood biological phe-
nomena [Rigoutsos et al., 2006].
A paper by Csuros et al (2008) proposed that this distribution of k-mers across a
genome can be primarily characterised by a double paretolognormal distribution. This
would explain the observation that all genomic k-mer spectrum distributions appear to
exhibit lognormal and power law features. However, the authors also stated that careful
analysis of k-mer spectra should be made against random sequence to elucidate whether
over-representation of k-mers is a product of the character of the genome, or of proba-
bility, in which case it will be exhibited in random sequence [Csuros et al., 2007]. This
observation could be applied in k-mer spectra analysis as a method of quickly identifying
exceptional k-mers within sets of k-mer spectra, indicating either highly conserved regions
which could be examined as potential drug targets or genetic biomarkers, or highly di-
vergent regions to interrogate as highly specific biomarkers. The results indicate that the
analysis of motif frequency within a genome should be treated with care due to the heavy
tail within the k-mer distribution spectrum, particularly if this result is also exhibited
within random text [Csuros et al., 2007].
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1.4.1.3 Applications of K-mer Analysis
The use of k-mers in bioinformatics has typically been associated with de-novo genome as-
sembly and genomic and metagenomic annotation [Compeau et al., 2011, Edwards et al.,
2012]. K-mer based genome assembly typically involves the construction of De Brujn
graphs which are then used to map a set of reads for assembly into a longer contiguous
sequence by representing k-mers as nodes and edges as single base pair differences be-
tween the k-mers. Contigs are then assembled by calculating a path through the graph
[Compeau et al., 2011].
K-mer analysis can also be used to facilitate quality assurance of next-gen sequenc-
ing datasets. KmerStream is a k-mer streaming algorithm for estimating the number of
unique k-mers that occur within NGS data sets. The authors report that its primary
applications are in error and genome size estimation within high throughput sequencing
data [Melsted and Halldorsson, 2014]. Likewise, Kontaminant is a tool developed at The
Genome Analysis Centre (TGAC) for filtering sequencing reading before assembly. The
tool involves the generation of a k-mer library from a reference. The reads are then
filtered by comparison against these reference k-mers and subsequently discarded based
on whether the read bears a number of k-mers in common of less than a threshold value
(which is highly dependant on the value of k) [Ramirez-Gonzalez, 2014].
There has been prolonged use of the analysis and measurement of frequency and dis-
tribution of k-mers for the purpose of identification. The collection of k-mer frequency
distributions makes for an effective way of generating unique ’barcodes’ for genomes to
aid in species (and intraspecies) identification. A paper by Zhou et al (2008) investigated
the k-mer frequency distribution throughout the genomes of five prokaryotic organisms
to develop barcoding schemes, and their use in solving challenging genome analysis prob-
lems. The authors used their barcoding scheme to address two applicational problems:
metagenome binning problems and identification of horizontally transferred genes. The
study was based on the premise that each genome has a highly stable distribution of the
combined frequency for each k-mer within fragments of > 1kb [Zhou et al., 2008]. The
frequency distributions are used to generate a unique barcode for the genome. Toolkits
such as GenomeTester4 can facilitate such analyses, allowing the user to generate and
perform a range of operations on k-mer lists. In particular, GListCompare is a novel
tool within this toolkit which can be used to perform union, intersection and compliment
set operations. This allows for basic pairwise comparison of k-mer lists [Kaplinski et al.,
2015].
The problem of correct genome identification within fragmented metagenomic data
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has long been one of particular importance in metagenomic projects. Consistent and accu-
rate separation of these fragments within a metagenomic dataset would have a significant
implication on the fields of genomics and metagenomics [Zhou et al., 2008]. Kraken is a
very fast and powerful tool that uses known k-mer lists to identify reads in metagenomic
datasets. It classifies k-mers using a phylogenetic approach and then, by performing list
comparison against k-mer lists generated from known species it estimates the origin of
the organisms by closest match [Wood and Salzberg, 2014]. The development of the
database in Kraken is based on a set of k-mer lists and the lowest common ancestor for
all organisms. K-mers are queried to the database, whereby the lowest common ancestor
which contains all of the k-mers queried is calculated. The database is developed using
a list of genomes specified by the user, which dramatically decreases k-mer lookup time.
Due to the troubling nature of development of robust subtype differentiation in Cryp-
tosporidium, the application of k-mers to this problem may be particularly fruitful. Iden-
tification of k-mers specific to different isolates allows for a novel and direct approach
to solving this problem, since these k-mers act as isolate specific motifs which could be
detected by PCR amplification in a clinical laboratory.
1.4.2 Information Theory Based Analysis and Applications
The main concept behind information theory based methods is to recognise and compute
the intersection between the informational content of two sequences of interest. If one
treats amino acid and nucleotide sequences simply as strings of symbols (a common
practice), then their organisation becomes interpretable, and therefore their informational
content more accessible. There are many examples of informational content, but the most
important ones in bioinformatics are ones such as complexity and entropy. The calculation
of the complexity and entropy of a DNA sequence has been the focus of a great deal of
research, spanning many disciplines.
1.4.2.1 Sequence Entropy
Entropy in the context of informational content of DNA or amino acid sequence is not
comparable to entropy as referenced in thermodynamics, and should be treated as an
entirely different concept. The main concept behind entropy (termed ’Shannon entropy’,
after Claude Shannon, the father of information theory) is in investigating redundancy
within a string. For example, the meaning of the sentence ”the sky and the sea are blue”
would still be inferable if one were to remove the words ”the”, ”and”, and ”are”. This
idea of redundancy can be applied to DNA sequence, where rarely encountered ’words’
(k-mers) are more important to sequence analysis than more common ones. Shannon
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where pi is the probability of word number i appearing in in a stream of words. In the
context of sequence analysis, this would refer to a k-mer within a k-mer array.
Using this concept of Shannon entropy, Kullback and Leibler (1951) introduced a
measure of relative entropy, termed Kullback-Leibler divergence, allowing for the pairwise
comparison of DNA or amino acid sequence [Leibler and Kullback, 1951], involving the
calculation of word frequencies and summation of entropies within the sequences.
1.5 Data Structures used in K-mer Array Analysis
There are a number of discrete data structures which are utilised in the analysis of the
k-mer spectrum of DNA sequence. In principle, any data structure with functionality to
track the instance of events within a data-stream, and facilitate queries upon that set
about the presence or count of that event within the data-stream, may be applied to
sequence comparison using k-mer arrays. However, there are a select few with popular
application in sequence analysis. This is likely due to their memory scalability, allowing
these data structures to store large amounts of data in a memory efficient manner, and
lookup time. This is essential when dealing with large datasets, where simply storing the
set in memory and querying it directly is; at best, highly time and memory inefficient;
and at worst, not possible.
1.5.1 Hash Tables
Hashing is a technique used to efficiently store an array of elements and perform lookup
in O(i) time. The technique relies upon the input of elements within an arbitrarily large
array A into a hash table T , which is an empty array of fixed size. In this example we
define A ⊂ N. The problem lies in the fact that an element within A maps to a location
within T , and in this example where we map using a ’one to one’ system, this element
may be arbitrarily large. This forces |T | to be arbitrarily large, which may be highly
space inefficient. The solution to this is to implement hash-functions h which utilise a
’many to one’ system, meaning in this context that the value of an element within A does
not necessarily refer to an index within T .
If we redefine A = {2, 5, 9, 12, 50}, and h(x) = x mod |T | then |T | > |{h(x) | x ∈ A}|.
This is because when we hash x ∈ A using h, we produce a hashed array hA = {2, 5, 9, 2, 0}
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which we can use as index positions within T to map information to. However, as can be
seen, 2 and 12 hash to the same value using h (2) and therefore there exists a collision
within our hash table, where information from two elements within A have been mapped
to the same index in T . This can be resolved using a variety of approaches, usually
divided into open hashing and closed hashing approaches.
1.5.1.1 Open Hashing
Chaining is a method by which hash collisions can be resolved. In chaining, elements
are not stored in the hash table itself, instead the hash table stores linked lists which
store elements and keys. Upon a collision, a key element will be inserted to the index
position to form a chain of nodes. The initial node therefore stores the initial element
which was mapped to that index location within the hash table, and a key pointing to
the linked node containing the second element which caused the collision. Searching this
linked list is therefore performed in linear time.
1.5.1.2 Closed Hashing
Linear Probing is a method by which hash collisions are resolved by simply mapping
the element to the next empty index position within the hash table. This is achieved by
introducing a second function, f(i) = i, which incrementally increases the output from h
until an empty position within T is found. This adjusts h to h(x) = (h(x)+f(i)) mod 10
where i = {0, 1, 2, ...}. When a lookup is performed, the query element is hashed as usual
and a linear search (defined by f) is performed from the index position within T until
the query is encountered. If an empty index is encountered first, the queried element is
presumed to not belong to the hash table.
The major issue with linear probing is that it tends to induce clustering of data
within the hash table. This clustering results in a greater number of elements within
the hash table needing to be checked for each query, increasing lookup time. To resolve
this, Quadratic Probing may be implemented. Quadratic probing is identical to linear
probing, with the exception that f(i) = i2. This has the effect of evening out data
mapping throughout the hash table.
1.5.2 Bloom Filters
A Bloom filter is a memory efficient probabilistic data structure used to infer set mem-
bership. Bloom filters bear resemblance to hash tables, but differ in that they do not
store elements themselves, but adjust a fixed length common bit array according to the
element observed within a set. They achieve this by using a number of hash functions to
generate a bit signature for each element, and adjusting the bit array at positions dictate
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by this bit signature (see figure 1.6). This is a fast and highly efficient process, but due to
its probabilistic nature it can only infer set membership to a certain degree of accuracy
defined by a false positive rate. Because Bloom filters are of a fixed size, it can represent
a set of an arbitrarily large size, unlike a hash table. However, the false positive rate is
adjusted every time a new element is added, and therefore defining the length of the bit
array requires care.
To build a Bloom filter, an empty bit array of fixed length is initialised. n hash
functions are then utilised to hash elements of a set (S). When an item, x where x ∈ S,
is added to the filter, the bits at n indices h1(x), h2(x), ...hn(x) are adjusted immutably
to 1, where the indices are defined by the output from the hash functions. False positive
results can be controlled by adjusting the size of the Bloom filter, wherein a larger bit
array relative to the set being stored reduces the chance of false positive results. However,
this would also increase latency when elements are being added to and screened against
the Bloom filter. The probability of false positive results can therefore be calculated using
the size of the bit array, the size of the set, and the number of hash functions. Let m be
the size of the bit array, k be the number of hash functions utilised, and n be the number
of elements in the set used to generate the Bloom filter, the false positive rate (P ) can
be calculated as:
P = (1− [1− 1
m
]kn)k
The size of the bit array can be calculated if the expected number of elements to be added
to the Bloom filter, and the false positive rate are known. This can be calculated as:
m = −n lnP
(ln2)2





In the context of sequence analysis, Bloom filters can be used in conjunction with k-
mer arrays to infer sequence similarity between a given sequence and the sequence which
was used to generate the Bloom filter. Figure 1.6 illustrates the method by which a Bloom
filter is generated from a sequence. A k-mer array is generated from a given sequence.
This k-mer array is used as the set from which a Bloom filter can be built. Each k-mer
within the array is hashed using a number of hash functions, and the bit array adjusted
according to this output. After every k-mer has been added to the Bloom filter, screening
can commence using a k-mer array (using an identical k value, otherwise no intersections
will be detected) generated from a query sequence (see figure 1.7). Each k-mer from the
query sequence is hashed using the same hash functions that were used to generate the
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Bloom filter, and the subsequent output (termed the ”bit-signature”) compared against
the Bloom filter to detect intersections. Where intersections are detected, a counter is
incremented by 1. This hit counter can be used to determine the level of similarity
between the sequence used to generate the Bloom filter and the query sequence.
1.5.3 Count-Min Sketch
A count-min sketch is a probabilistic data structure capable of representing, and an-
swering queries of, a high-dimensional vector. It is in essence a frequency table, storing
events within a data-stream. In effect, it is a counting Bloom filter. Rather than storing
a one-dimensional bit array, a count-min sketch C is an array of counters of width w
and depth d, C[1, 1]...C[d, w]. w and s are fixed when the sketch is created. Upon being
presented with a new event i, each row j of the table is updated using the corresponding
hash function to obtain the column index k = hj(i). The counter at row j column k is
incrementally increased by one.
Upon the creation of this sketch, various queries on the data stream can be made.
The most apparent of which is simply a query of the count of an event. This is slightly
more problematic than it may seem, due to a number of positions within the sketch
being incremented by a single event, defined by the number of hash functions used in
its generation. Therefore due to different events potentially generating identical outputs
when consumed by different hash functions (in effect, hash collisions), the count at each
position generated by each hash function may not be the same. To resolve this, the
minimum count is taken as the actual count for the number of observations of an event
within a data-stream. Because of this, in a similar manner to Bloom filters presenting
with no type-2 error at the expense of manageable type-1 error, a count-min sketch may
overestimate the number of events within a data-stream, but can never underestimate it.
1.6 Conclusion
The importance of examining and resolving the current bottle neck between the genera-
tion and analysis of NGS data cannot be overstated. The wealth of information within
publicly available genomes which have yet to be analysed necessitates the development
of novel approaches to genome analysis and high-throughput application of the subse-
quently developed tools, reducing the amount of manual work that is required for large
scale biological data analysis. Analysis of sequencing reads from raw read files is a po-
tential solution to this problem, which would dramatically speed up analysis time due
to avoiding the necessity of genome assembly and therefore obviate the requirement for
costly equipment such as a High-Performance Computing (HPC) cluster, allowing for
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Figure 1.6: A graphical representation of utilising a k-mer array to generate a Bloom
filter. An input sequence is k-merised and the k-mers hashed using a number of hash
functions. The output of the hash functions refers to index positions on the bit array,
which are then adjusted immutably to 1.
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Figure 1.7: A graphical representation of the process of screening a set of k-mers generated
from a query sequence against a Bloom filter (see figure 1.6). Each k-mer within the query
array is hashed using the same hash functions that were used to generate the Bloom filter,
and the output used to infer intersections. If an intersection is detected, the hit counter
is increased by 1.
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analysis to be carried out on the standard workstation computer or laptop. The applica-
tion of k-mer analysis tools to this area could be a potentially valuable approach in the
discovery of biomarkers for species identification or small conserved sequences associated
with gene regulation which could be examined as targets for novel therapies.
Chapter 2
From Gastroenteritis to Genome:
Generating Genome Assemblies from
Clinical Samples of Cryptosporidium
The sequencing and assembly of whole or partial genomes has become an essential tool in
modern science, facilitating research in almost every area of biology. A primary concern
in Cryptosporidium research is extracting from clinical samples sufficient amounts of
high quality, low contaminant DNA for sequencing. Without this, sequencing may result
in low coverage sequence, variable sequencing depth and poor quality genome assemblies
[Morris et al., 2019b, Morris et al., 2019a]. In the area of Cryptosporidiosis research, the
impact of genomics has been limited by the need to propagate the parasite in animals
to generate enough oocysts from which to extract DNA of sufficient quantity and purity
for analysis [Abrahamsen et al., 2004]. In 2015 this problem was overcome through an
approach that now allows genomic Cryptosporidium DNA suitable for whole genome
sequencing to be prepared directly from human stool samples [Hadfield et al., 2015].
Hadfield et al. (2015) applied their method to the whole genome sequencing of eight
C. parvum and C. hominis isolates. Presently, the Cryptosporidium genomics resource,
CryptoDB [Puiu et al., 2004], currently gives access to 13 complete genomes, with a total
of 10 available from the NCBI.
Currently clinical diagnosis of Cryptosporidiosis relies on conventional genotyping
tests. The availability of whole Cryptosporidium genome sequences provides much higher
resolution information for genotyping. In addition, the genomes can be used to study a
wide array of aspects of pathogen biology, such as identity, taxonomy in relation to other
pathogens, sensitivity or resistance to drugs, development of novel therapeutic agents,
virulence, and epidemiology. My interest is to build on current genotyping tests by devel-
oping a standardised multi-locus typing scheme. This will allow sources of contamination
and routes of transmission to be characterized and compared in a cost- and time-efficient
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manner [Perez-Cordon et al., 2016, Chalmers et al., 2017]. Here variable-number of
tandem-repeats (VNTR) are used, with recent investigations concluding that additional
loci need to be identified and validated [Chalmers et al., 2017]. Our work is building on
that of Perez-Cordon et al. (2016), who used Tandem Repeats Finder [Benson, 1999]
to identify polymorphic VNTR’s around the genome of C. parvum, and analysed them
for variation across the eight genomes sequenced by Hadfield et al. (2015). I aim to use
whole genome sequencing of additional isolates and species to help achieve this goal, but
this work is hampered by the quality of available genome sequences [Perez-Cordon et al.,
2016].
This chapter is structured as follows. First, I explain the quality issues associated
with genome sequences extracted from clinical stool samples containing Cryptosporidium
oocysts. Then I describe our methods, including the data sets used, the novel utilisation
of Gini and Gini-granularity curves to measure the distribution of read depth in a set of
sequenced reads, the process of assembly with the identification of misassemblies, and the
effect Whole Genome Amplification (WGA) has on coverage distribution. In the results
and discussion sections, I summarise properties of the sequenced reads, show how they
can lead to misassemblies, and give evidence of the types of misassembly encountered. I
also describe how using the Gini coefficient, and analysis of Gini-granularity curves can
explain some of these assembly errors and characterise the distribution of reads across
a genome. I then give an outline of the strategy used to generate genome assemblies of
sufficient quality to use for the discovery of novel VNTR’s in Cryptosporidium, and use
it to generate genome assemblies for an extended dataset of C. parvum and C. hominis.
Finally I discuss the value of WGA in generating high quality assemblies clinical samples
of Cryptosporidium, and how it affects the coverage across a genome.
Data within this chapter was published in the Proceedings of the 12th International
Joint Conference on Biomedical Engineering Systems and Technologies - Volume 3: BIOIN-
FORMATICS under the title Identifying and Resolving Genome Misassembly Issues Im-
portant for Biomarker Discovery in the Protozoan Parasite , Cryptosporidium. A further
publication is currently (as of October 2019) in peer review, to be published in a special
edition Springer CCIS series book under the title Generating Reliable Genome Assemblies
of Intestinal Protozoans from Clinical Samples for the Purpose of Biomarker Discovery.
2.1 The Problem
Although it is possible to derive high quality Cryptosporidium DNA by culturing the
parasite in donor animals [Abrahamsen et al., 2004], this is expensive and time consuming,
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and is not appropriate for clinical samples, since sequence identity may be modified during
asexual reproduction or sexual recombination. Sustaining sequence identity of clinical
samples is of great importance in epidemiological surveys. Sequencing Cryptosporidium
from clinical samples suffers from three major problems:
1. The yield of oocysts from clinical samples is low.
2. The oocysts are extracted directly from faeces, necessitating extensive cleaning and
purification before DNA extraction.
3. The DNA yield per oocyst is low.
Figure 2.1: A: Read depth of coverage across chromosome 7 of the C.parvum IowaII
reference genome (top track) and C.parvum UKP3 (bottom track) genomes to illustrate
the extreme coverage inequality of the UKP3 isolate genome (UKP3 Gini = 0.5489,
IowaII Gini = 0.112). Image produced using IGV. Note that the IowaII DNA sequences
were derived from an animal model, and have low or ”normal” read depth variation,
whereas UKP3 is more typical of DNA sequences extracted from clinical samples. B: The
coverage over chromosome 1 for 2 genomes: UKP6 (G | W1 = 0.255, nAUC = 0.921)
and UKP5 (G | W1 = 0.278, nAUC = 0.884) with G | W1 across chromosome 1 alone of
0.262 and 0.264 respectively. UKP6 illustrates large, broad peaks (blocking) in a number
of areas. These do not appear to correspond to any obvious features, however, it is
presented here as a useful example of a type of coverage inequality. See Section 2.2.4 for
an explanation of the annotation.
These three problems commonly result in sequenced data sets with very uneven depth
of coverage, see Figure 2.1 for examples. The reasons for uneven depth of coverage are
unclear; in this chapter I have attempted to elucidate some of the issues. Uneven se-
quencing depth has been identified in datasets obtained from published and unpublished
paired end read libraries generated by different groups, and which were prepared using
the standard Nextera XT DNA sample preparation kit. Moreover, many groups use
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WGA to increase the quantity of extracted DNA. This may have additional impact on
the depth of coverage. WGA has been touted as a potential solution to samples which
yield low levels of DNA or for which little DNA exists [Lasken and Egholm, 2003, Zhang
et al., 2006, Hosono et al., 2003]. There has, however, been limited rigorous research into
coverage bias introduced by such DNA enrichment techniques. Moreover, laboratory kits
and equipment have been demonstrated as a potential source of confounding contami-
nation, which is potentially greatly exacerbated by the amplification of DNA using such
enrichment techniques [Salter et al., 2014, Mohammadi et al., 2005, Van Der Horst et al.,
2013]. Uneven sequencing depth may lead to genome misassembly, and I have identified
this an issue with a number of popular de novo assemblers. Poor quality genome assem-
blies can find their way into public repositories of genome sequence and this can confound
the development of novel prevention strategies, therapeutics, and diagnostic approaches.
2.1.1 Datasets
Figure 2.2: The workflow for assembly, adapted from that used by Hadfield et al. for the
assembly of genomes with high coverage depth inequality.
Two main datasets were used within this chapter. These datasets a differentiated
by their origin: published by Hadfield et al. (Dataset 1 as a whole), or generated using
methods described in this chapter (Dataset 2).
2.1.1.1 Dataset 1: Hadfield et al. Data
Dataset 1 refers to the dataset generated by Hadfield et al [Hadfield et al., 2015]. This
dataset is split into two subsets based on how they were assembled (Datasets 1.1 and
1.2).
2.1.1.2 Dataset 1.1: The Published Hadfield et al. Genome Assemblies
Dataset 1.1 refers to the assemblies generated by Hadfield et al., using the 18 fragment
C. parvum IowaII assembly [Abrahamsen et al., 2004].
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2.1.1.3 Dataset 1.2: The Reassembled Hadfield et al. Genomes
Dataset 1.2 refers to the assemblies carried out here. These assemblies used the updated
C. parvum IowaII reference genome for C. parvum, and the C. hominis TU502 genome for
C. hominis, which bear non-fragmented chromosomes (totalling all 8 large chromosome
scale scaffolds).
Reference to ’Dataset 1’ refers to either the isolates in a general sense or the raw data
used to generate the assemblies in Datasets 1.1 and 1.2. The 18 fragment Hadfield et al.
assemblies in Dataset 1.1 were used to investigate the misassemblies caused by uneven
depth of coverage. These were then reassembled using the pipeline detailed in Figure
2.2, to generate Dataset 1.2. These isolates were NOT subjected to DNA enrichment by
WGA prior to sequencing. The genomes in Dataset 1 were used because they currently
represent the largest collection of published Cryptosporidium draft genomes from clinical
isolates.
2.1.1.4 Dataset 2: New Genome Assemblies
The assembly workflow detailed in this chapter (see Figure 2.2) was used to generate
29 new C. parvum and 19 new C. hominis assemblies. These isolates were subjected to
DNA enrichment using WGA (by multiple displacement amplification) prior to sequenc-
ing. This new dataset of assemblies will hereafter be referred to as ’Dataset 2’. The
isolation of oocysts, purification of DNA and subsequent WGA of Dataset 2, was done
by myself as detailed in this chapter.
All datasets were used to investigate the correlation between genes transferred to
chimeric regions and Gini, read distribution, and the effect of WGA on coverage.
2.2 Sequencing and Read Analysis Methodology
2.2.1 Oocyst purification and DNA preparation
Purification of Cryptosporidium Oocysts from Dataset 2 was carried out according to Had-
field et al.. Cryptosporidium oocysts where harvested from 1 - 2 ml of each faecal sample,
using a saturated salt solution as a first pass purification approach. Oocyst numbers
where then quantified by staining with FITC-labelled anti- Cryptosporidium monoclonal
antibody (Crypto-Cel, Cellabs, Australia) and visualised under light microscopy using a
Neubauer improved haemocytometer (C-Chip, Peqlab, Sarisbury Green, UK) to count.
The oocysts where then subjected to a second pass purification step using an Isolate®
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IMS kit (TCS Biosciences, Botolph Claydon, UK) according to manufacturers standard
documentation of use. Oocysts where dissociated from the ferromagnetic beads during
IMS purification and decanted into 1.5ml microfuge tubes (Ekay, Basingstoke, UK), for
surface sterilisation by iterative bleaching and washing steps. One cohort of UKP2 being
isolated using an alternative Caesium chloride (CsCl) gradient centrifugation protocol.
Oocysts where enumerated by microscopy prior to and following surface sterilisation.
Oocysts were shattered using an iterative liquid nitrogen freeze thaw protocol.
2.2.2 DNA library Preparation and Sequencing
Barcoded paired-end libraries were prepared for each isolate using the Nextera XT DNA
sample preparation kit (Version C protocol, Illumina). Amplicons exceeding 500bp in
size were selected during the post-PCR purification stages (however, this was not sub-
jected to verification). DNA quantification by Qubit HS DNA assay demonstrated that,
for the majority of the samples, the Nextera XT libraries were very low concentration.
Consequently, these libraries were pooled to give 0.1nM concentration, and subjected to
SpeedVac to dramaticaly improve concentration. In the pilot phase, the libraries were
sequenced on the Illumina MiSeq platform using 2 x 151 bp reads, and on the Illumina
HiSeq 2500 platform using a 2 x 151 bp rapid run during the main phase [Hadfield et al.,
2015].
2.2.3 Raw read analysis
The reads were mapped to a reference genome (C. parvum IowaII for C. parvum and C.
hominis TU502 [Xu et al., 2004] for C. hominis) using Bowtie2 v2.3.3.1 [Langmead et al.,
2009]. Coverage analysis was then performed using Samtools v1.5 [Li and Durbin, 2009].
Depth of coverage over each assembly was calculated using the ’depth’ tool within
the samtools package [Li and Durbin, 2009]. The Gini coefficient is a metric used to
measure the inequality within a dataset. It is commonly used in economics to measure
the distribution of income within a population, where it is represented by a value between
0 and 1, with 0 representing perfectly even distribution, and higher values representing
higher inequality of distribution. Here I have applied this coefficient to measure inequality
of depth of coverage across a genome. For each of the genomes, I calculated the Gini
coefficient of read depth. The Gini coefficient is calculated as:
G = A/(A+B)
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Figure 2.3: Graphical representation of the Gini coefficient. In this graph, the Gini
coefficient can be calculated as A/(A + B), which represented area under the Lorenz
curve (blue) inversely proportional to the line of equality (red). The green dotted lines
denote the percentage of reads which cover 80% of a genome used to generate the Lorenz
curve (unequal coverage depth) as compared to a perfectly equal distribution of reads.
Figure 2.4: Gini curves for a selected number of genome assemblies from Dataset 2. LoE
refers to the Line of Equality, wherein theoretic perfect equality of the coverage from a
single isolate is represented, achieving a Gini of 0. These Gini curves were generated
using a window size of 500.
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where A is the area under the line of equality, and B the area under the Lorenz curve,
on the graph of distribution inequality (see Figure 2.3). The green dotted lines (marked
at 80% on the x axis) in Figure 2.3 gives an example of how, in the dataset used to
generate the Lorenz curve, 80% of the genome is covered by only 40% of reads (the value
at the position of collision of the green dotted line on the y axis), whereas in a perfect
distribution it would be covered by 80% of reads.
The algorithm for calculating a genome’s Gini coefficient of read depth coverage in-
volves first calculating the mean depth of coverage of 1bp windows (W = 1) over the
genome. These windows are ordered according to their depth of coverage values, and
these values rescaled between 0 and 100. This ordered set of read depth values is used to
generate the Lorenz curve, L, where the value at every position i on the curve represents
the sum of all values at positions ≤ i. A line of equality, E, was generated to represent
perfectly even distribution of reads across a genome. The difference between the values
at each position on E and L is then calculated and the summed inverse proportional
difference (the Gini coefficient) of these values calculated.
Here, the Gini coefficient of coverage across a genome is calculated as half the relative
mean absolute difference. The mean absolute difference of a population is the average
of the distance (absolute difference) between all given pairs across a population. Take a









where xi and xj are positions i and j in population x. In the context of coverage anal-
ysis, this refers to the mean coverage across window i and j within the ordered set of
all windows. To get the relative mean absolute difference, this must be divided by the
average of x, x̄.









which is mathematically equivalent to G = A/(A+B).
The Gini coefficient for each genome represents the unevenness of read depth across the
genome sequence (see Figure 2.1A for an example of uneven coverage across chromosome
7 of UKP3 as compared to Iowa II).
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2.2.4 Gini-Granularity Curves
To further investigate the read distribution throughout each assembly, the Gini coef-
ficient was calculated across window sizes of 1-10,000 nucleotides. Furthermore, these
curves were normalised such that the Gini at maximum data granularity (which is ob-
tained by calculating G at window size of 1) is adjusted to 1 for the purpose of simplified
comparison. For each of these normalised and un-normalised curves, the area under the
curve (AUC) was calculated. These curves are hereafter referred to as Gini-granularity
curves.
More formally, consider a nucleotide sequence s where the array of depth of coverage
for each position in s is c. A partitioned array of c is generated using window size w,
forming N partitions where N = |c|
w
:
P cw = {c[j,j+w]
∣∣ j = iw, 0 ≤ i < N, i ∈ N} (2.3)
The mean coverage over each partition is consequently:
Ccw = {n̄
∣∣ n ∈ P cw} (2.4)
where n̄ is the mean depth of coverage of partition n. Taking Gcw as the Gini of C
c
w (see
Equation 2.2 for the calculation of the Gini coefficient), an array of Gini values over a
range of partition sizes is, r = [i, j] where r ⊂ N is:
Gcr = {Gcw
∣∣ w ∈ r} (2.5)
Acr is the area under the curve generated by G
c
r. The normalised area under the curve,
normAcr is calculated as the area under normG
c
r where:
normGcr = {Gci + (1−Gc1)
∣∣ 0 < i ≤ |Gcr|, i ∈ N} (2.6)
The area and the normalised area under the Gini granularity curve for a sample will
hereafter be referred to as AUC and nAUC respectively.
2.2.5 DNA Enrichment using Whole Genome Amplification
Due to the low DNA yield of Cryptosporidium isolated from clinical samples, WGA by
Multiple Displacement Amplification (MDA) was utilised to enrich the DNA for sequenc-
ing. The protocol was followed as documented in the protocol: ’Amplification of Purified
Genomic DNA using the REPLI-g Mini Kit’ by Qiagen. This was carried out as follows:
5µl Buffer D1 was added to 5µl template DNA, vortexed to mix, and briefly centrifuged.
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These were then incubated at room temperature for 3 minutes. During this time a master
mix was prepared using 29µl REPLI-g Mini Reaction Buffer and 1µl REPLI-g Mini DNA
Polymerase, to a total of 30µl. 10µl Buffer N1 was added to the samples and mixed
by vortexing, and centrifuged briefly. The master mix was then added to 20µl of this
denatured DNA, and incubated at 30oC for 16 hours. After this incubation period, the
REPLI-g Mini DNA Polymerase was inactivated by heating the sample at 65oC for 3
minutes.
2.2.6 Sequencing Bias Analysis in WGA datasets
Figure 2.5: % GC content plotted against mean coverage over window sizes of 1000bp of
C. parvum UKP99. This isolate was subjected to DNA enrichment by WGA (see Section
2.2.5). This plot was generated using kernel density estimation, and overlaid with contour
lines, equating to thresholds (t). The red dot marks the calculated centre of mass of the
graph object (see Equations 2.9 and 2.10 in Section 2.2.6.1). R2 = 0.365 G = 0.238
To investigate bias which may exist in how DNA is enriched using WGA, or sequenced,
I used the depth tool within the Samtools package. Bespoke python scripts were written
to analyse the relationship between coverage and GC content across windows of various
sizes. Kernel density estimation was carried out on these datasets to investigate the rela-
tionship between coverage and genomic content using the SciPy package in Python v3.6
[Jones et al., 2001].
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The angular momentum of the graph objects generated by the distribution seen within
these plots was calculated as described in Section 2.2.6.1. Angular momentum was used
as it is a metric which considers the mass, shape, and size of an object. This makes it ideal
for comparing the effect of WGA on a graph object, and by extension, a genome. Given
a matrix K generated by the kernel density estimation of a dataset of % GC content
against mean depth of coverage of windows over a genome, a graph object A ⊆ K is
defined as:
A = {x
∣∣ x ∈ K, x ≥ t} (2.7)
where t is some threshold. Figure 2.5 shows an example of these objects, where a contour
line is a threshold, and therefore defines the outer limits of a graph object.
2.2.6.1 Angular Momentum of a Rigid Body
When analysing graphs of mean coverage vs GC content of a genome assembly (such as
that seen in Figure 2.5), there were two major variables which were important in inter-
pretation: the size of the distribution, and the shape of the distribution. The angular
momentum of the graph objects (as defined in Equation 2.7) were therefore calculated,
since angular momentum is a product of these two variables. Consequently, the effective
shape of the distribution can be characterised by this single metric.
Consider a two dimensional system (the rigid body) of n particles of massesm1,m2, ...,mn,
whos coordinates are (x1, y1), (xn, yn), ..., (xn, yn) respectively, situated at distances r1, r2, ..., rn





and the coordinates for the centre of mass of the system as
xcm =
m1x1 +m2x2 + ...+mnxn




m1y1 +m2y2 + ...+mnyn
m1 +m2 + ...+mn
(2.10)
Let v1, v2, ..., vn be the linear velocities of the particles respectively, then the linear
momentum of the first particle is L1 = m1v1. Since vn = rnω and the linear momentum
of a particle = mn(rnω), the moment of linear momentum of the particle is therefore
= (mnrnω)× rn, and the angular momentum = mnr2nω.
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The angular momentum of a rotating rigid body is calculated as the sum of the






























i , the moment of inertia of the rotating rigid body around the centre
of mass.
2.3 Assembly and Post-Assembly Improvement Method-
ology
Assembly was initially carried out using the raw reads from Dataset 1 (published by Had-
field et al.), and the updated (8 chromosome) reference genome assemblies for reference
guided scaffolding. This generated Dataset 1.2. The pipeline used to produce the reli-
able genome assemblies from the Dataset 1.2 (see Figure 2.2) was then used to generate
assemblies from Dataset 2.
2.3.1 De novo Assembly
First de novo assembly was undertaken in the same manner as those reported by Had-
field et al. (2015). SPAdes v3.7.1 [Bankevich et al., 2012] de novo assembler was used
to construct scaffolds from paired end read files. K-mer sizes of 23, 33, 55, 65, 77 & 89
were used in the assembly, with 1 iteration used for error correction, repeat resolution
was enabled and the coverage cut off set to ’off’. Various k-mer sizes, coverage cut-offs,
repeat masking, and a reference guided assembly approach were used in an attempt to
improve assembly quality.
Velvet v1.2.10 assembler [Zerbino and Birney, 2008] was run in two parts, as is stan-
dard. The hashing program, velveth was run using a maximum k-mer length of 31,
and options of -fastq, -separate, and -short. The De Bruijn graph construction
program, velvetg was run with coverage cutoff set to auto, alignments exported for
assembly analysis, long nodes which where eliminated by coverage filters exported, and
-coverage mask set to 2.
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A third assembly was undertaken using IDBA-UD [Peng et al., 2012], to resolve low
coverage regions whilst attempting to prevent generation of chimeric fragments during
assembly and scaffolding. Read files in .fastq format were merged using fq2fa prior to
assembly with IDBA-UD. IDBA-UD was run using these merged read files, and using
default parameters.
2.3.2 Post Assembly Processing
The assemblies were improved using the Post Assembly Genome Improvement toolkit
(PAGIT) [Swain et al., 2012]: a pipeline consisting of four standalone tools with the aim
of improving the quality of genome assemblies. The tools are, in suggested order of exe-
cution: ABACAS [Assefa et al., 2009], IMAGE [Tsai et al., 2010], ICORN [Otto et al.,
2010], & RATT [Otto et al., 2011].
The workflow of this assembly pipeline can be found in Figure 2.2. The differences
between this workflow and the one used by Hadfield et al. is in the de novo assembler
used (IDBA-UD rather than SPAdes) and the updated reference genome assemblies, of
which the C. parvum IowaII reference genome was in 8 chromosomes rather than the 18
fragment version used in their approach.
2.3.2.1 ABACAS: Algorithm Based Automatic Contiguation of Assembled
Sequences
ABACAS is a contig-ordering and orientation tool which is driven by alignment of the
draft genome against a suitable reference. Suitability of the reference is defined by amino
acid similarity of at least 40%. Alignment is performed by NUCmer or PROmer from the
MUMmer package [Kurtz et al., 2004]: a tool designed for large scale genome alignment.
Contigs from the draft assembly are positioned according to alignment to the reference
genome, with spaces between the contigs being filled with ’N’s, generating a scaffold of
the draft assembly.
ABACAS was executed using the updated (All 8 chromosomes resolved) C. parvum
IowaII [Abrahamsen et al., 2004] reference genome with default parameters.
2.3.2.2 IMAGE: Iterative Mapping and Assembly for Gap Extension
IMAGE uses Illumina paired end reads to extend contigs by closing gaps within the scaf-
folds of the draft genome assembly. IMAGE uses read pairs where one read aligns to the
end of a contig and the other read overhangs beyond the end of the contig into the gap.
This gap can then be partially closed using the overhanging sequence and by extending
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the contig.
IMAGE was run in groups of three iterations at k-mer sizes of 91, 81, 71, 61, 51, 41,
& 31, totalling 21 iterations. Scaffolding was then performed with a minimum contig size
of 500, joining contigs with gaps of 300 N’s.
2.3.2.3 ICORN: Iterative Correction of Reference Nucleotides
ICORN was developed to identify small errors in the nucleotide sequence of the draft
genome, such as those which may occur due to low base quality scores. It was designed
to correct small erroneous indels, and is not suitable for, or capable of, correcting larger
indels or misassemblies.
ICORN was run using 8 iterations and a fragment size of 300.
2.3.2.4 RATT: Rapid Annotation Transfer Tool
RATT is an annotation transfer too used to infer orthology/homology between a ref-
erence genome and a draft assembly. This is achieved by utilising NUCmer from the
MUMmer package to identify shared synteny between annotated features within the ref-
erence genome, and sequence within the draft assembly. Annotation files (EMBL format)
are produced which contain regions which are inferred to be common features. The re-
gions are filtered and transferred dependant on whether the transfer is between strains
(Strain, similarity rate of 50-94%), species (Species, similarity rate of 95-99%), or differ-
ent assemblies (Assembly, similarity rate of >=99%).
RATT was run using IowaII annotations in EMBL format, downloaded from Cryp-
toDB, as a reference. The Strain parameter was used to transfer feature annotations to
the draft assembly.
2.3.3 Analysis of Draft Genomes
VNTR’s around the reference and draft genomes were identified for the purpose of VNTR
comparison and polymorphism analysis. Tandem Repeats Finder v4.09 [Benson, 1999]
was used to identify VNTR’s around the C. parvum IowaII reference genome using a
matching weight of 2, mismatch and indel penalties of 5, match and indel probabilities
of 80 and 10 respectively, minimum score of 50 and maximum period size of 15. The
number of VNTR’s per gene is included as a heat map in Figure 2.13.
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2.3.4 Identification of Misassembly
The observation that only low coverage and low complexity regions formed the interface
between chimeric contigs indicated that the chromosomal translocation events were a re-
sult of misassembly rather than an actual biological signal. Consequently, experimental
validation was considered to be unnecessary.
The draft genomes were analysed in two ways (1) by transferring gene annotations
from the reference genome to the drafts using RATT, and (2) by aligning the contigs (from
IDBA-UD) or scaffolds (from SPAdes/Velvet) from the draft assemblies to the IowaII
reference genome. RATT was used to identify the number of genes which were trans-
ferred between genomes: it provided a convenient way of identifying putative chimeric
regions i.e. regions on a draft chromosome that contained genes from 2 or more refer-
ence chromosomes. NUCmer was then used to investigate these putative chimeric regions
by performing whole genome alignments. NUCmer (from the MUMmer package [Kurtz
et al., 2004]) was used with a minimum length of match set to 100, preventing the report
of small regions of similarity, a maximum gap of 90, and a minimum cluster length of 65.
2.3.5 Quality assessment with Gini
The Gini coefficient for each isolate was calculated using the average coverage over win-
dows of 1000 and plotted against the number of genes transferred to chimeric regions
(detailed in section 2.3.4). The coefficient of determination (R2) was used to calculate
the amount of variance in the number of genes transferred to chimeric regions explained
by the Gini coefficient.
2.3.6 Data Visualisation
The C. parvum assemblies (UKP2-8) were visualised alongside the C. parvum IowaII
reference genome using the Circos package v0.69 [Krzywinski et al., 2009]. Mapped reads
were visualised using Integrative Genomics Viewer v2.4.16 [Thorvaldsdóttir et al., 2013].
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UKP2* 0.93 1.00 51.8 0.892 0.223
UKP3* 0.89 0.99 166.42 0.815 0.556
UKP4* 0.89 0.99 192.48 0.805 0.566
UKP5* 0.85 0.99 26.86 0.884 0.277
UKP6* 0.82 0.99 104.83 0.921 0.255
UKP7* 0.89 0.99 77.85 0.804 0.555
UKP8* 0.84 0.98 174.39 0.796 0.566
UKP10 0.89 0.99 94.87 0.783 0.55
UKP11 0.89 0.99 145.87 0.783 0.57
UKP12 0.98 0.78 34.7 0.810 0.432
UKP13 0.95 0.70 73.87 0.783 0.499
UKP14 0.99 0.94 65.55 0.790 0.532
UKP15 0.93 0.98 134.890 0.827 0.402
UKP16 0.96 0.99 157.880 0.828 0.398
UKH3* 0.90 0.98 34.710 0.888 0.236
UKH4* 0.85 0.96 209.170 0.786 0.601
UKH5* 0.81 0.96 201.920 0.777 0.584
WGA
UKP90 0.96 1.00 111.850 0.969 0.297
UKP94 0.95 1.00 116.179 0.976 0.255
UKP95 0.96 1.00 183.517 0.968 0.267
UKP97 0.75 1.00 122.642 0.972 0.406
UKP98 0.28 0.98 179.686 0.968 0.615
UKP99 0.96 1.00 224.938 0.970 0.238
UKP102 0.89 1.00 204.001 0.972 0.324
UKP103 0.95 1.00 125.109 0.964 0.286
UKP104 0.97 1.00 249.685 0.971 0.224
UKP106 0.96 1.00 103.495 0.971 0.242
UKP107 0.78 1.00 123.906 0.964 0.501
UKP118 0.97 1.00 123.549 0.966 0.25
UKP119 <0.01 0.17 123.305 0.945 0.638
UKP120 0.96 1.00 171.077 0.969 0.272
UKP121 0.90 1.00 127.770 0.972 0.313
UKP122 0.78 1.00 106.596 0.968 0.433
UKP123 0.11 0.66 140.564 0.961 0.765
UKP124 0.38 0.98 186.368 0.965 0.59
Continued on next page
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UKP125 0.95 1.00 119.095 0.969 0.243
UKP126 0.09 0.79 121.587 0.958 0.667
UKP127 0.53 0.99 121.092 0.969 0.502
UKP128 0.90 1.00 117.884 0.971 0.349
UKP129 0.53 0.99 106.458 0.969 0.452
UKP130 0.98 1.00 129.992 0.966 0.222
UKP131 0.97 1.00 229.840 0.964 0.219
UKP132 0.03 0.43 122.373 0.957 0.749
UKP133 0.40 0.98 126.124 0.967 0.556
UKP134 0.92 1.00 123.355 0.975 0.277
UKP135 0.16 0.80 124.486 0.963 0.733
UKH51 0.97 1.00 227.015 0.970 0.215
UKH55 0.97 1.00 207.896 0.971 0.218
UKH56 0.97 1.00 258.286 0.969 0.217
UKH57 0.90 0.99 123.245 0.970 0.227
UKH58 0.80 0.94 162.412 0.935 0.514
UKH59 0.90 0.99 149.380 0.970 0.224
UKH60 0.90 0.99 179.545 0.970 0.214
UKH61 0.92 0.99 199.525 0.969 0.212
UKH62 1.00 1.00 221.506 0.969 0.213
UKH63 1.00 1.00 232.824 0.976 0.492
UKH64 1.00 1.00 232.824 0.976 0.492
UKH65 1.00 1.00 207.611 0.975 0.329
UKH66 1.00 1.00 208.255 0.972 0.234
UKH67 0.95 1.00 184.459 0.975 0.355
UKH68 0.96 1.00 214.868 0.976 0.265
UKH69 0.96 1.00 203.663 0.974 0.248
UKH70 0.96 1.00 198.205 0.976 0.285
UKH71 0.96 1.00 205.866 0.973 0.254
UKH72 0.96 1.00 220.255 0.977 0.391
Table 2.1: Bowtie2 mapping statistics for C. parvum and C. hominis reads. The
Gini coefficient is included in this table as an indication of uneven depth of coverage
(IowaII=0.112). Cryptosporidium reads were mapped to appropriate reference genomes
for each species: *C. parvum IowaII, †C. hominis TU502. Included is the the area under
the normalised Gini granularity curves as an indication of read distribution (see Section
2.2.4). *Isolates which were originally published by Hadfield et al. and updated using
the described workflow. All other genomes were newly assembled and analysed. Isolates
highlighted in red cover an insufficient portion of the reference genome, and are therefore
considered to have failed in the objective of sequencing the entire genome.
Table 2.1 indicates high depth of coverage inequality throughout the genomes, repre-
sented by relatively high Gini coefficient values in comparison to that exhibited by the C.
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Figure 2.6: Gini granularity curves generated from Gini values (G) calculated using
different window sizes (W ) for the genome assemblies presented in this chapter. Black
samples were not subjected to DNA enrichment prior to sequencing, grey samples were
subjected to DNA enrichment by WGA (see Section 2.2.5). Samples of interest are
colourised as: red = UKP5, green = UKP6.
parvum Iowa II reference genome (G | W1 = 0.112), which the mean depth and breadth of
coverage (fraction of the reference covered) will not indicate. This appears to be a com-
mon issue when sequencing intestinal protozoans from human clinical samples. Paired
end read libraries accessed from GenBank, sequenced by the Welcome Trust Sanger In-
stitute (Bioproject PRJEB3213), and those published by Troell et al. (2016) (Bioproject
PRJNA308172), who was attempting to generate whole genome sequences from single
cells using whole genome amplification [Troell et al., 2016], also suffered from very high
Gini coefficients, indicating that this problem is not restricted to a single research team.
See Figure 2.1 for an example of how the Gini value corresponds to actual read depth
variation.
Gini granularity curves are presented here as a more complete indication of the cov-
erage over a genome. The premise behind this is based on two shortcomings of using the
Gini coefficient alone as a measure of depth of coverage inequality:
 Two genomes with identical ordered coverage arrays will produce identical Lorentz
curves, and therefore an identical Gini. This does not take into account the distri-
bution of depth of coverage across the genome.
 The Gini coefficient is known to be confounded by data granularity [Monfort, 2008].
Curves generated from Gini granularity analysis are found in Figures 2.6 and 2.7.
These curves show a similar set of characteristics, which can be defined by two phases:
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Figure 2.7: Normalised Gini granularity curves generated from normalised Gini values
(G) calculated using different window sizes (W ) for the genome assemblies presented in
this chapter. Black samples were not subjected to DNA enrichment prior to sequencing,
grey samples were subjected to DNA enrichment by WGA (see Section 2.2.5). Samples
of interest are colourised as: red = UKP5, green = UKP6.
Figure 2.8: G | W1 plotted against nAUC. Four different cases are presented in each
corner as an indication of how this graph can be interpreted. Black samples were not
subjected to DNA enrichment prior to sequencing, grey samples were subjected to DNA
enrichment by WGA (see Section 2.2.5). Samples of interest are colourised as: red
= UKP5, green = UKP6. Blue and purple samples belong to Cyclospora cayetanensis
genomes, and are included to demonstrate that these areas of the graph can be populated.
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1. Decline phase: The Gini value (G) decreases quickly as the window size (W ) in-
creases.
2. Perturbation phase: The Gini value plateaus, and perturbation increases, as window
size increases.
The two phases of the Gini granularity curves (Figures 2.6 and 2.7) may be indicative
of characteristics of each dataset, and the method by which they were generated. The
magnitude of the drop exhibited during the decline phase appears to vary considerably,
with some isolates presenting a large decrease in G over smaller window size increases
(e.g. UKH5), and others presenting with very little drop. The initial drop in G may be
as a result of the window size being less than the insert size of fragments used to generate
these reads. Variation in the rate of drop during the decline phase may indicate higher
coverage spiking1. There appears to be some amount of variation in the characteristics
of the curves generated for each species. For example, the Cryptosporidium data (seen in
grey) differentiates into two discrete groups in Figure 2.8, when using G | W1 (the Gini
calculated using a window size of 1, and therefore at maximum granularity). This is also
seen in Figure 2.4:
1. UKH4, UKP3, UKP4, UKP7, & UKP8 exhibiting G = 0.55− 0.60
2. UKH3, UKH5, UKP2, UKP5, & UKP6 exhibiting G = 0.22− 0.28
The magnitude and length of the decline phase appears to vary depending on the Gini
value calculated over single base windows (W = 1 or W1). Greater G | W1 values appear
to exhibit an extended decline phase (see Table 2.1). Likewise, the perturbation phase
differs between the two groups, where group 1 (higher G) levels off at a much slower rate,
and shows large levels of G perturbation, and group 2 (lower G) levels off at a quicker
rate and shows lower levels of G perturbation. The variation in the characteristics of the
perturbation phase may be as a result of a number of factors, such as the level of noise
within the dataset, genome incompleteness, and the number of contigs within the final
assembly. These results indicate that the analysis of these Gini curves hints at coverage
features which are lost by considering a single Gini value alone.
Within high Gini isolates, a lower area under the normalised curve indicates uniform
spiking, whereas a higher area under the normalised curve indicates aggregation of reads
throughout the genome (see Figure 2.7). Analysis of these curves allows for a more
comprehensive analysis of problematic genomes with high depth of coverage inequality,
1’Spiking’ and ’blocking’ are used here to describe the density of peaks and troughs in coverage across
a sequence, wherein spiking refers to a high spike granularity and a larger number of peaks and troughs
within a sequence, and blocking refers to low spike granularity and the aggregation of reads into areas
of high coverage, resembling blocks. See Figure 2.1B for examples of spiking and blocking.
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wherein spiking indicates a general problem with sequencing, and high read aggregation
indicates problems sequencing particular regions. Colourised are curves of particular in-
terest, such as green (UKP6) and red (UKP5) which represent the differences which may
be exhibited by two genomes with similar G | W1. These curves suggest two different dis-
tribution types, due to UKP5 bearing a more pronounced decline phase than UKP6, and
therefore bearing a lower area under the normalised Gini-granularity curve, suggesting
greater levels of spiking. Figure 2.1B shows the coverage over chromosome 1 for both of
these genomes to be very different in character, despite there being only a 0.002 different
in Gini at absolute granularity. Coverage over UKP6 appears to present as relatively
even, but with localised spikes of coverage reaching and exceeding 1000x (’blocking’). In
contrast UKP5 presents with non-localised homogeneous pronounced spiking, with little
width (high spike-granularity), and reach similar depth. This should serve as a clear ex-
ample of how the difference in the nAUC of genomes which bear similar G | W1 related
to the distribution of read coverage across a genome.
Figures 2.6 and 2.7 illustrate that WGA significantly alters the distribution of cover-
age over a genome (seen in the grey samples, which were subjected to WGA). It appears
to effectively remove the decline phase in Gini-granularity curves using these window
sizes, increasing the nAUC of a sample. This results in an upward drift on the nAUC vs
G | W1 plot seen in Figure 2.8. The position of the isolate within Figure 2.8 indicates the
nature of the read distribution across a genome, wherein nAUC describes the amount of
spiking or blocking (aggregation) of the reads, and G | W1 describes the unevenness of
coverage. Consequently, the ideal coverage profile of an isolate would be high read ag-
gregation (low nAUC, indicating blocking) and low inequality of coverage (low G | W1).
This would indicate the read coverage across the genome is evenly distributed. nAUC
becomes more descriptive of the read distribution across a genome as G | W1 increases,
where it will indicate the level to which reads aggregate (blocking), or whether uneven-
ness of coverage is universal across the entire genome (spiking). Figure 2.9 is a graphical
representation of the how nAUC and G | W1 characterises the distribution of data (in
this case, reads) within a dataset (in this case, across a genome). One criticism of this
figure is that it is not clear how the bottom left (represented by even coverage and high
spiking) can be populated, since as G | W1 trends to 0, the nAUC is likely to trend to
1, since the change in in G | Wn across values of n will also decrease. Assemblies with
perfect coverage equality could be interpreted as: all reads aggregate to a single block
which spans the entire assembly, rather than organising into discrete blocks across the
genome.
WGA acts to amplify large (> 10kb) regions of the genome. These results suggests
a bias in which regions are amplified, which results in significant coverage aggregation
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Figure 2.9: A graphical representation of the types of distribution of data characterised
by comparing nAUC and G | W1, wherein the darker the tone of the cell, the more data
(as a proportion of the whole) that cell contains. Cases A, B, C & D are equivalent in
position to the four cases seen in Figure 2.8. Set A (G | W1 = 0.00) represents high
nAUC and low G | W1, wherein data is evenly distributed and aggregated (though in
this case, the location at which the data aggregates represents the whole set). Set B
(G | W1 = 0.50) represents a high nAUC and high G | W1, wherein data is highly
aggregated and unevenly distributed, resulting in high aggregation of data within the
set. Set C (G | W1 = 0.25) represents a low nAUC and a low G | W1, wherein data
is moderately evenly distributed, but some spiking is present. Set D (G | W1 = 0.50)
represents a low nAUC and a high G | W1, wherein data is not aggregated and not evenly
distributed, leading to high spiking. Gini values here are approximate and used only as
an example.
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(blocking, indicated by low nAUC) in large regions which are preferentially amplified
during this process. This would lead to a decrease in nAUC, as seen in these data. Since
G was calculated over window sizes of between 1-10000 bases, the decline phase would
be effectively eliminated. However, increasing the window size beyond the average size
of the regions amplified during the WGA process may resolve these decline phases.
Considering the effects of WGA, Figure 2.10 shows kernel density estimation plots
from 4 isolates of C. parvum, where GC content is plotted against mean coverage over
windows of 1000 nucleotides (see Section 2.2.6). The isolates within this dataset can be
split into two cohorts:
 Genomes which were sequenced from DNA extracted and purified from clinical
isolates without any further processing to enrich DNA prior to sequencing.
 Genomes which were sequenced from DNA extracted and purified from clinical
isolates and then enriched using WGA, as detailed in section 2.2.5.
These results show that in isolates where the Gini score is high, indicating low depth
of coverage equality across the genome, coverage over regions exhibiting GC content of
30% ≥ is significantly higher than that of regions exhibiting GC content of 30% ≤ (Figure
2.10a). In instances where Gini is low, indicating high depth of coverage equality across
the genome, there is a less clear increase, or none whatsoever (Figure 2.10b). Gini scores
from these genomes are variable, indicating variable levels of depth of coverage inequality
(see Table 2.1).
The results illustrate much more dispersion in the graphs generated from enriched
genomes than those generated from un-enriched genomes. These results indicate that
the distribution, and subsequent shape of the graph, is at least partially associated with
the Gini score. There appear to be two major distinct types of distribution based in the
shape of the distribution and the position of the centre of mass (see Section 2.2.6 for a
description of how the centre of mass was calculated) of the distribution:
Type I A very tight distribution with a greater than linear distribution, exhibiting a
defined increase in coverage at 30% GC content. An example of this type of distri-
bution can be seen in Figure 2.10a.
Type II A radially dispersed distribution with no clear trend, and a centre of mass at
30% GC content. An example of this type of distribution can be seen in Figure
2.10b.
These types account for the majority of all distributions seen within the dataset. However,
there also appears to be two minor types of distribution which do not easily fit into the
two major types:
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Type III A linear distribution with a fairly dense centre of mass and some dispersion.
An example of this type of distribution can be seen in 2.10d.
Type IV A large and widely dispersed distribution, with some windows exhibiting very
high coverage relative to the centre of mass. Low density centre of mass, which lies
at 30% GC content and low coverage. An example of this type of distribution can
be seen in Figure 2.10c, where coverage over some windows exceeds 4000x. This
may be considered to be a variation on type II dispersion, as when a maximum
coverage cut-off is applied, the dispersion appears to be type 2.
The centre of mass within these kernel density arrays indicates the mean % GC con-
tent and coverage across the genome. Since the plots here described are all generated
using Cryptosporidium genome assembles, the centre of mass is expected to be at a sim-
ilar location ( 30% on the x-axis), however, the mean coverage (y-axis) is expected to
vary. The shape of the graph object (see Section 2.2.6 for a working definition of ’graph
object’) is therefore dictated by the distance of all points with intensity greater than a
given threshold within the kernal density array from the centre of mass. The angular
momentum will therefore vary dependant on the shape and density of a graph object,
and consequently the relationship between % GC content and coverage over the genome.
The results detailed in Figure 2.10 illustrate that the implementation of WGA as
a means to enrich DNA prior to sequencing significantly alters the coverage over the
genome. Rather than increasing the mean depth of coverage over the genome uniformly,
however, more our analysis highlights that it selectively amplifies certain sequences. Due
to the existing GC bias which has been reported within Illumina sequencing data [Ben-
jamini and Speed, 2012] (illustrated by Type I distribution, as seen in UKP4 in Figure
2.10), this has the effect of compensating for this bias, resulting in a much more
radially dispersed distribution with a far less clear positive correlation between coverage
and GC content. These results highlight the value of using DNA enrichment by WGA for
generating high quality, reliable genome assemblies from clinically isolated Cryptosporid-
ium samples. However, it also hints at a complex relationship between depth of coverage
and sequence content across enriched genomes.
Figure 2.11 shows Gini content plotted against angular momentum of distribution
objects exhibited in GC content vs coverage plots, such as those shown in Figure 2.10.
Angular momentum is calculated for graphed distribution objects with density cut-offs
(shown above the plot). These cut-offs are highlighted as contour lines in plots shown
in Figure 2.10. As the cut-off threshold (t) increases, the correlation between Gini and
angular momentum for both the WGA (red) and non-WGA (blue) datasets increase, with
the highest correlation being seen at t = 0.000256, which exhibits R2 values of 0.872 and
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0.931 for WGA and non-WGA datasets respectively. The R2 scores then drop consid-
erably at t = 0.000512. Thresholds of higher than this exceeded the maximum density
of some of the isolates, which resulted in data loss. There is a strong negative corre-
lation between the Gini scores and the angular momentum of distributions in genomes
which are subjected to DNA enrichment using WGA, and a similarly strong positive cor-
relation in genomes which were not subjected to WGA. There also appears to be some
clustering based on distribution types, with type I (circle) showing loose clustering at
the upper-right area (high angular momentum and high Gini), type II (triangle) showing
tight clustering primarily in the lower-middle/lower-right areas (moderate to high angu-
lar momentum and low Gini), type III (square) only being represented by a single datum
in the lower left area (low angular momentum and Gini), and type IV (cross) moderately
clustering in the upper left portion (low angular momentum and high Gini). These results
indicate that the optimal cut-off threshold for elucidating structure within these data is
t = 0.000256.
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(a) UKP4 (non-WGA) R2 = 0.823 G = 0.4693
(b) UKP94 (WGA) R2 = 0.396 G = 0.2539
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(c) UKP98 (WGA) R2 = 0.182 G = 0.6145
(d) UKP6 (non-WGA) R2 = 0.455 G = 0.2508
Figure 2.10: Coverage vs GC contents plotted within 1000bp windows for 4 UK isolated
C. parvum genomes. UKP3 and UKP6 were not subjected to enrichment by a Whole
Genome Amplification (WGA) process. DNA of UKP94 and UKP98 were enriched by a
WGA process (φ29) prior to sequencing. The plots were generated using kernel density
estimation, overlaid with contour lines, equating to thresholds (t). The red dot marks
the calculated centre of mass of the graph object (see Equations 2.9 and 2.10 in Section
2.2.6.1).
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Figure 2.12: Read coverage across chromosome 4 of UKP90 (WGA) (nAUC = 0.969,
G | W1 = 0.297) showing high levels of read aggregation.
The results in Figure 2.11 demonstrate that there is a complex relationship between
the Gini and the angular momentum of isolate genomes. The nature of this relationship
depends on whether the DNA extracted from the isolate has been enriched using whole
genome amplification (see Section 2.2.5 for a description of this process). Isolates which
have been subjected to WGA appear to have angular momentum which bears strong
negative correlation with their Gini score. Furthermore, the structure of the distribution
graph is influenced strongly, where WGA appears to result primarily in a type II dis-
tribution, with some exhibiting a type IV distribution. This distribution correlates very
strongly with low Gini coefficient. Furthermore, isolates which have not been subjected
to WGA prior to sequencing illustrated a strong positive correlation between Gini and
angular momentum. These non-WGA isolates exhibit primarily type I distribution, with
some type II. Type I distribution (typical of non-WGA samples) clearly shows a bias
towards coverage at higher GC content, characterised by a clear increase in coverage at
30% GC content (e.g. 2.10a), indicating that the process of DNA extraction and high-
throughput Illumina sequencing biases higher GC content sequences. This GC content
bias within Illumina sequencing data has been reported since 2008 [Dohm et al., 2008],
with subsequent attempts to characterise and address this bias [Benjamini and Speed,
2012, Ross et al., 2013].
The results detailed in Figure 2.11 illustrate that enriching DNA using WGA prior
to sequencing significantly alters the coverage over the genome. Rudimentary analysis
suggests that it merely increases the mean depth of coverage over the genome, however,
more thorough analysis indicates that it selectively amplifies certain genomic regions to
a higher degree than others. Due to the existing GC bias which has been reported within
Illumina sequencing data (illustrated by Type I and type IV distribution, as seen in
Figures 2.10a and 2.10d), this has the effect of compensating for this bias, resulting in a
much more radially dispersed distribution with a far less clear positive correlation between
coverage and GC content. The amplification bias of WGA which was previously discussed
and indicated in Figures 2.6, 2.7 and 2.8, may be responsible for compensating for the
Illumina GC bias by preferentially amplifying large (> 10Kb) regions of the genome
[Alsmadi et al., 2009] (as seen in Figure 2.12) by some other set of criteria, leading to
alteration in the type of distribution seen, and consequently the angular momentum of the
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No. N50 Av. (kb)
UKH3 168 149.9 54.0 9293 12 3792 (401)
UKH4 522 57.4 17.5 9594 95 3791 (467)
UKH5 463 54.6 19.6 9357 92 3787 (496)
UKP2 157 216.0 58.2 9254 23 3720 (356)
UKP3 270 109.8 33.7 9336 23 3688 (453)
UKP4 235 175.2 38.7 9226 22 3770 (349)
UKP5 447 70.7 20.3 9271 51 3800 (430)
UKP6 689 332.6 14.1 9826 13 3731 (96)
UKP7 521 62.6 17.3 9257 19 3797 (475)
UKP8 369 93.0 24.7 9473 26 3803 (518)
Table 2.2: The assembly statistics (SPAdes and post-PAGIT) include the number of scaf-
folds (No.), scaffold N50 metric, scaffold mean length (Av.), and the total size of the final
assembly. Gene annotations were transferred by RATT out of a total of 3805 gene annota-
tions in the reference assembly. Genes erroneously transferred refers to genes transferred
to regions which have been identified as chimeric (and therefore misassemblies). Within
C. hominis, the erroneous transfers are putative, due to differences between C. parvum
and C. hominis.
isolates read distribution. Such bias has been documented previously, but not investigated
thoroughly, and is often characterised as random [Alsmadi et al., 2009, Börgstrom et al.,
2017]. Further investigation into this bias must be carried out to characterise this in more
detail, along with the relationship between the Illumina %GC bias and WGA.
2.5 Results and Discussion for Assembly and Post-
Assembly Processing
Table 2.2 shows the results of assembly using SPAdes. The results from assembly with
Velvet were comparable to that of SPAdes, and therefore are not shown here. Table 2.3
shows the results of assembly using IDBA-UD. The results shown in these tables indicate
that SPAdes produced assemblies with longer and fewer contigs than IDBA-UD, high-
lighting the differences between the assembly approaches adopted by the assemblers.
Both the assemblies were then run through the PAGIT pipeline to make the improve-
ments described in the methods section, including gap closing and the transfer of gene
annotations. The results can be found in Tables 2.2 and 2.3. The SPAdes assemblies
required fewer gaps to be closed by IMAGE. The mean percentage of genes transferred
by RATT to the improved SPAdes assemblies is >99%. The mean percentage of genes
transferred to chimeric regions is 10.6%.
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No. N50 Av. (kb)
UKH3 419 52.9 21.5 9102 104 3757 (0)
UKH4 627 39.7 14.3 9212 229 3688 (44)
UKH5 619 38.7 14.5 9197 247 3699 (32)
UKP2 360 63.9 25.2 9143 241 3776 (0)
UKP3 563 47.8 16.0 9168 312 3767 (1)
UKP4 509 53.7 17.7 9154 292 3772 (0)
UKP5 1830 11.2 4.8 9273 1791 3552 (1)
UKP6 768 51.4 12.1 9135 105 3702 (2)
UKP7 829 32.0 10.7 9184 288 3775 (6)
UKP8 614 40.7 14.7 9177 293 3756 (0)
Table 2.3: Statistics for draft genomes assembled using IDBA-UD as per Table 2.2. An
extended table including assembly stats from the extended C. parvum and C. hominis
dataset can be found in the Appendix (Table 1).
Table 2.3 shows the results of assembly using IDBA-UD, and subsequent improve-
ment and annotation using PAGIT. These genomes benefited greatly from gap closure by
IMAGE over those produced by SPAdes (see Tables 2.2 and 2.3), since gaps in intragenic
repetitive regions were much more common, potentially confounding VNTR analysis. The
mean percentage of genes transferred by RATT to the improved IDBA-UD assemblies
is 98%. The mean percentage of genes transferred to chimeric regions is 0.2%. In the
IDBA-UD assemblies, the C. hominis genomes performed slightly worse, with 0, 44, and
32 genes transferred to chimeric regions respectively across UKH3, UKH4, and UKH5.
The dramatic decrease in the number of genes transferred to chimeric regions indicates
significantly fewer misassemblies in improved genomes generated by IDBA-UD than in
those of SPAdes, marking a significant improvement. This indicates the effectiveness of
using ABACAS to identify gaps within the IDBA-UD assemblies, and IMAGE to close
them, which SPAdes would resolve during assembly.
NUCmer, from the MUMMER package was used to identify misassembly, as detailed
in section 2.3.3. Figure 2.13 shows the extent of misassembly in the isolate genomes,
denoted by coloured bars corresponding to which chromosomes regions belong to accord-
ing to NUCmer. Extensive misassembly was identified in all of the genomes, to varying
degrees. The most consistently misassembled chromosome is chromosome 7, with a con-
sistent chromosome 8 misassembly. The most misassembled isolates where UKP3 and
UKP8, with 8 misassemblies of larger than 10kb. These two isolates have very high Gini
scores (see Table 2.1), of 0.5489 and 0.5570 respectively.
Figure 2.14 illustrates a moderate correlation (R2 = 0.41) between the Gini coeffi-
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Figure 2.13: Misassembled regions on each SPAdes assembled Hadfield et al. C. parvum
genome. Regions are colour coordinated by which chromosome of the C. parvum IowaII
reference genome (represented by the outer track) they map to. From outermost to
innermost, the inner tracks represent the genomes of each isolate from UKP2-8. The
innermost track (UKP8) also includes a linkage map showing precisely where the regions
map to in the IowaII reference genome. The second from outer track shows a heatmap of
genes bearing Tandem Repeats (TR’s), from light yellow denoting a single VNTR within
the gene to dark red indicating many TR’s within the gene. TR’s were identified using
Tandem Repeats Finder (see section 2.3.3).
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Figure 2.14: The percentage of genes transferred to chimeric (misassembled) regions
against Gini coefficient of coverage for 45 isolates of C. parvum and C. hominis. R2 is
the coefficient of determination.











Table 2.4: The number of VNTR regions missing within the IDBA-UD assemblies pre
and post gap closing with IMAGE.
cient and number of misplaced genes within misassembled chromosomal regions across
45 isolates of C. parvum and C. hominis.
Table 2.4 shows the number of VNTR regions that were missing from the IBDA-
UD assemblies before and after gap closure with IMAGE. These results show that a
large amount of VNTR regions were resolved using IMAGE, indicating the importance
of post-assembly genome improvement in the generation of accurate and reliable genome
assemblies.
Figure 2.13 shows putatively misassembled regions (translocations) within the C.parvum
UKP2-8 [Hadfield et al., 2015] PAGIT-improved SPAdes assemblies. A heatmap showing
the number of VNTR’s per coding sequence (CDS) is included. Every genome assembly
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within the dataset exhibits significant misassembly across all chromosomes, particularly
at the terminal end.
Whole genome alignments were used to identify in silico translocation events (con-
sidered putative misassemblies), as detailed in section 2.3.3. Figure 2.13 illustrates that
translocation occurred in a similar fashion throughout each of the assemblies, with the
same areas being merged into similar chimeric genomes, as can be seen in chromosome
7, where the initial 120kb region has merged into the end of chromosome 8 throughout
all of the genomes. It is interesting to note that only on UKP3 was a 70kb area from
chromosome 5 seen starting at 500kb on chromosome 7. Similarly only in UKP8 was a
unique 70kb translocated region seen in chromosome 7 from chromosome 3. These two
genomes bear high Gini coefficients, as detailed in Table 2.1, which may contribute to
this. A peculiarity of these misassemblies is the observed trend of chimeric chromosomes
being a result of the native chromosome being flanked upstream by 80kb of the down-
stream extreme portion of the subsequent chromosome. This is illustrated very clearly in
Figure 2.13.
Taxonomic evaluation carried out by Hadfield et al. utilising the gp60 marker show
that there are five gp60 subtypes within the C. parvum dataset. This variation within
the Hadfield C. parvum isolates is supported by Perez-Cordon et al. [Perez-Cordon et al.,
2016] which shows clear variation across 28 VNTR loci, suggesting a number of genetic
lineages. The very low likelihood of similar translocation occurring across different popu-
lations of C. parvum indicates that these events are as a result of misassembly by SPAdes,
rather than a biological observations.
Examination of one such chimeric contig (the chr8-chr7 chimeric region at 0-0.14Mb
of UKP3 on Figure 2.13) revealed that the region has very low depth of coverage, with no
single read spanning the chromosomal fragments. Moreover, the sequences from differ-
ent chromosomes are joined using a simple ”AT” repetitive region with only three reads
spanning the repeat region and no reads pairing across it (see Figure 2.15). This was
observed in a number of other chimeric interface regions. Due to the low complexity, high
repeat rich nature of the Cryptosporidium genome, coupled with the difficulties associ-
ated with DNA extraction and sequencing of this parasite, there is insufficient evidence
to suggest that this represents true biological variation. Instead, it may be attributed to
a misassembly by the SPAdes software. This kind of assembly error was also typical of
the assemblies produced by using Velvet de novo assembler.
Unlike SPAdes, the IDBA assembler leaves these sequence fragments unjoined, with
the result that significantly less chimeric regions are seen in the IDBA assemblies. This
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Figure 2.15: The misassembly interface between fragments from chromosomes 8 and 7 on
the chimeric chromosome 7 of UKP3. Single reads are shown, as is a colourised sequence
track (A = Green, T = Red, C = Blue, G = Orange) at the bottom where the repeat
region implicated in the formation of this chimeric contig can be seen. Image produced
using IGV.
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Figure 2.16: A multiple alignment of a VNTR region within cgd5 350 in the C. parvum
dataset utilised in this chapter that was resolved within IDBA-UD assemblies using IM-
AGE. Four alleles are seen within this alignment, defined by variation in the number of
’ACC’ and ’ACT’ codons present within the region. Differences such as this within a
VNTR region can be used to define distinct genotypes, used for diagnostic evaluation.
This VNTR was identified by VaNTA, as discussed in Chapter 3.
is because IDBA is designed for the task of assembling genomes of highly uneven depth
of coverage. Although IDBA-UD did not create so many chimeric contigs, the low com-
plexity regions were often left unassembled, with the result that CDS regions contained
gaps. Unfortunately, these gaps often included the VNTR’s that require for a multi-locus
subtyping scheme.
Both SPAdes and Velvet (data from Velvet not shown) produced full, ungapped CDS
regions (see Table 2.2). Thus the IDBA assemblies were not suitable for VNTR analysis
and further biomarker identification without significant improvement. PAGIT was used
to improve the genomes from all assemblers (see section 2.3.2), and this improved the
resolution of low complexity regions within the IDBA-UD assemblies. Within PAGIT,
ABACAS performs scaffolding on the genome assemblies and introduces gaps across the
unassembled regions, the IMAGE tool then performs gap closure on these regions, result-
ing in high quality intragenic VNTR’s for biomarker analysis.
An example of a region resolved by IMAGE can be seen in Figure 2.16, which shows
a multiple alignment of the cgd5 350 gene from each of the Hadfield C. parvum assem-
blies. This region exhibits 4 distinct alleles, and can therefore be used to define specific
genotypes: an essential tool of clinical diagnostics. The number of gaps closed within the
IDBA-UD assemblies was significantly higher than within the SPAdes assemblies. This
difference in gaps closed was expected, as IDBA-UD was designed for the purpose of
assembling genomes which suffer from poor depth of coverage equality, and is therefore
more conservative in extending reads across regions with shallow coverage.
The C.parvum assemblies produced by IDBA-UD and PAGIT exhibited very few
misassemblies compared to the SPAdes assemblies. However, the C. hominis genomes
suffered from a greater amount of putative misassemblies within the IDBA-UD genomes,
as measured by the number of genes being transferred between chromosomes. Note
that, genes are transferred from the C. parvum IowaII reference genome, which is as
different, albeit similar species, and so some biological changes may be expected. Further
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analysis is required to fully eliminate assembly error as a cause of these chromosomal
translocations. Table 2.4 shows that IMAGE is essential within this workflow for the
resolution of repetitive regions which are not resolved during assembly with IDBA-UD.
The results show a five to six-fold decrease in the number of VNTR regions missing within
the assemblies.
2.6 Conclusion
In this chapter I have performed a detailed analysis of 10 Cryptosporidium genomes
(Dataset 1) assembled with 3 popular assemblers. The results of this analysis was then
used to direct the re-assembly of Dataset 1.1 to generate Dataset 1.2, and to assemble
a further 48 Cryptosporidium genomes (Dataset 2: 29 C. parvum and 19 C. hominis)
isolated from UK clinical samples.
To investigate sequencing depth and breadth of coverage, I have developed a novel
approach that uses the Gini coefficient to determine coverage inequality. I also present
a novel technique which allows for further investigation of depth of coverage inequality
by generating Gini-granularity curves. I demonstrate how these curves characterise the
distribution of reads across a genome and relate this to the quality of subsequent genome
assemblies. Distribution of reads across a genome are characterised by the aggregation
of reads, leading to coverage ’blocking’ and ’spiking’, describing the appearance of read
coverage. This aggregation of reads is quantified by the use of Gini-granularity curves.
I have demonstrated that the use of WGA to enrich DNA within clinical samples is
a viable way of increasing read coverage. However, these results also demonstrate that
there is a complex relationship between the selectivity of amplified DNA during WGA,
and its sequence content, which is characterised by non-uniform amplification of large
(tens of kilobases) regions of the genome, resulting in a read coverage bias (see Figure
2.12 for an example of this preferential amplification of large regions, leading to read
aggregation). The results suggest that this bias introduced by WGA compensates for the
Illumina GC content bias.
I found the SPAdes and Velvet assemblies to be problematic on our datasets. This led
to misassemblies across low coverage, low complexity regions, resulting in the creation of
chimeric chromosomes: up to 15% of all genes were being placed within these chimeric
chromosomes. Although the assemblies generated by IDBA-UD did not suffer from the
problem of chimeric sequences, they were problematic due to a different assembly ap-
proach, leading to a large number of gaps, particularly in repetitive regions. This is a
significant issue because these gaps often contained the VNTR sequences that are impor-
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tant to us for developing new clinical genotyping strategies. However, the IMAGE gap
closing tool from the genome improvement pipeline, PAGIT, was able to resolve these
missing low complexity regions. Using this strategy, of assembly with IDBA followed by
gap closing with IMAGE, it will be possible to perform more in depth VNTR analysis
with the intention of identifying biomarkers that will facilitate the development of novel
prevention strategies in the fight against Cryptosporidiosis.
In the following Chapter, I will discuss the use of these high-quality, reliable genomes in
identifying novel biomarkers. I will introduce a novel bioinformatic tool which automates
the process of identifying Variable Number Tandem Repeat (VNTR) regions around a
CDS dataset generated using these genomes.
Chapter 3
VaNTA: Automated Discovery and
Variant Analysis of VNTR’s Within
Coding Regions.
3.1 Introduction
Due to the advent of high throughput next generation sequencing (NGS) approaches, the
amount of genomic data able to be produced has significantly increased. However, a bot-
tle neck exists in the analysis of these genomic data. The fast and cheap nature of NGS
in modern biology has allowed for sequencing of multiple populations of the same species,
which opens the door for comparative genomic analysis. The current state of sequencing
in biology necessitates the development of high throughput, lightweight bioinformatic
tools and pipelines, which automate the process of genome analysis in a cost, and time
effective manner.
Tandem Repeats (TR’s) are low complexity regions within DNA sequence consisting
of a single motif or subsequence repeated a number of times. The presence of these tan-
dem repeats has been implicated in disease, and may act as regulatory and epigenetic
elements within a genome. They have been interrogated and their variation exploited for
the purpose of laboratory diagnostics, whereby their presence or absence, and/or their
variation has been used to define groups of organisms or infer evolutionary lineage.
Tandem repeats are a common feature of many genomes, with 10% of the human
genome comprising of this type of sequence. In particular, telomeric regions are highly
repetitive in nature, which serves a number of biological and evolutionary purpose, such
as acting as expendable sequence during DNA replication.
TR regions are subject to high rates of mutation. This is thought to be largely due
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to a process called slipped strand mispairing, whereby DNA strands are displaced during
DNA replication, resulting in mispairing of complementary bases. Depending on the na-
ture of the slippage, this can result in the expansion or retraction of a repetitive region.
Further point mutations, insertions or deletions of this repetitive sequence may result
in further sequence variation, resulting in approximate copies of a repeat subunit being
exhibited, which are then subject to the same replication errors. These processes can
produce highly polymorphic sequences within a population over relatively few genera-
tions. Due to their high mutagenicity, particularly in repeat copy number, they are ideal
candidates for defining genotypes. When repeat copy number within a TR is identified
as polymorphic within a population, it is considered a Variable Number Tandem Repeat
(VNTR).
Within the context of this paper, we shall consider a VNTR to be a TR region that
exhibits > 1 allele within a population, and can therefore be used to define subpopula-
tions.
It is common for research groups to develop and use their own ’in house’ pipelines
when carrying out TR analysis and detection. A typical example of this is reported by
Perez-Cordon et al., who used Tandem Repeats Finder (TRF) to detect VNTR regions
within the genome of Cryptosporidium parvum Iowa II isolate and aligned them to ho-
mologues within a dataset of genomes generated by Hadfield et al. [Perez-Cordon et al.,
2016, Benson, 1999, Hadfield et al., 2015].
The Garner lab uses a method which also utilised TRF to identify VNTR regions
around the human genome, followed by alignment of reads against the VNTR reference
set using a bespoke set of scripts driven by BLAST and BWA [McIver et al., 2013, McIver
et al., 2011, Altschul et al., 1990, Li and Durbin, 2009].
There are a limited number of tools available for VNTR analysis. The tools which are
available come under two general classes: TR discovery, and variant detection. lobSTR
is a Short Tandem Repeat (repetitive regions of 2-6 nucleotide repeat subunits) profiler,
which uses known STR’s within a genome detected by TRF and aligns sequencing reads
to them. However, it is known to be limited to the number of microsatellite loci it can
call, and is not able to call monomers [McIver et al., 2013, Gymrek et al., 2012]. Re-
peatSeq is a tool for genotyping microsatellite repeats, using a Bayesian model selection
guided by an error model incorporating sequence and read properties. Reads are mapped
to a reference region and the mapped reads realigned using the GATK IndelRealigner
tool, with reads not fully spanning the region being discarded. Genotypes are assigned
using a fully Bayesian approach, considering the reference length of the repeat, the repeat
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subsequence size, and the average base quality [Highnam et al., 2013, Alkan et al., 2011].
As should now be clear, many of these tools use very similar approaches, being repeat
discovery using TRF, followed by variant detection by read mapping onto these repeat
reference loci. Because of this, they are subject to similar weaknesses, specifically the
usage of reads to detect variation, which may be confounded by reads generated by unsup-
ported sequencing technologies, poor read coverage or quality, or contaminant sequence,
and scales poorly with the size of the .fastq file and query dataset. They also do not take
advantage of the wealth of assembled DNA sequence which is far more readily available
and easily accessible over the internet, as well as annotation data.
Here we present the Variable Number Tandem Repeat Analysis Pipeline (VaNTA),
a bioinformatic pipeline designed to automate in silico discovery and variability analy-
sis of VNTR’s within a query data set of coding regions (CDS’), using a TR reference
library generated using a suitable reference genome. CDS regions are interrogated for
VNTR’s due to the higher selective pressure being exerted on these regions, resulting
in a higher probability of variation at these loci. The approach utilised in the VaNTA
pipeline avoids the usage of raw reads in favour of fully assembled and annotated genomes
due to the intention of identifying VNTR’s in large datasets of multiple genomes, which
would necessitate significant time and computational resources to achieve by processing
raw reads. Furthermore, it was designed with the intention of utilising the enormous
amount of assembled genomic sequence and annotation data available online to stream-
line and automate a typical pathogen biomarker identification workflow, which provide




Two data sets (assemblages) consisting of protozoans belonging to the apicomplexa were
assembled (Table 3.1). The data sets were constructed with the objective of identifying
VNTR biomarkers that can be used to define genotypes. VaNTA was run using each
assemblage as a dataset, totalling two separate runs.
3.2.2 .vff Format and Construction
Annotation files in .embl or .gff format are reformatted into .vff format; a bespoke anno-
tation format developed for the purpose of storing all information required by VaNTA.
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Assemblage Reference Query data set
A1 C. parvum Iowa II [Abra-
hamsen et al., 2004]
C. parvum (n=7): UKP2-8 [Hadfield
et al., 2015]
A2 P. falciparum 3D7
[Gardner et al., 2002]
P. falciparum (n=7): Pf2004, Pf7G8,
PfDD2, PfE5, PfHB3, PF-IT, PfNF54
Table 3.1: The contents of assemblages 1 and 2.
This format has both annotation and concatenated sequence data to streamline file pars-
ing. The format is structured in a linear fashion similar to .gff format. A single line is
structured as follows:
feature ID feature class start cat end cat strand chromosome ID start chr end chr
Where:
feature ID: The designated name of the annotation feature (e.g. the name of the a
gene).
feature class: The class of the annotated feature (e.g. CDS, gene, mRNA, exon
etc.).
start cat: The first base of the feature within the concatenated sequence at the end
of the .vff file.
end cat: The last base of the feature within the concatenated sequence at the end of
the .vff file.
strand: The strand the feature can be found on (’+’ or ’-’).
chromosome ID: The designated name of the chromosome the feature can be found on
(e.g. chr 1).
start chr: The first base of the feature within the chromosomal sequence alone.
end chr: The last base of the feature within the chromosomal sequence alone.
The annotation lines are followed by a single line, reading ’##FASTA##’, denoting
the start of the full concatenated genome sequence. This comprises all chromosomal se-
quences merged together into a single unbroken whole genome sequence.
These .vff files were generated using .gff annotation files of the assemblages (TTable
3.1) downloaded from CryptoDB (A1), and the Welcome Trust: Sanger FTP server (A2
& A3). A tool for reformatting .embl or .gff format files into .vff can be found in the
VaNTA github repository or on the Galaxy platform.
3.2.3 VaNTA Input and Arguments
The input for VaNTA necessitates the generation of an arguments file for command line
usage. An example of this argument file can be found in figure 3.1. This file can be
autogenerated using a VaNTA wrapper script, whereby only the essential arguments are
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Figure 3.1: The layout of the VaNTA argument file.
provided, and a unique temporary directory structure is created in the local /tmp/








Where the root /tmp/VaNTA.XXXXXX is generated using the mktmp command, and
.XXXXXX refers to a unique string to identify this run. All output will be deposited into
this temporary working directory structure.
Table 3.2 details the parameters used to run Tandem Repeats Finder and EMBOSS-
water local aligner. Parameters used for TRF were selected to favour minisatellites and
smaller microsatellite repeats which had little variation in period (repeat subunit) se-
quence. Parameters used for EMBOSS-water local aligner were generic, which was suit-
able for flank conservation and TR variation analysis.
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TRF Argument Value EMBOSS-Water Argument Value
Matching Weight 2 Gap Penalty 10





Max Period Size 15
Options -h
Table 3.2: Arguments and options used for Tandem Repeats Finder [Benson, 1999] and
EMBOSS-water [Rice et al., 2000].
3.2.4 Step 1: CDS and TR Reference Library Construction
Feature libraries may be constructed from any feature present in the .vff annotation files
(e.g. exons, intron, mRNA etc.), however, this tool was designed to identify VNTR’s
within CDS’, due to the higher selective pressure exerted upon them in comparison to
non-coding sequence.
CDS libraries were constructed using the .vff format annotation files. A TR reference
library generator script driven by Tandem Repeats Finder (TRF) [Benson, 1999] is then
used to identify tandem repeats within the reference CDS library, which are then isolated,
along with flanking regions, to form a library of reference TR’s (Figure 3.2A). The flanking
region is user defined, and accomplished two tasks, the first being to guide pairwise
alignment, since VNTR regions are, by their nature, highly polymorphic and therefore
subject to misalignment. The second being to allow regions flanking the TR to be checked
for conservation throughout the isolates for the purpose of primer design.
3.2.5 Step 2: TR and Flank Alignment
Using this TR reference library, pairwise alignments are carried out between the reference
TR’s and query homologs using a script driven by EMBOSS-Water local aligner [Rice
et al., 2000]. EMBOSS-Water local aligner was used due to its efficacy in aligning regions
with high sequence similarity.
Flanking regions are then isolated from the TR loci and individually subjected to a
similar pairwise alignment to establish upstream and downstream flank conservation.
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Figure 3.2: Workflow of VaNTA VNTR discovery pipeline. A. TR reference library
construction. B. TR and flank alignment and analysis.
Pairwise TR alignment occurs on a one against all basis, in which all query homologs
are aligned to a single reference TR and subjected to indirect evaluation by score com-
parison, which results in an analysis time of O(N) where N is the number of query CDS
libraries (Figure 3.2B).
3.2.6 TR Evaluation
Each TR locus is then evaluated by calculating a score based on how polymorphic the
locus is, the level of flank conservation and the length of the repeat region (Figure 1B).
The V-score is calculated as follows.
Take f 1 and f 2 to be the sets of alignment similarity percentages of flanks 1 and 2
respectively. These were generated by aligning TR locus flanks from each of the isolates







where j ∈ {1, 2}. Also take p to be the length of the TR period (e.g. p = 3 in a
TR consisting of TCA repeats), and l to be the length of the TR locus in the reference
genome. The V-score is calculated as
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V score = 100v + F 1 + F 2 − 10p− l
This score is weighted to bias smaller repeat regions with small repeat unit size, high
flank conservation and high repeat unit number polymorphism. The premise behind
selecting for smaller repeat regions is to select for copy number variation, rather than
sequence variation. In smaller regions, the impact that a single repeat unit variation
has on the relative sequence difference of the region is larger. Likewise, smaller repeat
units bear a lower probability of non-repeat insertion or SNP events, which may confound
analysis by undesirably exaggerating the variability of the TR locus.
3.3 Results
Running VaNTA on assemblage 1 (A1) using TRF and EMBOSS-Water options detailed
in figure 2, 889 TR’s were identified and aligned in at least one of the query CDS libraries
across 532 genes. Of these, 283 were identified as VNTR’s (2 or more alleles identified)
across 192 genes.
Table 3.4 (see next page) shows the comparison between results obtained by Perez-
Cordon et al. and VaNTA. Of the 25 coding regions identified by Perez-Cordon et al., 19
were identified and aligned by VaNTA, with similar results in number of alleles identified
at each locus within the dataset. Non-coding regions were not analysed during this run
of VaNTA. Of the 6 which were not identified, 4 were as a result of the period size ex-
ceeding our defined max period size detailed in figure 2 (cgd2 3300 1504, cgd4 1340 1688,
cgd4 3940 298, & cgd7 1010 9527) with no potential to reduce the period into a smaller
repeat period as seen in cgd2 3690 5176 (cgd2 3690.P.5111-5261) and cgd6 4290 9811
(cgd6 4290.P.9810-9902). However, increasing the max period size to 18 resolved these
loci. The two which were not identified by VaNTA (cgd1 3670 5956 & cgd2 3490 2029)
were investigated. cgd1 3670 5956 was resolved by setting the mismatch and indel penal-
ties to 7, to prevent it being reported as an 18 bp repeat and subsequently rejected for
being >15bp, and cgd2 3490 2029 was resolved by reducing the minimum score to 30, to
prevent it from being screened from the output (see figure 2).
The VNTR present at the gp60 locus (cgd6 1080.P.106-163) was identified within all
7 query CDS libraries and places at rank 3 with a V-score of 1943, exhibiting 5 alleles.
The results from VaNTA are in accordance with the known gp60 subtypes of this dataset,
seen within table 3.3.












Iowa II IIaA15G2R1 PRJNA15586 3805 4042 1154/NA
UKP2 IIaA19G1R2 PRJNA253836 3694 3963 1089/65
UKP3 IIaA18G2R1 PRJNA253840 3642 3931 1091/63
UKP4 IIaA15G2R1 PRJNA253843 3613 4333 1077/77
UKP5 IIaA15G2R1 PRJNA253845 3559 4733 1014/140
UKP6 IIaA15G2R1 PRJNA253846 3684 3939 1118/36
UKP7 IIaA17G1R1 PRJNA253847 3604 3951 1061/93
UKP8 IIdA22G1 PRJNA253848 3602 3911 1064/90
Table 3.3: Summary of the C.parvum isolates used in assemblage 1. N.B. Annotation
features collapse intronic genes into a single feature, which are split into separate exons
during CDS library generation.
assemblage 1 with flanking and repetitive regions highlighted. Figure 3.3c illustrates a
region (cgd1 3170.P.4280-4371) which exhibits a number of adjacent repeat subsequences
(periods), resulting in 4 identifiable alleles. Figure 3.3d shows the gp60 VNTR locus
(cgd6 1080.P.106-163) isolated by VaNTA, illustrating that all 5 expected alleles (as de-
tailed in table 3.3) were resolved and identified.
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Figure 3.4 shows the consistency in conservation of TR regions across the isolates
included in assemblage 1 (A1). The major high density TR regions are exhibited across
all isolates, such as those seen in chromosomes 3, 6 and 7. There are few TR regions
which are not exhibited by all isolates, but instances of such can be seen in chromosome
1 at approximately 0.5mb, where UKP5 lacks a TR, and chromosome 3 at approximately
0.4mb where UKP5 lacks a TR, and again in chromosome 3 at approximately 1.0mb
where UKP4 and UKP6 lack TR regions.
Running VaNTA on assemblage 2 (A2) using TRF and EMBOSS-water options de-
tailed in figure 2, 11,151 TR’s were identified and aligned in at least one of the query
CDS libraries across 2597 genes. Of these 2160 were identified as VNTR’s (2 or more
alleles identified) across 959 genes.
3.4 Discussion
The results presented in table 3.4 illustrate the value of automated analysis of poly-
morphic VNTR identification. It is apparent that the reported repeat subunits (periods)
differ between those reported by VaNTA and those reported by Perez-Cordon et al., most
commonly only by a single reading frame shift, such as that seen in cgd2 430.P.433-494
(cgd2 430 451) where the subsequence is reported by Perez-Cordon et al. to be TCAAGT,
and by VaNTA to be CAAGTT. This is likely due to an artefact of tandem repeats finder
reporting slightly differing scores due to different option parameters.
Missing data points such as those present in figure 3.3 were also observed in the anno-
tation files for these isolates, which suggests lack of assembly of these regions, possibly due
to poor local coverage, resulting in incomplete annotation. Table 3.3 demonstrates that
the gp60 VNTR locus exhibits 5 alleles within assemblage 1. However, as seen in figure
3.4, the downstream flanking region is poorly conserved, and there are a number of point
mutations which can be observed, particularly within the UKP8 isolate. In comparison,
the loci illustrated in figures 3.1-3.3 each exhibit 4 alleles within assemblage 1, but with
much better flank conservation, and (with exception of an A/G point mutation within
cgd1 3170.P.4280-4371, exhibited in figure 3.3) polymorphism constrained to repeat sub-
sequence copy number. If only repeat copy number is taken into consideration, gp60
exhibits 4 alleles within assemblage 1, since UKP2 and UKP8 vary only in A/G point
mutations in two positions. This sequence polymorphism necessitates sequencing of the
locus to identify subtypes. This difference in allelic designation is a non-trivial issue in a
clinical context. Diagnostic laboratories use either sequence polymorphism or fragment
length polymorphism to distinguish subtypes. The former necessitates sanger sequencing
of the interrogated region, which is more expensive and time consuming than fragment
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Figure 3.4: A circularised representation of VNTR density (number of VNTR’s within a
CDS) across the genomes of C. parvum isolates, from outermost to innermost: IowaII,
UKP2-8. The outermost ring, representing the karyotypic ideogram of the C. parvum
IowaII reference genome also includes gene positions represented as blue bars. The
heatmap spectrum goes from light yellow (lowest density) to crimson (highest density).
This figure was generated using Circos v0.69-6.
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length polymorphism, which looks for differences in the length of the region and infers
repeat copy number from this, but is more accurate. Therefore different results may be
obtained depending on which convention is used, which may confound investigation.
The currently available tools use similar approaches of generating a set of reference
tandem repeats (TR’s) and map reads to them all suffer from similar weaknesses, primar-
ily that they require a great deal of computational power to run. VNTRseek [Gelfand
et al., 2014], which attempts to reduce the number of reads mapped against the reference
TR dataset by running TRF on every read within a short read archive, generating a set
of reads which contain repetitive elements. These low complexity reads are then mapped
to the TR reference dataset and VNTR’s identified. This approach is highly RAM, disk
space, CPU and IO intensive. Approaches such as that employed by lobSTR, which maps
reads to flanking regions for the purpose of short tandem repeat profiling are efficient and
effective for STR profiling [Gymrek et al., 2012]. STRScan performs a similar task as
lobSTR, but uses a more targeted approach, only profiling a set of user defined STR’s,
reducing redundancy of analysis [Tang and Nzabarushimana, 2017]. Such STR profiling
approaches are effective for the analysis of single datasets but unsuitable for the discovery
and analysis of repeats across multiple genomes. More relevant tools such as that devel-
oped by Denoeud and Vergnaud (2004) [Denoeud and Vergnaud, 2004] and implemented
in an online platform, achieve the task of TR comparison within strains. However, this
tool is limited to 16 bacterial species, and the orthopox viruses, and therefore lacks the
scope and versatility of VaNTA. popSTR attempts to utilise the mapping approach seen
in lobSTR and STRscan, but applies it to population scale datasets in a time and mem-
ory efficient manner. This is achieved by generating a reference micro-satellite profile
and using mapped paired end illumina reads stored in a BAM file to identify VNTR’s
throughout a query dataset by positional comparison [Kristmundsdóttir et al., 2016].
However, this approach represents only half the workflow of VNTR detection, as paired
end read mapping still needs to be carried out. This tool is therefore subject to the same
criticisms as the lobSTR and STRscan.
Tan et al. (2010) performed a detailed analysis of VNTR’s within the P. falciparum
genome. They reported that 489 (9%) of the 5268 genes within the 3D7 reference bore
VNTR regions when aligning against the HB3 and/or Dd2 strains [Tan et al., 2010]. In
this paper we report 959 (18.2%) genes bearing VNTR’s across the P. falciparum genome.
This increase may be attributed to the fact that we used a larger dataset of 7 strains
rather than 3. Furthermore, they only reported perfect or near perfect TR’s of up to 12
bases repeat period size and maximum repeat size of 2000 bases, compared to our 15 base
repeat period size and no limit to maximum repeat size. The majority of the repeats were
<1000 bases in length, though one particularly notable repeat within the PF3D7 1038400
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Figure 3.5: A Screenshot of the Galaxy implementation of VaNTA.
gene was reported at 24.6Kb with a period sequence of TGAAGAAGTTATACC, though
it did not exhibit any variation within this dataset.
VaNTA necessitates the assembly and annotation of multiple genomes which, due to
the constantly expanding number of high quality genomes being made publicly available,
and the ever increasing ease with which they can be sequenced and assembled, VaNTA
will become more and more valuable and applicable for large scale genomic analysis. We
consider that most research teams are likely to have access to a sufficient number of high
quality genomes and their corresponding annotations. These data should be utilised to
their fullest extent, with particular emphasis on using annotation data to identify poly-
morphic TR’s within coding regions, which are much more likely to be under selective
pressure and therefore more likely to exhibit polymorphism that could be associated with
strain virulence.
VaNTA is currently available for use via the Aberystwyth University Galaxy platform,
facilitating its use by researchers who are not familiar with using tools designed to run via
the Linux command line. Figure 3.5 shows a screen shot of the Galaxy implementation
of VaNTA.
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3.5 Conclusion
In this chapter we have presented VaNTA: a new bioinformatics pipeline which utilises
an approach which is novel in its automation in detecting and analysing VNTR regions
across multiple genomes. VaNTA represents the automation of a commonly used workflow
which is usually carried out manually by research groups, and produces results that are
comparable, allowing for identical downstream analysis and processing. We have shown
that VaNTA can be used on data sets of two different apicomplexan parasites which can
be accessed via online databases. However, usage of VaNTA is not limited to any or-
ganism in particular. VaNTA utilises the constantly increasing amount of high quality
sequence and annotation data to perform ab initio VNTR identification and analysis in
a time efficient and computationally un-intensive manner. To the best of our knowl-
edge, this is the first pipeline or tool that has been made available to utilise assembled
genomes and annotation data for the purpose of VNTR detection and analysis. Unlike
the majority of the tools available, the VaNTA pipeline is intended to be run on personal
computers and laptops in a reasonable amount of time. This allows for research groups
and/or individuals who do not have access to high performance computing platforms, or
belong to bodies or institutions which utilise sensitive data that cannot be submitted to
tool hosting websites or for analysis on cloud computing services, such as the NHS, to
carry out analysis.
In the next chapter, I present a computational tool which was developed to identify
regions, such as the VNTR loci presented in this chapter, contained within reads from
next-generation sequencing datasets. Using these loci, we may very quickly and accurately
pull out and analyse reads which map to loci of interest.
Chapter 4
BlooMine: A Bloom filter driven
tool for mining raw sequencing reads
4.1 Introduction
Alignment-free sequence analysis has the capacity to resolve the significant bottle neck be-
tween data generation and analysis which has been well documented in ’omics research, as
it may be both faster and more computationally efficient than sequence alignment based
approaches. This allows for the development of tools which can mine information from
raw sequencing reads, obviating the significantly time consuming and computationally
expensive task of assembly. Furthermore, in instances where sequences are divergent,
alignment-free approaches may be more reliable than alignment based ones. The applica-
tion of alignment-free sequence analysis should be treated with care, however, as it may
be less accurate for some tasks. For example, it may be less sensitive than alignment
based approaches if the sequences are highly conserved.
There are a great many tools which employ alignment-free methods to identify nu-
cleotide and protein sequence similarity, developed to resolve problems in just about every
discipline within Bioinformatics, including, but not limited to:
 Assembly
de novo assembly [Zerbino and Birney, 2008, Zimin et al., 2013, Bankevich
et al., 2012, Simpson et al., 2009, Rustagi et al., 2016, Peng et al., 2012]
Read clustering [Marchet et al., 2017]
Assembly error correction [Otto et al., 2010]
 Mapping
Transcript quantification [Patro et al., 2014]
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Variant calling [McKenna et al., 2010]
General read mapping [Li and Durbin, 2009, Langmead et al., 2009, Kojima
et al., 2016]
 Metagenomics
Assembly-free phylogenomics [Pajuste et al., 2017, Wood and Salzberg, 2014]
Taxonomic profiling [Pajuste et al., 2017, Gupta et al., 2016]
However, no tools have been developed for the specific purpose of resolving multiple
pathogen populations within clinical NGS data. The reason for this is that it requires
a depth of read coverage which, until recently, have not been readily achievable from
clinical data, where DNA yield may be low. This has lead to alternative approaches
being used to attempt to identify heterogeneity of clinical samples (see Section 5.1 for a
description of these approaches). Furthermore, multiple populations of pathogen species
within a single host (termed Multiplicity of Infection - MOI) has been poorly documented
for the vast majority of pathogens, with the majority of the research in this area being
carried out on disease causing eukaryotes such as Plasmodium falciparum [Bell et al.,
2006], Trypanosoma brucei [Balmer and Tanner, 2011], and pathogenic bacteria such as
Mycoplasma tuberculosis [Gardy et al., 2018]. With modern methods of DNA isolation
and purification, and the fall in price of using high-throughput NGS technologies to per-
form whole genome sequencing (WGS), investigating MOI by mining WGS reads has
become a more feasible approach. Furthermore, it allows for unrestricted investigation
of local heterogeneity at any position within the genome, something which is simply not
possible to carry out using experimental methodologies.
Identifying VNTRs and MOI accurately and robustly is essential within a clinical
context. The presence or absence of specific VNTRs in a clinically isolated NGS dataset
may indicate disease within the patient. Diseases such as Alzheimer’s have a documented
relationship with the fragment length of a VNTR within ATP-Binding Cassette Subfamily
A Member 7, wherein expansion of this region is strongly correlated with the development
of Alzheimers disease [De Roeck et al., 2018]. Despite great advances in the use of NGS
data for assembly-free genomic analysis, low concordance of variant calling pipelines has
been reported, which remains a troubling issue [O’Rawe et al., 2013]. It is therefore of
utmost importance that clinicians can be confident in the reliability of the bioinformatics
tools and pipelines they employ to identify variants.
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4.2 BlooMine
Here we present BlooMine: a novel raw read mining tool developed to facilitate quick and
computationally efficient local analysis of sequences captured within raw reads generated
by whole or partial genome sequencing projects. It utilises Bloom filters, a highly space
efficient probabilistic data structure, to perform set membership queries and infer se-
quence homogeneity (see Section 1.5.2). The BlooMine package consists of three primary
scripts to perform read mining:
 BlooMine gen: Bloom filter generation
 BlooMine screen: Bloom filter driven read screening
 BlooMine spaln: Second-pass alignment free screening
During an analysis, scripts are called as a pipeline in this order (see Figures 4.1 an 4.3
for for a diagrammatic of the first two steps).
4.3 Bloom filter Generation: BlooMine gen
Figure 4.1: The procedure for generating a Bloom filter and control file using
BlooMine gen.
BlooMine gen is the first script to be executed in the sequence mining pipeline. It is
used to generate a Bloom filter from a target sequence in fasta format, which is necessary
to screen reads against later in the pipeline. This is achieved by generating a kmer array
from the target sequence, Kkt (where K
k
t is a kmer array generated using kmers of size k
from target sequence t), before passing each kmer through n hash functions, h, to gener-
ate a bit signature’ for this kmer, which can be used to alter the bit array, Bt (where Bt
is a bit array generated from a target sequence t). This bit array (also referred to as the
Bloom filter) is output to a file in binary format (see Figures 1.6 and 1.7 for a graphical
representation of how a Bloom filter is generated from a query sequence). A control file
is also generated by this script, which details the arguments and target sequence used to
generate the Bloom filter. The structure of the control file can be seen in Figure 4.2. This
control file includes the arguments and files used to generate the Bloom filter, as well as
the path to each Bloom filter generated. If a multifasta file is parsed into BlooMine gen,
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a Bloom filter will be generated for each, and the headers written to the end of the control
file.
##BF_LOG## BlooMine control file generated 01-01-01 12:00:00
Output Path: /home/user/BlooMine/WD/
k: 7
false positive rate: 0.05
bit array length: Default
Parent FASTA path: /home/user/BlooMine/query_f1.fasta
Sequences detected in FASTA file: 1
>query_flank_1
Figure 4.2: The layout of the BlooMine gen control file.
4.4 First-Pass Screening: BlooMine screen
Figure 4.3: A diagrammatic representation of the BlooMine screen algorithm. T is the
threshold for minimum number of common kmers, c is the number of kmers intersection
the target and read kmer arrays, inferred by Bloom filter hit events.
The control file detailed in Figure 4.2 is used as an argument when running BlooMine screen,
along with a raw read file in .fastq format. The BlooMine screen tool constitutes the first
pass screening, using the Bloom filter generated by the BlooMine gen tool (see Algorithm
1 for a description of the Bloom filter generation process). The first pass screening tool
(detailed in Algorithm 2) screens reads within the .fastq file against the Bloom filter.
Each read is used to generate a kmer-array using the value of k detailed in the control
file. This tool then iterates through this kmer-array and hashes each kmer using the
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Algorithm 1 BlooMine gen: Generate a Bloom filter
Input 1: a target sequence, t, in fasta format.
Arguments: integer value for k
Output: a Bloom filter and a control file.
1: Kkt ⇐ Kmerise : t, k
2: for all Kmer ∈ Kkt do
3: bt ⇐ {h1 : Kmer, ..., hn : Kmer}
4: incorporate the target sequence bit signature, bt, into the Bloom filter bit-array
5: end for
6: write Bloom filter bit-array and control file to disk
Where:
t = A target sequence in .fasta format, with which a Bloom filter will be generated.
Kmerise = A function which takes a sequence and generates an array of Kmer, K, of
size k, ST is the minimum score to trigger a hit.
h1, h2, ..., hn = A set of n hash-functions, h.
bt = The bit signature for a single Kmer within K
k
t , generated by feeding the Kmer to
each hash-function. E.g. if there are 3 hash-functions, a single Kmer will yield 3 hashes
(one for each hash-function), and therefore a bit signature consisting of these 3 hashes
(see an example in Figure 1.6).
set of hash functions which were used to generate the Bloom filter. The subsequent bit
signature generated by this hashing process is screened against the Bloom filter bit-array
to infer set membership. The detection of a hit increments the score by 1. If the overall
score for the read exceeds the minimum score threshold, sequence similarity is inferred
and the read returned and written to disk in .fastq format. This process can be seen on
lines 3 to 13 of algorithm 2, and can be effectively represented (by stripping out Bloom
filter functionality) as:
if |Kkt ∩Kkr | ≥ T then
return r
end if
Where Kkn is a kmer array of sequence n of kmer size k, r is a read sequence, t is the
target sequence, and T is the threshold for minimum number of common kmers.
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Algorithm 2 BlooMine screen First-pass screen: Bloom filter driven kmer set intersec-
tion
Input 1: a set of reads in .fastq format.
Input 2: a control file generated using BlooMine gen.
Output: a set of reads bearing similarity to the target sequence, in .fastq format.
Require: a set of n hash functions (hn) used to generate the Bloomfilter.
1: for all read ∈ fastq do
2: Kkr ⇐ Kmerise : read, k
3: for all Kmer ∈ Kkr do
4: bKmer ⇐ {h1 : Kmer, ..., hn : Kmer}






11: if score ≥ ST then
12: return read
13: end if
14: Write read hits to disc in .fastq format
15: end for
Where:
bKmer = A bit-array generated by hashing a Kmer using the hash function array used to
build the Bloom filter.
Kmerise = A function which takes a sequence and generates an array of kmers, K, of
size k.
ST = the minimum score to trigger a hit.
During this first pass screening procedure, the minimum score threshold is intention-
ally set low, allowing for a lower fraction of the target array to intersect with the read
array to trigger a read hit. This results in a reduction of type-II error (FN) at the expense
of a significant increase in type-I error (FP). The result of this is that the returned set of
’hit’ reads contains a large number of reads which do not contain the target sequence, and
triggered a hit due to simply bearing a sufficient number of similar kmers. These reads
represent a subset of a larger set of reads contained within the fastq file. The intention
of this first-pass filtering is to significantly reduce the number of reads which should be
assessed for homology with the target sequence using the second-pass filtering tool (see
Section 4.5); which performs in a very time-inefficient manner on very large datasets in
comparison to the Bloom filter driven first-pass approach. This high type I error rate is
resolved during second-pass screening.
4.5 Second-Pass Screening: BlooMine spaln
4.5. SECOND-PASS SCREENING: BLOOMINE SPALN 95
Algorithm 3 BlooMine spaln Second-pass screen: Alignment-free alignment inference
Input 1: A set of reads in .fastq format generated by the first pass screen.
Input 2: A target sequence used in the first pass screening process.
Output: A set of reads in .fastq format containing the target sequence.
1: Kkt ⇐ Kmerise : target, k
2: for all read ∈ fastq do
3: Kkr ⇐ Kmerise : read, k
4: Initialise array of 0’s, N , of length |read|
5: for all Kmer ∈ Kkr do
6: if Kmer ∈ Kkt then
7: i = index position Kmer maps to within Kkr
8: Kmeri, ..., Kmeri+k−1 7→ Ni, ..., Ni+k−1
9: end if
10: end for
11: gap count = 0
12: for all p ∈ N do
13: if p is a gap then
14: increment gap count
15: else if p is a hit then
16: if gap count ≥ T then
17: split N at p− 1
18: gap count = 0
19: else




24: s⇐ score alignments : N





B = A bit-array generated by hashing using a hash function array used to build the
Bloom filter.
Kmerise = A function which takes a sequence and generates an array of kmers, K, of
size k.
p = a position within N .
T = a gap threshold, calculated as detailed in Equation 4.1.
score alignments = a alignment scoring function, detailed in Equations 4.2 and 4.3.
MST = the minimum score to trigger a hit.
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BlooMine spaln performs the second-pass filtering using a novel ’soft-alignment’ ap-
proach. The algorithm driving this soft-alignment can be seen in Algorithm 3. Given a
target kmer array (line 1) and a read file in .fastq format, BlooMine spaln will generate a
kmer array for each read, retaining the relative positions of each kmer (line 3). A blank
array, N , of the same length as the read is initialised (line 4), to act as a framework onto
which kmers which intersect the read and the target arrays can be mapped. It will then
proceed to identify sequences of kmers within the read array that intersect with those in
the reference array (lines 5-7). These intersecting kmers are mapped onto N at the posi-
tion the kmer hits within the read array. Alignment is inferred by identifying sequences
of overlapping kmers within N (referred to here as contigs or contiguities), and scoring
them in a manner similar to a standard pairwise aligner, where scores are improved by
the presence of longer, or multiple contiguities, and penalised by gaps. This is achieved
by iterating through the alignment array, N , and assessing each position for whether is it
a hit or a gap (line 12-23). Upon the detection of a gap, gap count is incremented (line
13-14). This gap count is retained until a hit is encountered, upon which, if the gap count
exceeds the gap threshold, T , then the alignment array, N , is split at the position prior
to the encountered hit, and gap count set to 0 (line 15-18). If gap count < T , gap count
is set to 0 and sub-alignment assessment proceeds (line 19-20). This yields an array of
sub-alignments, each of which can be assessed by a scoring function, and the highest scor-
ing sub-alignment returned (line 24). This scoring function can be seen in Equations 4.2
and 4.3. If the score of this maximum scoring sub-alignment exceed the minimum score
threshold, MST (calculated as detailed in Section 4.5.1), a target hit is called and the read
is considered to contain the target sequence, upon which the read is returned (line 25-26).








h = match score.
k = kmer size.
g = gap open penalty.
n = gap extend penalty.




A : ci (4.2)
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A : ci =

s+ h | ci ∈ Kkt
s− g | ci /∈ Kkt ∧ ci−1 ∈ Kkt
s− n | ci /∈ Kkt ∧ ci−1 /∈ Kkt
(4.3)
Where:
sc = the score of the aligned chunk, c.
h = the value the score is incremented by when a hit is triggered.
g = the value the score is penalised by when a gap is opened.
n = the value the score is penalised by when a gap is extended.
ci = a position, i, within the aligned chunk, c.
This gap threshold, T , is calculated such that a single kmer hit followed a gap equal
to the gap threshold will result in a score of approximately 0. The alignment is broken at
each position where a gap exists of ≥ T . Every permutation of sequential sub-alignments
are then scored, totalling n(n
2
+ 0.5) where n is the number of sub-alignments.
A worked example of how an alignment array is processed and scored to
identify the optimal scoring sub-alignment.
Consider N as the alignment ACT---GACT----ACTG-----GACTGA, and param-
eters of k = 3, h = 4, g = 4, n = 2. Using Equation 4.1, we calculate the gap




This initial step is achieved by splitting N at gaps ≥ T . The purpose of this step is
to define sub-alignments which will be processed as a single unit. ACT---GACT has
been redefined as a single sub-alignment due to the gap between ACT & GACT < T ,
and will therefore not be split during the next step. These will form six sequential
sub-alignments:
ACT---GACT s = 20
ACTG s = 16
GACTGA s = 24
ACT---GACT ---- ACTG s = 26
ACTG ----- GACTGA s = 28
ACT---GACT ---- ACTG ----- GACTGA s = 38
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This step generates every sub-alignment within N . Each of these will be assigned
a score (s) using the function described in Equation 4.2 and the maximum scoring
sub-alignment returned. If the score of this sub-alignment exceeds the minimum score
threshold, MST , then a hit is triggered and the read returned as containing the target
sequence. In this example, the highest scoring sub-alignment using these parameters
is the entire alignment (s = 38).
This scoring algorithm reveals the optimum local alignment of the target sequence
within the read using only a positional kmer intersection approach.
4.5.1 Minimum Score Threshold
Take |s| to be the length of a given sequence, s, and F to be a mismatch frequency,
whereby the maximum threshold for the number of mismatches across s resolves to |s| 1
F
.
The calculation of the minimum score threshold, MST , is based on the premise that
mismatches cluster, rather than present as an even distribution such as: match match
match mismatch, since if k ≥ F , there will be no kmers mapping to the read array
and consequently will yield a score of 0. The score of an alignment where mismatches
are clustered must be calculated.
To achieve this, windows of size k + F − 1 are utilised, within which we can approxi-
mate there to be on average one kmer from the target array, Kkt , which does not map to
the local region within the read which has triggered an alignment (this will be a region
of approximately the same length as the target sequence, referred to previously as the
maximum scoring sub-alignment). The number of kmers within Kkt which must fail to
map to a window in order that there are |s| 1
F
base mismatches is therefore calculated
as e =
k+F−1
F . This method attempts to approximate the score of a sequence with a
mismatch frequency of
1
F . This cannot be resolved by simply calculating the minimum
score as h · (|Kkt | −m) (where h is the value the score is incremented by when a hit is
triggered, and m is a value the score is penalised by when a mismatch is triggered) due
to the dynamic nature of the scoring, whereby gap-open events are penalised differently
to gap-extension events. For example, an alignment of AT-AC-AA will yield an event-
string of [hit hit gap-open hit hit gap-open hit], whereas an alignment of
AT--ACAA will yield a event-string of [hit hit gap-open gap-extend hit hit
hit hit]. These event-strings will yield different scores if g 6= n, despite having identi-
cal lengths and hit counts.
The minimum score threshold (MST ) is calculated using the following approach: Take
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h as the value the score is incremented by when a hit is triggered, g as the value the score
is penalised by when a gap is opened, n as the value the score is penalised by when a
gap is extended (mismatch), and F as the frequency of mismatches, where F refers to
the number of positions within the alignment which contains 1 mismatch on average.
The number of observation windows, w, across the alignment is:
w =
|Kkt |
k + F − 1
(4.4)
Where a single observation window is as a set of adjacent positions of length k + F − 1
within N .
The expected number of mismatch events within an observation window, e, is:
e =
k + F − 1
F
(4.5)
For example, if k = 5 and F = 10, an observation window will be a stretch of 14 positions
within N . This will resolve as an acceptable threshold of 1.4 errors within a single window.
The total acceptable number of mismatches within the entire alignment, M , is therefore
calculated as:
M = e(w − 1) (4.6)
Consequently the minimum score threshold is:
MST = h · |Kkt | − wg + nM (4.7)
= H − wg + nM (4.8)
Where H is the score of a perfect match to the target sequence (repeats collapsed1),
calculated as h · |Kkt |.
The purpose of performing these calculations across multiple windows of size k+F−1
is to calculate the number of match and mismatch events assuming mismatches cluster,
rather than occur in a consistently distributed manner.
Therefore, the approximate observed rate of mismatch events is resolved by assuming
that you will see F − 1 kmer hits followed by a sequence of mismatch events which will
resolve to
1
F mismatches over a given alignment.
1Repeats were effectively collapsed by taking the kmer array for the target sequence as a set.
100 CHAPTER 4. BLOOMINE
This alignment algorithm is novel and uses concepts from both alignment and alignment-
free sequence analysis approaches for the purpose of establishing highly gapped or rear-
ranged alignments, since regions flanking highly poymorphic target regions may be poorly
conserved. Furthermore, alignments are carried out on small sequences (single reads) po-
tentially many thousands of times, which may render conventional alignment approaches
less efficient.
4.5.2 Screening Algorithm Runtime Comparison
Figure 4.4: A comparison of the processing speed of BlooMine screen vs BlooMine spaln
on a paired end read file containing reads generated by the sequencing of the clinical
isolate Cryptosporidium parvum UKP10. The 5’ gp60 flanking was used to screen these
reads. Time was measured at every 1000 reads processed. The paired end read file
contained a total of 1391780 reads. No minimum read length cutoffs were used in the
generation of these data.
A comparison of the speed of BlooMine screen against BlooMine spaln can be seen
in figure 4.4, which shows that BlooMine screen is significantly faster in screening reads
than BlooMine spaln. The paired end read file was generated by the concatenation of
the forward and reverse read files, to prevent the manipulation of low complexity regions
that may occur during read pair merging. A greater number of read hits to the 5’ gp60
flank were identified in the reverse read file. The drop in processing rate at roughly 700K
reads (indicating the start of the reverse reads) can be explained by the increased amount
of time read hits require to process compared to read misses.
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4.6 Implementation as a Pipeline to Investigate Mul-
tiplicity of Infection
Multiplicity of Infection (MOI) is a state in which an individual is host to multiple sub-
populations of a single pathogen species. It is generally used when referring to a plurality
of genetically distinct populations of a pathogenic bacteria or parasite within the host.
Nomenclature for viruses may vary, with the term ’quasi-species’, referring to a popula-
tion of viruses which diverge within a host, is roughly analogous. The implementation of
this tool as a pipeline for the purpose of investigating MOI is straightforward, and is de-
tailed in Figure 4.6. The pipeline is similar to the standard pipeline for target sequence
detection, consisting of running the Bloom filter generation tool followed by the first-
pass then the second-pass filtering tools. The MOI detection pipeline involves a few more
steps. In this instance, the target region is presumed to be highly polymorphic and/or low
complexity, which would make direct identification very difficult and could likely result in
high False Positive (FP) and/or False Negative (FN) rates. Consequently, identification
of more conserved and high-complexity regions directly adjacent to the target region are
identified (termed ’flanks’ or ’flanking regions’). With this approach, reads containing
the target region can be isolated, despite the target region itself bearing large amounts
of variation, which would confound a direct reference guided approach (see Figure 4.5).




flank 2︷ ︸︸ ︷
GACTGAGATCCGAT︸ ︷︷ ︸
complete target region
Figure 4.5: A model of a putatively polymorphic, low-complexity target region with
conserved high-complexity flanking regions. Identification of both flanking regions within
a single read imply the presence of the target region within this read.
Bloom filter generation using BlooMine gen and first-pass screening using BlooMine screen
are carried out as usual, using flank 1 as the proxy target region. This first-pass screening
step outputs the set of all reads which bear high kmer-content similarity to flank 1 (Rfp).
Second-pass screening using BlooMine spaln is split into two parts, second-pass screen I
and second-pass screen II. Second-pass screen I is carried out using Rfp, and the target
region (flank 1), outputting a read set (Rsp1) which consists of reads containing flank 1,
where Rsp1 ⊆ Rfp. Second-pass screening II is carried out using the corresponding flank
of the pair (flank 2) as the target region, screened against the Rsp1. The output from
second-pass screening II (Rsp2) is a set of reads that have captured both flanks, and
therefore the target region, where Rsp2 ⊆ Rsp1. A diagrammatic representation of this
multi-pass BlooMine spaln screening approach can be seen in Figure 4.7. This figure
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Figure 4.6: A diagrammatic representation of the pipeline implementation of BlooMine
used to investigate sub-populations within a set of reads.
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shows examples of different alignment outcomes, such as:
 Fragmented and weak alignment: indicating a read which bears kmer-content simi-
larity but no homology to the flanking sequence, and therefore does not exceed the
minimum scoring threshold (reads 1 and 5).
 Strong full, fragmented and partial alignment: indicating reads which contain the
flanking sequence exhibiting strong full (read 3 for flank 1 and read 2 for flank 2),
strong partial (read 3 for flank 2), or strong fragmented (read 2 and 4 for flank 1,
and read 2 for flank 2) alignments which exceed the minimum scoring threshold.
 Single flank alignment: indicating a read which exhibits only a single flanking
sequence, and therefore captures only part of the target sequence (read 4).
Reads 2 and 3 of the example within the diagram have captured the target region (the
region between the flanking sequences) in it’s entirety, and will therefore be subject to
further analysis within this pipeline.
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Figure 4.7: A diagrammatic representation of the second-pass screen I & II by
BlooMine spaln, used to identify reads which capture the full target region for MOI
investigation.
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An example of potential erroneous local fragment resolution by target-
flank interface variation using a standard alignment approach.
Take the complete target region to be:
flank 1: f1︷ ︸︸ ︷
CGGTCTT
target: t︷ ︸︸ ︷
TCATCATCATCATCA
flank 2: f2︷ ︸︸ ︷
GACTGAG︸ ︷︷ ︸
complete target region
and the read to be the sequence:
Sequence: ATAAGTACGGTCTATCATCATCATCATCAAACTGAGACAAGAA
| | | | | | | | |
Position: 0 5 10 15 20 25 30 35 40





Position: 0 5 10 15 20 25 30 35 40
resulting in a partial alignment of flank 1 from position 7-12, and partial aligment of
flank 2 from position 30-35. Positions 13 and 29 (representing the last and first base
of the flanks respectively) present as mismatches, which would lead to the target re-
gion being isolated from position 13-29 and reported as ATCATCATCATCATCAA.
This presents an ’off-by-one’ error for both flank alignments, as the actual target
region spans from position 14-28.
Isolation of this flank for the purpose of further polymorphism analysis downstream
analysis would result in erroneous reporting of alleles (by fragment size) which are
a result of sequence variation within the flank, rather than any variation within the
target region itself.
Figure 4.8: A worked example of how using conventional hard-alignment tools to identify
the start/end indices of a target region may lead to erroneous results.
Following this, a process to determine the number of alleles of the target sequence that
are present within this final read set is carried out using BlooMine subpop check. These
alleles are presumed to represent discrete sub-populations if a single copy of the target is
present in the organism genome. It achieves this by performing a longest-kmer anchoring
approach to identify the first base of the target region. This is necessary because if
there are variations in the sequence at the interface between the flank and the target
region due to either biological variation or sequencing error, a standard local aligner may
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report a premature start/end of the target sequence (see Figure 4.8). If these coordinates
are used to isolate the target sequence for fragment length and sequence polymorphism
analysis, then it will report artefact alleles. This can be resolved, but would require
further processing to identify the longest matching substring, which is precisely what the
longest-kmer anchoring approach achieves without the need for an alignment step. This
longest-kmer anchoring approach is detailed in Algorithm 4. It takes a set of reads in
.fastq format generated by the second-pass screen II by BlooMine spaln, and generates
a kmer array for each of these reads (line 1). For each flank, f1 and f2, a ’kascade’
array is generated. These are a set union of kmer-arrays from k = kmin (where kmin is
the minimum size a kmer must be to constitute an anchor) to k = |t| (the length of the
flanking region), where t ∈ {f1, f2} (the set of both target flanking regions) refers to an
unbroken string of elements, n, where n ∈ {A, T, C,G} (lines 2 - 3). Each kmer within the
kascade array, K
[k,|t|]
t , is tested for membership within the read kmer array, K
k
r , and the
longest intersecting kmer used as the anchor point for calculation of the target start/end
indices (lines 6 - 8). The first and last bases of the target are calculated using the position
the longest kmer maps to within the read sequence (ti) relative to the position it maps to
within the flank (Kmertj). The equations used to calculate these indices are as follows:
target start = f1i + |f1| −Kmerf1j (4.9)
target end = f2i −Kmerf2j − 1 (4.10)
Where:
f1i & f2i = the position the longest Kmer maps to within the read, for flank 1 (f1) and
flank 2 (f2) respectively.
|f1| = length of the flank 1 (f1).
Kmertj = the position the longest Kmer maps to within a flanking region, t, where
t ∈ f1, f2.
An example of this approach can be seen in Figure 4.9.
The indices produced by this algorithm can be used to very precisely isolate the target
region between the provided flanking regions. This is necessary to investigate variation
which is present within these target regions alone, and ignoring variation which may exist
within the rest of the read.
The output from BlooMine subpop check is a report file in .txt format containing
information about the amount of variation at the target region which is captured within
the raw read file. Variation is assessed at both sequence and fragment length levels. An
example of the report file can be seen in figure 4.10.
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Worked Example of Longest Kmer Anchoring.
Take the complete target region to be:
flank 1: f1︷ ︸︸ ︷
CGGTCGA
target: t︷ ︸︸ ︷
TCATCATCATCATCA
flank 2: f2︷ ︸︸ ︷
GACTGAG︸ ︷︷ ︸
complete target region
and the read to be the sequence:
Sequence: ATAAGTACGGTCTATCATCATCATCATCAAACTGAGACAAGAA
| | | | | | | | |
Position: 0 5 10 15 20 25 30 35 40
The kascade array for flank 1 (f1) from k = 3 to k = |f1| = 7, K [k,|f1|]f1 , is therefore:
Position k = 7 k = 6 k = 5 k = 4 k = 3
0 CGGTCGA CGGTCG CGGTC CGGT CGG
1 GGTCGA GGTCG GGTC GGT
2 GTCGA GTCG GTC
3 TCGA TCG
4 CGA
This kascade array is then iterated over, and each Kmer mapped to the read sequence.
The longest Kmer to map to the read sequence is CGGTC, which maps to position
0 within f1 (Kmerf1j = 0) and position 7 within the read (f1i = 7). We can then
calculate the start position of the target region, t, as:
target start = f1i + |f1| −Kmerf1j (4.11)
= 7 + 7− 0 = 14 (4.12)
This process is then repeated for flank 2 (f2), which yields the longest mapping kmer
of ACTGAG, which maps to position 1 within f2 (Kmerf2j = 1) and position 30
within the read (f2i = 30). We can calculate the end position of the target region, t,
as:
target end = f2i −Kmerf2j − 1 (4.13)
= 30− 1− 1 = 28 (4.14)
Which yields the target start-end coordinates as 14-30. Using these coordinates, the
target sequence is identified as TCATCATCATCATCA.
Figure 4.9: A worked example of the longest Kmer anchoring approach used to identify
target locus start and end points within a read.
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Algorithm 4 Multiplicity of Infection Investigation: Longest-kmer anchoring
Input 1: A set of reads in .fastq format generated by second-pass screen II.
Input 2: The flanking regions of the target sequence.
Output: A report detailing sequence variation at the target location, across reads within
the read file.
1: Kkr ⇐ Kmerise : r, k






Kmerise : t, k
4: for all Kmer ∈ K [k,|t|]t do
5: Kmerj ⇐ index Kmer maps to in Kkt
6: if Kmer ∈ Kkr then





12: yielding f1i and f2i
Where:
t = a sequence, flank 1 or flank 2, flanking the target region. See Figure 4.5.
[k, |t|] = {k ∈ N | kmin ≤ k ≤ |t|}.
f1i and f2i refer to the index the longest kmer of flank 1 and flank 2 respectively map
to in the read array; Kkr .
Kmerise = a function which takes a sequence and generates an array of kmers, K, of
size k.
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Figure 4.10: An example of a report file generated by BlooMine subpop check. The
target sequence was cgd6 1080 at positions 108-164, referring to the VNTR within the
gp60 locus. The read file mined for variation was Cryptosporidium parvum isolate UKP3
[Hadfield et al., 2015].
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4.7 Method
4.7.1 Prediction Accuracy and Read Recovery on Simulated
Data
To validate the precision of read recovery from .fastq files, a single-end read set con-
taining artificial target sequences exhibiting multiple alleles was simulated. The target
sequence consisted of a ’TCA’ repeat locus flanked by 40 nucleotide regions which was
utilised as flanking sequences for target recovery. The target sequence exhibited 28 alleles
within the read set, of lengths spanning a single repetition (3 nucleotides) to 10 repeti-
tions (30 nucleotides) at increments of a single nucleotide. The purpose of varying the
alleles (defined here as a variation in the target sequence) by less than a single repeat
unit is to simulate challenging data to test the precision of the tool when identifying
target regions as thoroughly as possible. The flanking sequence was varied, from 0 to 7
SNP’s throughout the entire sequence. N’s were introduced within the flanking sequences
at random positions, and randomly selected bases, to simulate variations which avoids
the possibility of false-positive kmer hits. This totals 8 flanking sequences each flanking
27 allele sets at a depth of 30 reads for each flank-allele variation pair, for a total of
6720 simulated reads containing the target sequence in full. The non-target reads were
generated as random strings of 130 nucleotides. The total number of reads within the
simulated read set was 200,000. A model for the target sequence can be seen in figure 4.11.
TCAGAGGAACTTTAAAGGATGTTCCTGTTGATGGG TCA... GGGATCGCACCAGCAAATAAGGCAAGAACTGGAGA
Figure 4.11: A model for the target sequence, showing the target region (orange) consist-
ing of a TCA repeat region, and flanking regions (blue). Where ... refers to an arbitrary
number of the preceding repeat motif.
The BlooMine pipeline was ran 8 times on the simulated dataset with different kmer
sizes for each screening pass in the pipeline (BlooMine screen: first-pass, BlooMine spaln:
second-pass, & BlooMine spaln: third-pass). The kmer sizes used are detailed in Table
4.1. Runs VI - IIX are hybrid runs, in that they use different kmer sizes for each screening-
pass.
To identify optimal parameters for identifying target exhibiting reads within read sets,
Receiver Operating Characteristic curves were generated by running BlooMine screen tool
on the simulated dataset using the threshold (-t) parameter set to 1 to 100, totalling
100 iterations. The threshold setting takes an integer for use as a minimum percentage of
kmers within the target kmer array which must intersect with the read kmer array. False-











I 3 3 3
II 4 4 4
III 5 5 5
IV 6 6 6
V 7 7 7
VI 7 4 4
VII 7 5 5
IIX 7 5 4
Table 4.1: The kmer sizes used for the first, second and third-pass screening processes,
within the BlooMine pipeline, executed on the simulated dataset.
derived as detailed in section 4.7.2.
4.7.2 Confusion Matrix Derivations
A confusion matrix was used to derive metrics to elucidate the effectiveness of each
BlooMine run in identifying target reads within a simulated dataset (see section 4.7.1).
A confusion matrix is generated by calculating the False-Positive (FP), False-Negative
(FN), True-Positive (TP), and True-Negative (TN). Metrics are derived from this matrix
as follows:
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Figure 4.12: Total recovery rates from running the BlooMine pipeline on the simulated
dataset at each kmer size. Proportions are shown as the total number of reads bearing
targets of all allelic variations, grouped by the number of introduced flank errors.
4.8 Results
4.8.1 Results of BlooMine Simulated Dataset Mining
Figure 4.12 shows the recovery rates of target regions of varying error rates (0-7) from
the simulated read set. The data illustrates that the recovery rates for run I (k=3) were
100% across all error rates, however the false-positive rates were also extremely high at
this kmer size (0.9663). Run II (k = 4) also exhibited very high recovery rates, as well
as very high false-positive (FP) rates (0.8675). Runs III-V illustrate some loss of target-
exhibiting reads, where they were not identified as containing the target sequence due
to flank variation. FP rates dropped as the kmer size increased, with run III (k = 5)
exhibiting an FP rate of 0.0002, and runs IV and V (k = 6 and k = 7 respectively)
showing FP rates of 0.0. The hybrid runs (VI-IIX) reported the best results in terms
of overall read recovery rates and FP rates of 0.0, with run IIX (k=7, 5, 4) illustrat-
ing the highest recovery, wherein all target exhibiting reads bearing 0 - 6 errors within
each flanking region were recovered. Target exhibiting reads containing flanking regions
bearing 7 errors were not recovered. In flanking regions of 40 nucleotides, 7 errors would
resolve at approximately 1 error per 5.71 nucleotides. If k ≥ e|f | (where e is the number
of introduced errors, and |f | is the length of the region flanking the target), the read is
unlikely to be returned as containing the target sequence, as there may not be a sufficient
number of kmers which map to the target flanks to trigger a hit event.
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Figure 4.13: Rates of a set of metrics given as proportions between 0-1. Metrics calculated
using the confusion matrix of returned reads by running the BlooMine pipeline on the
simulated dataset using various kmer sizes. Metrics are calculated as detailed in section
4.7.2. See table 4.1 for a full description of the BlooMine runs shown on the x-axis.
Where FPR = false-positive rate, TPR = true-positive rate, PPV = precision, NPV =
negative predictive value, and FOR = false-omission rate.
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Figure 4.14: The receiver-operating characteristic (ROC) curve for BlooMine ran on the
simulated dataset. False-Positive is plotted against True-Positive rates at each threshold
level. The dashed line is a curve representing results which would illustrate predictive
power no better than a random guess.
Figure 4.13 shows the False-Positive Rate (FPR), True-Positive Rate (TPR), Pre-
cision (PPV), Negative Predictive Value (NPV), and False-Omission Rate (FOR) for
each BlooMine run. The results illustrate that hybrid kmer sizes used through the three
screening procedures in the BlooMine pipeline are the most effective at identifying target-
exhibiting reads. Of these, run IX (k = 7, 5, 4) produced the most favourable results.
Figure 4.14 shows the Receiver Operating Characteristic curve for BlooMine screen
run iterations using minimum kmer match thresholds of between 1 and 100. The results
illustrate clear distinction between type I (FP) and type II (FN) error. Figure 4.15 shows
curves of all confusion matrix derivatives generated from BlooMine screen executed at
different threshold levels. The results indicate that accuracy increases sigmoidally, with
maximum accuracy being achieved at a threshold of 35-40. Accuracy then decreases in an
approximately linear fashion as the threshold surpasses 50. False positive rate decreases
in an inverse sigmoidal fashion, with 0 being achieved at a threshold of roughly 35. True
positive rate drops at a threshold of roughly 25, and plateaus at 30 before steeply declining
at thresholds ≥ 50. Precision (Positive Predictive Value) increases in a sigmoidal fashion
before reaching maximum at a threshold of roughly 37. False omission rate starts to
increase at a threshold of roughly 50. These results indicate that the optimum threshold
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Figure 4.15: Confusion Matrix derivation curves for each threshold. See section 4.7.2 for
a description of CM derivations used within this plot. Where FPR = false-positive rate,
TPR = true-positive rate, PPV = precision, NPV = negative predictive value, FOR =
false-omission rate, and ACC = accuracy.
to maximum TPR and TNR whilst minimising FPR and FNR is around 40.
4.9 Discussion
The number and quality of whole-genome sequenced Cryptosporidium samples taken from
clinical samples is rapidly expanding, largely due to recent advancements the extraction,
purification, and enrichment of high-quality DNA, and sequencing technologies. This
facilitates the assembly-free analysis of parasite genomes, as well as the in silico inves-
tigation of MOI within clinical samples. The bottle neck currently observed between
the generation and analysis of genomes can only be alleviated by advances in how we
investigate genomic data, such as performing analysis on raw reads rather than genome
assemblies. Investigation into the extent of MOI within clinical samples of Cryptosporid-
ium will greatly improve our understanding of the evolution of virulence, drug efficacy,
infection dynamics, pathogenesis, and transmission of Cryptosporidium. BlooMine is a
general purpose read analysis tool which can be used for local analysis of genomes, quality
assurance by investigating local read depth, and rapid determination of MOI by targeting
regions flanking known variable loci. Sufficient read depth is required to establish MOI
within a set of reads, particularly if the loci varies on a sequence level, rather than by
fragment length. Furthermore, multiple copies of the target locus within the read set may
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confound results of MOI analysis. We have shown that false-positive and false-negative
results can be significantly alleviated by performing multiple stages of read screening
based on different strategies, results in highly accurate and reliable detection of target
sequence exhibiting reads within a read set. BlooMine has only been used with Illumina
sequencing data, and as such, it is unclear as to whether it is usable with other sequencing
technologies. Although k-mer based sequence analysis approaches should not vary based
on the technology used to generate the sequence, aspects such as coverage uniformity
and depth, error rate, and sequencing bias are known to vary, and therefore could affect
results. For example, GC-bias is a documented issue observed in Illumina sequencing
data [Benjamini and Speed, 2012].
Comparison of BlooMine against other tools developed to quantify MOI is difficult
for a number of reasons:
1. Tools are generally developed to identify MOI in BAM files which have been gener-
ated using conventional mapping software, and are therefore subject to the weak-
nesses of these software.
2. These tools generally focus on SNPs and small INDELs, and are poor at identifying
larger variations (such as VNTRs).
3. There are very few entirely in silico tools available to investigate MOI.
To my knowledge, the kmer soft-alignment algorithm implemented in the second-pass
screening script is novel. There are a small number of tools which utilise positional kmer
intersection approaches similar to the one we present in this script, such as that used
in the Segmental Duplication mapping tool, ASGART [Delehelle et al., 2018], but none
which utilise this approach to perform sequence alignment. This algorithm is highly ef-
fective at aligning small sequences with a high degree of accuracy, making it ideal for
precise local analysis within reads. However, due to its method of investigating every
possible sub-alignment and set of sub-alignments within a sequence to find the maximum
scoring alignment, this algorithm scales poorly with sequence size. Consequently, it is
unlikely to be appropriate for larger scale alignment.
A comparison of the technical functionality of BlooMine against similar tools can
be found in Table 4.2. Due to fundamental differences in how BlooMine works when
compared to approaches driven by conventional read mapping software (aligning small
sequences against reads, as opposed to aligning reads against larger sequences), a direct
comparison using a dataset was not practical.
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TOOL target organism input format Supported Variant Types variation tolerance
SNP INDEL VNTR (n/v)
BlooMine any FASTQ yes yes yes k + 1
estMOI any BAM yes yes limited mapper dependant
quasitools virus BAM yes yes limited mapper dependant
Table 4.2: Comparison of BlooMine against two other available in silico MOI/quasispecies
analysis tools [Marinier et al., 2019, Assefa et al., 2014]. The error tolerance threshold is
given as nucleotides per variation (n/v).
The primary strengths of BlooMine over other similar tools are its capacity to run
directly on raw reads, rather than BAM files, which circumvents the error tolerance
thresholds employed by many read alignment tools. Although such tools can comfort-
ably handle smaller indels which high fidelity, these thresholds often make it more difficult
to align reads which exhibit high indel-type variability, such as that seen in many tan-
dem repeat regions [Ziemann, 2016]. Due to the method BlooMine employs, sequence
variation captured in reads can be identified to a degree which is beyond the capacity of
popular read mapping tools such as BWA and Bowtie2.
The memory usage of this tool is very efficient due to the use of Bloom Filters to
store sets of kmers. This allows for its usage on personal desktops and laptops, obviating
the necessity of using High-Performance Computing systems. The benefit of this is to
allow it to be utilised in analysing datasets by research teams who do not have access to
such systems. Furthermore, with some adaptation, BlooMine could be adapted for use
in tandem with the new generation of highly portable sequencers, such as the Oxford
Nanopore MinIon platform, wherein reads could be screened in real time as they are pro-
duced by the MinIon. The error rate currently exhibited by MinIon may affect the results
of BlooMine, though the results presented in this chapter indicate that BlooMine is ef-
fective at handling relatively high error rates. This should be treated with care, however,
as the recovery rate of reads with high error rates is highly sensitive to the parameters
used (see Figure 4.12).
Due to the run time limitations of writing BlooMine in Python, a great deal of im-
provement on execution time could be achieved by rewriting parts of this tool using a
compiled language, such as C, C++, or Rust. Such an improvement may decrease the
execution time of first and second pass screening by around 100 times.
BlooMine still requires optimising to be able to handle multiple query sequences when
assessing a .fastq read set for variation at these target regions. Presently, it can perform
first stage screening (see Section 4.4) on multiple target sequences, but not second stage
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screening (Section 4.5) or MOI assessment (Section 4.6).
4.10 Conclusion
In this chapter I have presented BlooMine, a novel bioinformatics tool to facilitate local
analysis of sequences from raw read files. I have demonstrated its efficacy at identifying
reads which contain a target sequence from large simulated read sets, which is performs
to a high degree of accuracy and reliability. Furthermore, I have detailed extended
functionality which allows the user to characterise Multiplicity of Infection by identifying
target variation within a set of reads with a high degree of accuracy. The reliability and
sensitivity of BlooMine to identify target sequences within read sets and quantify MOI
will increase as sequencing technologies improve, allowing for deeper genome sequencing
with more even coverage. Furthermore, as the number of genomes available increases, the
population structure and relationship between populations will continue to be resolved





Multiplicity of Infection (MOI) is a well documented observation within the natural world.
It has been reported that the majority of parasitic infections consist of multiple parasite
species or discrete genetic lineages. In 1999, Lord et al reported that the majority of
human adults infected with Plasmodium falciparum were host to more than five distinct
strains [Lord et al., 1999]. Multiple infections have a significant impact on the incidence
and spread of parasites, along with their virulence. These factors have been acknowl-
edged to be of enormous importance to public health. An incomplete understanding of
the subtypes and genotypes of a parasite within a host leads to potentially inaccurate
assumptions about the clinical presentation and outlook of the infection. In particular,
the virulence of experienced by a host infected by multiple subtypes/genotypes of a par-
asite (often referred to as ’overall virulence’) is a result of the interactions between the
different sub-populations within the host, resulting in an overall virulence of anywhere
from greater than the most virulence to less than the least virulent, depending on various
biological factors [Seppälä et al., 2009, Seppälä et al., 2012, Alizon et al., 2013]. Efforts
have been made which illustrate that there exist general patterns when ecological and
evolutionary theory are applied to within-host dynamics, leading to the generalization
that ’basic ecological rules govern the outcome of co-infection across a broad spectrum
of parasite taxa’ [Graham, 2008].
It is both biologically plausible (due to unrestricted sexual recombination between
sub-populations, see Figure 5.1) and there is strong evidence (described below) that in-
fections can arise from, and give rise to, multiple sub-populations of Cryptosporidium spp.
which will be present in single clinical samples. The current approaches of sequencing
and assembly results in the resolution of a single allele at each locus which, if multiple
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Figure 5.1: A simplified schematic of genetic recombination in Cryptosporidium, po-
tentially generating variation between sporozoites within oocysts. In a mixed infection
population, different fertilization scenarios potentially occur - between the same geno-
types (resulting in identical daughter sporozoites) or between different genotypes, as in
the example shown, that result in a variety of outcomes depending on the random genetic
exchange, or lack of, that occurs during meiosis. For simplicity only two example chro-
mosomes are shown with DNA from different genotypes represented by blue and red. The
diploid zygote contains duplicate pairs of chromosomes, one set from each parent cell;
during interphase (In) the DNA in each chromosome is replicated to produce two identical
sister chromatids held together with a centromere; in prophase I (Pr I) the chromosomes
start to condense and pair up with the homologous chromosome from the other parent
cell, and cross-over can occur resulting in an genetic exchange; during metaphase I (Me I)
the paired chromosomes line up along the center of the cell and microtubules connect the
centromeres to the centrosomes (shown in green); during anaphase I (An I) each complete
set of chromosomes (still paired as sister chromatids) are pulled towards each centrosome.
The chromosomes from either parent are randomly combined at this phase introducing a
further opportunity for recombination (a blue and a red chromosome are drawn to each
centrosome in this example); in telophase I (Te I) the chromosomes start to unravel and
cytokinesis starts to split the cell into two, resulting in two haploid cells; in prophase II
(Pr II) the chromosomes condense again; during metaphase II (Me II) the chromosomes
line up along the center of the cells and microtubules connect the centromeres to the
centrosomes; this time during anaphase II (An II) the sister chromatids are separated
and pulled apart towards the centrosomes, creating new daughter chromosomes; finally
in telophase II (Te II) the chromosomes unravel and cytokinesis starts to split the cells,
which in the case of this example due to the crossover event in prophase I, results in
four genetically different haploid sporozoites. Depending upon whether random genetic
exchanges take place between chromosomes from different genotype parents (either in
prophase I or anaphase I) the resulting haploid sporozoites can either be all different, two
pairs of identical sporozoites that are different from each parent, or two pairs of identical
sporozoites that are the same as the two parents [Morris et al., 2019c].
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discrete sub-populations exist within the isolate, would in effect simply represent the
most populous sequence variant at each locus within the assembly. This may confound
epidemiological analysis, which generally relies on the assumption that large scale genetic
recombination does not occur within a host, and that in general a single host exhibits
a single population. It is therefore essential that these in-host variations are well un-
derstood and accounted for in order to develop novel prevention strategies in the fight
against Cryptosporidiosis and other parasitic diseases. The investigation into the impact
of MOI within a host relies on the accurate and reliable detection and discrimination of
discrete populations of parasites within a host.
There are a number of approaches to achieve this:
 Restriction Fragment Length Polymorphism (RFLP) analysis by PCR of variable
regions.
 Cloning and sequencing key loci to detect variation.
 Isolating and sequencing single oocysts from clinical isolates.
 Investigating sequence variation among reads within short read archive generated
by sequencing of clinical isolates.
These approaches attack this problem from very different angles: variable locus cloning
and single cell sequences from an experimental angle, and sequence variation within reads
from an in silico angle. This lends them unique challenges to overcome.
5.1.0.1 PCR-RFLP
In 2004, Henning et al. investigated the relationship between MOI and morbidity in
Tanzanian children infected with Plasmodium falciparum. They performed PCR on the
highly variable msp2 (a merozoite surface protein associated with host cell invasion) and
defined heterogeneity within samples by identifying restriction fragment length polymor-
phism (RFLP) within this locus. Their results indicated a complex relationship between
MOI, immune status, and endemicity. They found that children who are subjected to
continuous infection due to multiple infective bites over a period of time, and therefore
exhibit high levels of MOI, are less likely to exhibit high levels of morbidity than those
who are subjected to little previous exposure, but also show high levels of MOI. They
suggest that this is possibly linked to short-term immune cross-protectivity elicited by
long term exposure to multiple strains of P. falciparum [Henning et al., 2004].
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5.1.0.2 Biomarker Cloning
In 2013, Grinberg et al reported the presence of a number of sub-populations within sin-
gle isolates of C. parvum by cloning PCR amplicons of selected loci (gp60 and HSP70)
and utilising Next Generation Sequencing (NGS). They demonstrated the presence of two
HSP70 and 10 gp60 alleles within their two isolate dataset. Furthermore, they reported
that in both isolates there is a dominant allele, which represented the majority of the
amplicons sequenced, and a number of sub-dominant ones [Grinberg et al., 2013].
To compare the results obtained from Sanger sequencing and NGS, Zahedi et al.
compared results of Sanger and NGS sequencing of Gp60 amplicon from 11 C. hominis,
22 C. parvum, and 8 C. cuniculus animal samples from Australia and China. They
demonstrated that NGS is more effective at resolving the presence of multiple populations
of Cryptosporidium within a sample, and the extent of multiplicity of infection. There was
concordance between the subtypes identified by both platforms, but additional subtypes
were identified using NGS on C. parvum and C. cuniculus Gp60 amplicons, but not C.
hominis [Zahedi et al., 2017]. In 2017, Kaupke et al. attempted to resolve the presence
of multiple species of Cryptosporidium within pigs by using NGS (MiSeq sequencing)
on amplicons containing the 18 SSU rRNA gene locus. Molecular analysis suggested
the presence of Cryptosporidum species other than the pig-specific species, C. suis and
C. scrofarum, however, this was not demonstrated using NGS. These results indicated
that, although in-host subtype and genotype-level diversity may be complex, species-level
diversity may not be. The results also further indicate the discordance between molecular
and NGS based analyses when investigating MOI [Kaupke et al., 2017].
5.1.0.3 Single-Cell Sequencing
In 2016, Troell et al attempted to develop the protocol of single cell sequencing for Cryp-
tosporidium for the purpose of elucidating these putative intra-isolate sub-populations.
Using the protocol they developed, they sequenced 10 oocysts, resulting in assemblies of
49.4 - 91.8% of the size of the C. parvum IowaII reference genome [Abrahamsen et al.,
2004]. By pooling the reads from all 10 oocysts, they generated a 94.4% complete genome.
Using these genomes, the authors detected variation at multiple loci between the assem-
bled genomes, verifying the presence of discrete populations within the isolate [Troell
et al., 2016].
The major issue with these aforementioned experimental approaches is that they are
extremely labour intensive and time consuming, leading to poor scalability. This leads
to difficulties in generating sufficient data with which to begin to unravel the role of
these parasite sub-populations in altering their ability to reduce host-fitness (virulence)
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and transmission, as well as generating novel subtypes via sexual recombination and the
overall impact these factors have on global public health. There is therefore a great need
to develop strategies which can carry out this kind of analysis in a high-throughput man-
ner, utilising the wealth of raw genomic data which is available for Cryptosporidium and
other related parasites.
A few tools and pipelines have been developed for the purpose of identifying MOI
in NGS data. These tend to utilise conventional read mapping software, in conjunction
with bespoke scripts. estMOI is one such tool, which identifies local heterogeneity in
read sets using smalt, and a set of perl scripts. The authors demonstrated its efficacy on
clinical and cultured read sets of P. falciparum. However, as it is driven by smalt, it is
limited to SNP and small indel identification. It may therefore be confounded by more
variable, and/or lower complexity sequence, or larger levels of variation such as that seen
in Tandem Repeats [Assefa et al., 2014].
There are a number of tools which are dedicated to identifying homozygous varia-
tion (local variation between a query and a reference) within a read set, which could
potentially be adjusted to identify heterozygosity. Such tools include Dante, VNTRseek
[Gelfand et al., 2014], lobSTR [Gymrek et al., 2012], & RepeatSeq [Highnam et al., 2013].
Each of these tools identify TR variation by mapping reads onto a reference set of TR’s
previously identified by running a TR discovering tool (e.g. Tandem Repeats Finder
[Benson, 1999]) on a reference genome. The performance of these tools in their capacity
to identify heterozygosity within a read set is dependant largely on the read mapping
software that drives the tool, as some mapping software will deal with high-levels of local
variation in a manner more appropriate to variant calling. Larger amounts of variation
in the target locus may lead to data loss, where alignment is not achieved. Furthermore,
as these tools are not designed for identification of sample heterogeneity, they may need
development to support this function.
Problems associated with high levels of variation at a target locus, which could con-
found conventional read mapping approaches, can be circumvented by mapping to more
conserved regions flanking the target sequence. However, mapping to regions which are
less than the average read length is not possible. Consequently, an alternative approach
may be to, in effect, map the target flanking regions to the reads. Any read which con-
tains both flanking regions can be assumed to also contain the low complexity target
region. The method by which the presence of a sequence within a read is ascertained,
however, is an important factor, since there may be many millions of read pairs within
an NGS read file, which necessitates very time efficient methods of sequence similarity
assessment which can be repeated many millions of times in an appropriate time frame.










UKP2 16,121,704 128.86 51.80x 0.93 0.223
UKP3 67,417,128 132.65 166.42x 0.89 0.556
UKP4 74,741,128 137.86 192.48x 0.89 0.566
UKP5 10,571,200 148.14 26.86x 0.85 0.277
UKP6 44,788,256 138.44 104.83x 0.82 0.255
UKP7 29,974,248 137.68 77.85x 0.89 0.555
UKP8 89,290,752 124.82 174.39x 0.84 0.566
Table 5.1: Basic statistics for the Hadfield et al. C. parvum read file dataset. The
total reads includes both forward and reverse. The proportion of the genome covered was
calculated using bowtie v2.3.3.1 to align the reads against the C. parvum IowaII reference
genome. The GINI was calculated as detailed in Section 2.2.3.
5.2 Method
5.2.1 Predicting Multiplicity of Infection in Clinical Data
To investigate multiplicity of infection in clinical data from C. parvum, we utilised VNTR
regions identified by VaNTA within both of these organisms (see Chapter 3). We used
the 100 top scoring VNTR loci as targets (see Table 5.2), and the Hadfield et al. dataset,
consisting of raw read files from the single-host clinical samples UKP2-8 [Hadfield et al.,
2015]. Basic statistics for each of these read files can be seen in Table 5.1. For further
analysis of the viability of MOI-signatures as a novel typing scheme, C. parvum isolates
from Dataset 2 (see Section 2.1.1) were also investigated using 2 chosen loci. The mean
read length for all isolate read files within the Hadfield et al. dataset is 135.49x (see
Table 5.1), indicating that the total size of the target sequence and the two flanks should
be around this size or less to be captured in a single read. The algorithms for target
detection within BlooMine do not necessitate the entire flank being detected within the
read to trigger a hit, and there is therefore some flexibility. The targets which are likely
to significantly exceed the mean read length (where the size of both individual flanks
is 41 nucleotides) and therefore unlikely to be detected in full are highlighted in red in
Table 5.2. These target loci are included in this dataset for the purpose of providing an
example as to how these larger target sequences are processed by BlooMine, as target
fragments may still be identified and returned. Read pairs were not merged, due to the
potential for repeat collapse, which would affect the results of sub-population identifica-
tion in instances where the target is a repeat region.
Using the MOI data generated using the Hadfield et al. dataset, two loci were se-
lected for further analysis. C. parvum isolates from Dataset 2 (see Section 2.1.1) were
then analysed for MOI at these loci (n = 29).
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The G | W1 for UKP3, UKP4, UKP7, and UKP8 are high (0.556, 0.566, 0.555, and
0.566 respectively), which indicates a high level of coverage inequality. This suggests that
some loci will be covered to a higher depth than others, which may be reflected in the
level of in-host variation detected for target sequences.











cgd1 140.P.2350-2463 CTC 125 100 85.714
cgd5 4480.P.1455-1500 AAT 46 85.714 100
cgd3 1250.P.634-662 AT 29 100 100
cgd8 4170.P.2518-2555 TAA 38 100 100
cgd7 420.P.4749-4787 GAACAA 39 100 100
cgd7 1190.P.2275-2313 TCTTCC 39 100 100
cgd3 1330.P.464-501 TCC 38 100 100
cgd3 3620.P.935-981 AAAGAC 47 100 100
cgd2 3540.P.5762-5808 TCA 47 100 100
cgd6 1080.P.108-164 TCA 57 85.714 85.714
cgd8 660.P.1554-1715 CCAGGA 162 100 100
cgd4 1340.P.815-878 TAA 64 100 100
cgd7 440.P.1066-1129 AAG 64 100 100
cgd6 780.P.1043-1111 GA 69 100 100
cgd6 490.P.468-543 AAT 76 100 100
cgd8 680.P.2962-3038 CACAACCAT 77 100 100
cgd7 1010.P.8357-8436 TAA 80 100 100
cgd8 700.P.747-842 ACTCCT 96 100 100
cgd8 1220.P.825-881 ACTTCT/CTT 97 100 100
cgd5 4090.P.428-544 GAATCT 117 100 100
cgd8 700.P.5284-5400 CTGGTG 117 100 100
cgd2 3590.P.5378-5402 TAC 25 100 100
cgd3 280.P.3887-3911 AAT 25 100 100
cgd4 3450.P.4333-4357 AATCTG 25 100 100
cgd6 3930.P.1748-1773 AGCTCCTCC 26 100 100
cgd5 130.P.4193-4218 TCA 26 100 100
cgd5 4190.P.231-257 GTA 27 100 100
cgd1 800.P.182-208 ACA 27 100 100
cgd8 4860.P.506-532 GGA 27 100 100
cgd7 1010.P.4475-4501 AGG 27 100 100
cgd6 520.P.300-327 AAT 28 100 100
cgd8 4170.P.2262-2289 ATA 28 100 100
cgd8 2260.P.2694-2721 AAT 28 100 100
cgd8 2250.P.3218-3246 AAT 29 100 100
cgd1 3550.P.1267-1295 TAA 29 100 100
cgd7 420.P.3445-3474 ATA 30 100 100
cgd8 4170.P.1991-2020 GAT 30 100 100
cgd8 2250.P.3970-4000 TTATAATCGGGATCC 31 100 100
cgd7 4980.P.5482-5513 TAA 32 100 100
cgd2 3700.P.4257-4288 GAGGAT 32 100 100
cgd2 3550.P.1472-1504 TTCCACTTCTGC 33 100 100
cgd7 5010.P.3301-3332 GAG 32 100 100
cgd2 3540.P.4474-4507 TAA 34 100 100
cgd4 1610.P.322-355 ATA 34 100 100
cgd4 2090.P.192-226 GAAGGAGAG 35 100 100
cgd6 3690.P.595-629 AAG 35 100 100
cgd4 3970.P.1521-1555 CCTATG 35 100 100
cgd2 400.P.329-363 TCA 35 100 100
cgd2 3590.P.18288-18323 AAT 36 100 100
cgd7 1010.P.8072-8108 TAA 37 100 100
cgd6 610.P.1783-1819 TAA 37 100 100
cgd8 970.P.3734-3771 TCTGGATCTGGA 38 100 100
cgd3 90.P.1112-1149 AAT 38 100 100
cgd3 720.P.16227-16264 CTACAACTA 38 100 100
cgd8 550.P.5068-5107 TCATAATAATGACAA 40 100 100
cgd6 830.P.7342-7445 CAA/ACAACAGCAACAACA/CAT 140 100 100
cgd1 3170.P.4177-4216 ATTCTGATTCCA 40 100 100
Continued on next page
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Table 5.2 – continued from previous page











cgd4 3660.P.167-207 GAG 41 100 100
cgd6 5110.P.5014-5056 ATTCAG 43 100 85.714
cgd4 1420.P.405-447 AAT 43 100 100
cgd5 3750.P.497-608 GAT/ATA/AATAATAATAAC 146 100 100
cgd8 4940.P.1528-1573 TAG 46 100 100
cgd4 1360.P.1109-1155 TAA 47 100 100
cgd7 4500.P.633-679 CAC 47 100 100
cgd1 3450.P.494-540 GATTCT 47 100 100
cgd8 1570.P.575-622 TCT 48 100 100
cgd1 3060.P.589-637 CATCCT 49 100 100
cgd8 1380.P.662-811 GAACAA 150 100 100
cgd6 520.P.1935-1984 ATA 50 100 100
cgd6 730.P.3630-3679 AAT 50 100 100
cgd1 3270.P.668-717 TAA 50 100 100
cgd2 700.P.2705-2755 AGA 51 100 100
cgd6 4030.P.2123-2172 CCACCAGCC 50 100 100
cgd2 3870.P.4485-4548 CAAATAATAATAATT/AATAATAAAT/AAT 151 100 85.714
cgd2 680.P.5030-5079 CCACCT 50 100 100
cgd8 4830.P.581-715 ACATCCACATCT/CTACAT 152 100 100
cgd4 3630.P.1196-1247 AGCGG 52 100 100
cgd6 1430.P.373-425 TAA 53 100 100
cgd4 810.P.418-471 ATA 54 100 100
cgd5 4490.P.2933-2987 CCAGAG 55 85.714 85.714
cgd3 270.P.2731-2785 TACTGCTACTAC 55 100 100
cgd8 4510.P.486-541 CAAAACCAAAGC 56 100 100
cgd8 4840.P.6354-6611 GGAGCT 258 100 100
cgd8 2800.P.1088-1245 TAC 158 100 100
cgd4 600.P.751-809 ATA 59 100 100
cgd6 530.P.752-810 TAA 59 100 100
cgd6 830.P.6111-6169 TCT 59 100 100
cgd2 3980.P.632-691 AAT 60 100 100
cgd6 520.P.942-1001 ATA 60 100 100
cgd2 3850.P.340-499 TCCTGC 160 100 100
cgd2 430.P.435-495 CAAGTT 61 100 100
cgd8 4000.P.2102-2134 TCATCATCATCTTCT/TCATCATCTTCT 62 100 100
cgd5 350.P.56-117 ACT 62 100 100
cgd2 410.P.680-744 TCAAGG 65 100 100
cgd7 4990.P.19317-19382 AGAAGAAGGAAGAGA 66 100 100
cgd7 1010.P.10224-10288 GGAGGAATGA/AGG 66 100 100
cgd2 3340.P.137-202 GGAACA 66 100 100
cgd1 470.P.1417-1489 TTCTGA 73 100 100
cgd6 760.P.999-1073 CCAGCT 75 100 100
cgd2 1000.P.1638-1675 ACT/ACTAATACTACT 75 100 100
Table 5.2: Tandem Repeat (TR) target loci for MOI analysis. These loci represent the top
100 scoring tandem repeats generated by running VaNTA on UKP2-8 using C. parvum
IowaII as reference. The target locus name is formatted as {gene name}.P.{position}.
The TR subseq is the most likely repeat subsequence as reported by Tandem Repeats
Finder. Where multiple subsequences are reported, seperated by a forward slash, this
represented target regions where there are 2 or more adjacent TR’s with discrete repeat
subsequences, and have therefore been reported as a single TR. C. parvum IowaII TR
length refers to the length of the TR region alone (without flanking regions) in the
reference genome. Flank conservation is reported as the percentage of the query dataset
(UKP2-8) which exhibits complete sequence similarity in that flanking region. Targets
highlighted in red are those which bear cumulative flank and target sequence lengths of
greater than the mean read length across each dataset, and are therefore unlikely to be
fully captured in a single read.
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5.2.2 Target Variation Distance Calculation
To investigate target sequence and fragment-length variation within multi-dimensional




(qi − pi)2· (5.1)
Where q = (q1, q2, ..., qn) and p = (p1, p2, ..., pn) are points in an nth dimensional Eu-
clidean space, which in this context refers to a set of fragment-length/sequence variations
at a target locus.
Given a dataset of the number of fragment-length/sequence variations at a target
location within a set of single-host read libraries, Dn is calculated as a measure of the
value of the target for interrogation to elucidate multiple sub-populations within a single
host. The higher the Dn, the greater the overall variation throughout all read libraries,
and therefore the more common variation of this target is seen within a host. Figure 5.2
is a graphical representation of Dn in 3 dimensions. In the context of target variation
distance, each axis measures the number of alleles present within a single sample at the
locus being interrogated.
Figure 5.2: A graphical example of the Dn of a 3-dimensional dataset. The red, blue and
green lines denote the D1, D2, and D3 distances respectively.
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5.2.3 MOI Signature Distance
To examine the efficacy MOI-signature as a high-sensitivity and reliable measure of isolate
relatedness, isolates were clustered according to their MOI-signature. If we consider an
isolate, I, which is a sample containing an arbitrary number of alleles at each locus. An
allele, a, is defined as a variation in a target locus (in this instance, variation is dictated by
fragment length alone). The set Ma contains all alleles at the interrogated locus present
within I:
Ma = {a1, a2, ..., an} (5.2)
The allele count (cIa,i) is defined simply as the number of reads which contain allele i
within I. A vector of allele probabilities can be generated by calculating the probability
(pIa,i) of encountering each allele within I:
pIa = {pIa,1, pIa,2, ..., pIa,n} (5.3)















This vector of frequencies can be considered the MOI-signature for I. In order that
subdominant alleles within an MOI-signature are weighted to contribute more strongly






Euclidean distance (see Section 5.2.2) of MOI-signatures was calculated for each iso-
late, yielding a pairwise distance matrix. This pairwise distance matrix was then graphed
to reveal population data structure, and subsequent isolate relatedness. This was com-
pared against a phylogenetic tree of the dominant allele at this locus for each isolate
to reveal whether there was concordance between the two methodologies, and whether
MOI-signature distance reveals population structure which is lost by classic dominant
allele subtyping. Two loci were selected for further analysis in this manner: gp60
(cgd6 1080.P.108-164) and cgd7 440.P.1066-1129, due to their capacity to resolve sub-
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types of C. parvum.
5.2.4 Co-Occurrence Alleles Within MOI Signatures
To investigate the concordance of alleles within MOI-signatures, the coefficient of Linkage
Disequilibrium (L), which is defined as
LAB = pAB − pApB, (5.7)
of each allele within the C. parvum gp60 MOI-signature set was calculated. Where pA
and pB are the probabilities of encountering alleles A and B within the dataset, and pAB
is the probability of the co-incidence of alleles A and B within a single sample within the
dataset.
For the purpose of comparing L between different pairs of alleles, values were nor-





Although the coefficient of Linkage Disequilibrium is used here, it is applied only as
a statistical measure of the probability of co-incidence of alleles, and does not make any
implication about co-occurrence of alleles within a single genome. Likewise it makes no
implication of actual physical linkage. However, since the method of statistical analysis
is identical and the concepts similar, the co-occurrence of alleles will be hereafter referred
to as Linkage Disequilibrium.
5.2.5 Data Management and Visualisation
All data analysis was carried out using the NumPy [Oliphant, 2006, Van Der Walt et al.,
2011] and SciPy [Jones et al., 2001], and visualisation in Matplotlib [Hunter et al., 2007]
packages in Python v2.7.
5.3 Results
5.3.1 Results of BlooMine Read Mining on Real Data
Figure 5.3 shows the distribution of target loci (shown in Table 5.4) across the genome
of C. parvum. Also shown are target fragment length variation and sequence variation
distances (see Section 5.2.2), and TR-length. In-host TR variability appears to be uni-
formly distributed, with no obvious clustering of variable target loci across the genome
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Figure 5.3: Fragment length (y axis) and sequence (marker colour) variation of a TR
locus plotted against genomic position (x-axis). The diameter of the markers denotes
the length of the Tandem Repeat region within the IowaII reference genome (i.e. the
fragment length of the TR within the IowaII genome). Variation is presented as Euclidean
distance (Dn) in n-dimensions, where n is the size of the dataset, as detailed in section
5.2.2. Here, a greater Dn indicates a greater capacity for the TR locus to differentiate
isolates by either fragment length or sequence variation, as indicated by its variability in
the dataset. Target fragment length and sequence variation refer to the the two kinds of
variability at a locus, and can both be used to define an allele. Fragment length variation
refers to a difference in the length of an allele, measured in nucleotides. Sequence variation
refers to a difference in DNA sequence of the allele.
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Figure 5.4: Plotted values of reference target length (TR length) and fragment-
length/sequence variation (the number of alleles present in a sample defined by fragment-
length and sequence variation) for each target. Distance is calculated as detailed in section
5.2.2.
132 CHAPTER 5. MULTIPLICITY OF INFECTION
being presented. There appears to be correlation between fragment-length and sequence
variation within this dataset (illustrated by markers on the x-axis and marker colour). To
further examine the relationships between metrics within this dataset, they were plotted
against each other. Figure 5.4 shows scatter plots of target metrics within the dataset of
clinical read sets, where each marker within the plot represents the length of the target
within a reference genome, or the Euclidian distance of the fragment length or sequence
variation of the target within all datasets from 0 (with 0 representing no variation at all),
as detailed in section 5.2.2. A moderately strong positive correlation between variation
of target TR sequence and fragment-length can be seen, exhibiting an R2 of 0.594. This
indicates that target variation by fragment length and sequence are mutually explicable,
in that if there is variation in fragment-length of the target within a sample (indicat-
ing multiple populations), there is also likely to be variation at a sequence level. There
appears to be no correlation between the length of the target TR within the reference
genome and fragment-length (R2 = −0.008) or sequence variation (R2 = −0.001).
Table 5.4 shows results of the number of variable target alleles across the dataset.
Not all datasets exhibited all target regions, which is possibly due to lack of coverage
over these regions, or loss of the target loci. The .fastq read sets have been seen to
have uneven coverage across the genome, represented by GINI values in Table 5.1, where
higher values represent higher levels of coverage inequality. Table 5.1 also illustrates that
portions of the genome are not covered by reads within the datasets. 76 of the targets
exhibited multiple alleles (target variation present as either target length or sequence)
within at least one of the paired-end read sets. 58 of these targets exhibited variation
within 2 or more read sets, and 4 across all. 10 of the target loci detailed in table
5.2 were not captured in a single read within any of the isolate read sets. These were
cgd1 140.P.2350-2463, cgd8 700.P.747-842, cgd5 4090.P.428-544, cgd6 830.P.7342-7445,
cgd5 3750.P.497-608, cgd8 1380.P.662-811, cgd8 4830.P.581-715, cgd8 4840.P.6354-6611,
cgd8 2800.P.1088-1245, cgd2 3850.P.340-499. Each of these missing target sequences were
highlighted in table 5.2 as bearing cumulative flanking and target sequence lengths of










UKP2 4030426 472 66 2
UKP3 16854282 4866 990 177
UKP4 18685282 1291 1003 198
UKP5 2642800 49 24 11
UKP6 11197064 3658 100 23
UKP7 7493562 650 412 78
UKP8 22322688 6454 903 174
Table 5.3: The number of reads at each stage of screening: Unscreened (present in the
concatenated .fastq files), First-Pass (see Section 4.4), and Second-Pass screen I and II
(see Section 4.5). See Figure 4.6 for an outline of this process.
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Figures 5.5 and 5.6 shows the breakdown for gp60 and cgd7 440.P.1066-1129 fragment
lengths within a C. parvum dataset respectively. Table 5.3 shows the number of reads
which were output from each step of the screening process using the gp60 locus as the
target. The most abundant fragment length for each isolate in 5.5 represents the length
of the gp60 allele detected by PCR, shown in Table 2. Most isolates exhibit a similar
population structure, with the dominant allele accounting for the majority of the alleles
present within the sample. Hereafter we use the allele naming convention of ”allele #”,
where # refers to the fragment length of the allele. The results also show that UKP4, 5,
6, 118, 103, 133 and 134 each exhibit very similar gp60 MOI-signatures (defined here as
the relative abundance of each allele within the sample), with the same dominant allele
(allele 56) and sub-dominant allele (allele 53). Similarly, UKP3, 94, 95, and 124 have
similar MOI-signatures, bearing allele 65 as dominant and allele 62 as sub-dominant.
Cgd7 440.P.1066-1129 population structure appears to be dominated by allele 63, pre-
senting as the dominant allele of 17 isolates within this dataset. Similar MOI-signatures
can be seen in UKP90, 94, 104, 120, 122, 130MDA, and 131MDA, which bear allele 63 as
dominant and allele 60 as the only sub-dominant allele. Similarly, further sub-dominant
population structure can be seen in UKP3, 4, and 6, which each bear alleles 63 and 60
as dominant and sub-dominant respectively, but also exhibit a number of other alleles.
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Figure 5.7: A heat map of un-normalised Linkage Disequilibrium (see Section 5.2.4) of gp60
alleles (by fragment size) present within MOI-signatures in the C. parvum dataset. Positive
values indicate the level of co-occurrence of alleles, and negative values indicate the level of
mutual exclusivity of alleles. Both the x and y axis refer to fragment sizes of the gp60 allele.
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Figure 5.8: A heat map of normalised Linkage Disequilibrium (see Section 5.2.4) of gp60
alleles (by fragment size) present within MOI-signatures in the C. parvum dataset. Positive
values indicate the level of co-occurrence of alleles, and negative values indicate the level of
mutual exclusivity of alleles. Both the x and y axis refer to fragment sizes of the gp60 allele.
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Figure 5.9: A heat map of un-normalised Linkage Disequilibrium (see Section 5.2.4) of
cgd7 440.P.1066-1129 alleles (by fragment size) present within MOI-signatures in the C.
parvum dataset. Positive values indicate the level of co-occurrence of alleles, and negative
values indicate the level of mutual exclusivity of alleles. Both the x and y axis refer to
fragment sizes of the cgd7 440.P.1066-1129 allele.
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Figure 5.10: A heat map of normalised Linkage Disequilibrium (see Section 5.2.4) of
cgd7 440.P.1066-1129 alleles (by fragment size) present within MOI-signatures in the C.
parvum dataset. Positive values indicate the level of co-occurrence of alleles, and negative
values indicate the level of mutual exclusivity of alleles. Both the x and y axis refer to
fragment sizes of the cgd7 440.P.1066-1129 allele.
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To investigate the co-incidence of fragment sizes (alleles) within these isolates, the
Linkage Disequilibrium (LD) of allele pairs was calculated (see Section 5.2.4 Equation
5.7) for both loci (gp60 and cgd7 440.P.1066-1129). To clarify these data, the results
were normalised using the correlation coefficient (see Section 5.2.4 Equation 5.8)
Figure 5.7 shows the result of Linkage Disequlibrium calculations on gp60 allele pairs.
These results suggest non-random association of gp60 allele pairs within this dataset. The
results of normalisation can be seen in Figure 5.8. This shows that there is significant
positive LD between a number of read pairs, particularly alleles 71-74 (.702), 77-71 (.702),
77-74 (1.000), 53-56 (.788), and 62-65 (.642). Little negative LD was apparent, however,
allele 68 accounted for the majority of the negative LD presented within this dataset.
This suggests that allele 68 is strongly dominant within a population, and presents with
very few or no sub-populations. This is also indicated by results seen in Figure 5.5.
Figures 5.9 and 5.10 show the raw and normalise LD values for each allele pair for
cgd7 440.P.1066-1129. These results show high levels of non-random association, with
pairs of alleles presenting with positive LD, such as allele pairs 30-41 (1.000), 57-66
(0.651), 30-45 (0.703), 45-62 (0.703), 45-41 (0.703), and 60-63 (0.629). In particular, al-
lele 45 shows positive LD with 12 of the 15 alleles (0.096 to 0.703) and only slight negative
LD with the remaining 3 (-0.018 to -0.046). Allele 63 show the highest rate of negative
LD, exhibited across 5 allele pairing (-0.064 to -0.13) though it also exhibits moderately
high levels of positive LD in the remaining allele pairs.
For both of these loci, structure in the data, such as the clear positive LD ’boxes’
which can be seen at cgd7 440.P.1066-1129 alleles 39-45 and 57-63, and gp60 alleles 47-59
indicate that there may be higher levels of LD between allele pairs which are closer in
fragment length.
Figure 5.11 shows the Euclidean Distance (see Section 5.2.2) for MOI-signatures gen-
erated from interrogation of the gp60 locus within the clinical C. parvum dataset. The
data suggests clustering is occurring according to MOI-signature. To further explore this,
a nearest neighbour tree was generated from the MOI-signature pairwise distance ma-
trix. Figure 5.12 shows this dataset clusters into 4 distinct clades (green, red, azure, and
purple) and 1 less distinct clade (yellow). Green, red, azure, and purple clades consist of
isolate with dominant populations of alleles 56, 68, 65, and 50. Each of these major clades
pertain to distinct gp60 fragment lengths, and are therefore equivalent to gp60 subtypes.
Further discrimination is a result of the abundance of sub-populations of alleles within
each isolate. Large amounts of structure has been resolved at a sub-dominant level. The
yellow clade appears to be much more diverse, containing 3 dominant alleles (71, 59, and
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Figure 5.11: A heat map of the Euclidean Distance (see Section 5.2.2) of MOI-signatures
of isolates within the C. parvum dataset (detailed in Section 5.2.3) at the gp60 locus.
Both the x and y axis refer to C. parvum isolates.
53), and is consequently rooted more distantly from the leaves.
Figure 5.15 is a neighbour joining tree generated by multiple alignment of gp60 se-
quences from the C. parvum dataset. It indicates the presence of 11 discrete gp60 subtypes
within this dataset, with the largest (IIaA15G2R1) accounting for 10 of the 26 isolates.
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Figure 5.13: A heat map of the Euclidean Distance (see Section 5.2.2) of MOI-signatures

































































































































































































































Target Locus UKP2 UKP3 UKP4 UKP5 UKP6 UKP7 UKP8 length Dn sequence Dn
cgd4 3970.P.1521-1555 2 1 0 0 10 6 2 1 6 4 7 5 13 8 19.026 11.958
cgd7 440.P.1066-1129 2 2 6 8 6 11 2 2 8 13 4 4 6 11 14 22.338
cgd8 1570.P.575-622 3 3 4 4 6 7 2 2 7 9 6 6 4 6 12.884 15.199
cgd2 400.P.329-363 1 2 0 0 7 10 2 4 3 3 4 7 8 12 11.958 17.944
cgd6 1080.P.108-164 1 1 4 15 7 14 2 2 3 6 5 6 0 0 10.198 22.316
cgd8 4940.P.1528-1573 3 3 4 7 3 10 2 2 3 4 5 5 5 7 9.849 15.875
cgd6 3690.P.595-629 2 2 3 3 4 7 1 1 3 5 4 4 4 5 8.426 11.358
cgd2 1000.P.1638-1675 2 2 4 5 4 6 1 1 4 4 2 2 1 3 7.616 9.747
cgd6 780.P.1043-1111 0 0 1 1 4 4 1 2 4 4 2 2 3 3 6.856 7.071
cgd4 3630.P.1196-1247 1 1 2 8 3 13 1 1 1 3 3 5 4 6 6.403 17.464
cgd7 4500.P.633-679 1 2 3 5 2 5 1 1 1 1 3 4 4 4 6.403 9.381
cgd2 3340.P.137-202 1 1 3 9 3 9 1 1 2 2 2 5 3 14 6.083 19.723
cgd6 830.P.6111-6169 2 2 2 2 3 5 2 2 3 4 1 1 2 3 5.916 7.937
cgd2 3540.P.5762-5808 2 2 2 3 3 5 1 1 2 4 2 2 3 7 5.916 10.392
cgd4 2090.P.192-226 0 0 2 8 2 11 2 2 3 10 2 6 3 7 5.831 19.339
cgd8 4000.P.2102-2134 1 1 1 3 3 5 2 3 4 6 1 1 1 3 5.745 9.487
cgd4 3660.P.167-207 0 0 2 2 2 2 1 1 4 5 1 1 1 1 5.196 6
cgd8 970.P.3734-3771 1 1 3 9 3 8 1 1 1 1 1 1 2 7 5.099 14.071
cgd7 420.P.3445-3474 2 2 2 2 1 1 0 0 3 4 2 2 2 2 5.099 5.745
cgd5 350.P.56-117 1 1 1 2 3 4 1 1 2 3 2 2 2 2 4.899 6.245
cgd2 3540.P.4474-4507 1 1 2 3 1 2 2 2 3 3 2 2 1 1 4.899 5.657
cgd5 4490.P.2933-2987 1 1 0 0 2 7 1 1 1 2 1 1 4 7 4.899 10.247
cgd8 680.P.2962-3038 2 2 1 1 1 2 1 1 1 1 2 4 3 3 4.583 6
cgd6 490.P.468-543 1 1 1 1 2 2 2 2 3 3 1 1 0 0 4.472 4.472
cgd8 2250.P.3218-3246 1 1 1 1 1 1 0 0 4 4 0 0 1 1 4.472 4.472
cgd3 90.P.1112-1149 1 1 2 2 2 2 1 2 2 2 2 2 1 1 4.359 4.69
cgd7 1190.P.2275-2313 1 1 2 3 1 3 2 2 1 2 2 5 2 4 4.359 8.246
cgd2 430.P.435-495 1 1 1 6 3 3 1 1 1 2 1 1 2 3 4.243 7.81
cgd1 3550.P.1267-1295 2 2 2 2 2 2 0 0 1 1 1 1 2 2 4.243 4.243
cgd3 270.P.2731-2785 1 2 2 2 2 4 1 1 1 1 1 2 2 2 4 5.831
cgd5 4190.P.231-257 2 3 1 3 1 3 1 1 2 2 1 1 2 3 4 6.481
cgd2 700.P.2705-2755 1 2 1 2 2 3 1 1 2 1 1 1 2 4 4 6
cgd8 1220.P.825-881 1 1 2 2 1 3 1 2 1 2 2 2 2 4 4 6.481
cgd2 3980.P.632-691 1 1 2 2 1 1 2 2 2 2 1 1 1 1 4 4
cgd7 5010.P.3301-3332 0 0 1 1 2 4 0 0 1 1 3 3 1 2 4 5.568
cgd1 800.P.182-208 1 1 1 1 2 3 1 1 1 1 2 2 2 2 4 4.583
cgd8 4510.P.486-541 1 2 2 6 2 6 1 1 1 4 2 3 1 3 4 10.536
cgd2 3590.P.5378-5402 1 1 1 1 1 1 1 1 2 2 2 2 2 2 4 4
cgd4 1420.P.405-447 1 1 1 1 1 2 1 1 3 3 1 1 1 1 3.873 4.243
cgd3 1250.P.634-662 1 1 1 1 1 1 1 1 3 4 1 1 1 1 3.873 4.69
cgd7 1010.P.4475-4501 1 1 1 1 1 1 1 1 1 1 1 1 3 2 3.873 3.162
cgd4 1360.P.1109-1155 1 1 0 0 2 2 2 2 2 2 1 1 0 0 3.742 3.742
cgd8 4170.P.2518-2555 2 2 1 1 2 2 1 1 1 1 1 1 1 1 3.606 3.606
cgd6 3930.P.1748-1773 1 1 2 6 2 4 1 1 1 3 1 2 1 3 3.606 8.718
cgd8 4170.P.1991-2020 2 2 1 1 1 1 1 1 2 2 1 1 1 1 3.606 3.606
cgd1 3450.P.494-540 1 1 2 3 1 4 1 1 1 2 1 1 2 3 3.606 6.403
cgd1 3060.P.589-637 2 3 0 0 2 6 1 1 1 2 1 1 1 4 3.464 8.185
cgd2 3590.P.18288-18323 1 1 2 2 2 2 0 0 1 1 1 1 1 1 3.464 3.464
cgd8 550.P.5068-5107 2 2 1 1 1 1 1 1 1 1 1 1 1 1 3.162 3.162
cgd6 1430.P.373-425 1 1 1 1 1 1 2 3 1 1 1 1 1 1 3.162 3.873
cgd1 3270.P.668-717 0 0 1 1 1 1 2 2 2 3 0 0 0 0 3.162 3.873
cgd2 3700.P.4257-4288 1 1 2 5 1 1 1 1 1 2 1 1 1 3 3.162 6.481
cgd2 3550.P.1472-1504 1 1 1 3 1 2 1 1 1 2 1 3 2 4 3.162 6.633
cgd7 4980.P.5482-5513 1 1 1 1 1 1 1 1 1 1 1 1 2 2 3.162 3.162
cgd5 130.P.4193-4218 1 1 1 1 1 1 1 1 1 3 1 1 2 2 3.162 4.243
cgd4 3450.P.4333-4357 1 1 1 3 2 4 1 1 1 1 1 1 1 3 3.162 6.164
cgd4 810.P.418-471 1 1 1 1 1 1 0 0 1 1 2 2 1 1 3 3
cgd5 4480.P.1455-1500 1 1 1 1 1 1 0 0 1 1 2 2 1 2 3 3.464
Continued on next page
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Table 5.4 – continued from previous page
Target Locus UKP2 UKP3 UKP4 UKP5 UKP6 UKP7 UKP8 length Dn sequence Dn
cgd4 600.P.751-809 0 0 1 1 1 1 1 1 2 2 1 1 0 0 2.828 2.828
cgd8 4170.P.2262-2289 1 1 1 1 1 1 2 2 1 1 0 0 0 0 2.828 2.828
cgd3 280.P.3887-3911 1 1 1 1 1 1 0 0 2 2 0 0 1 1 2.828 2.828
cgd7 420.P.4749-4787 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2.646 2.646
cgd4 1610.P.322-355 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2.646 2.646
cgd3 720.P.16227-16264 1 1 1 2 1 1 1 1 1 2 1 2 1 2 2.646 4.359
cgd7 4990.P.19317-19382 1 1 1 2 1 2 1 1 1 3 1 1 1 2 2.646 4.899
cgd6 730.P.3630-3679 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2.646 2.646
cgd1 470.P.1417-1489 1 2 1 4 1 3 1 1 1 2 1 3 1 1 2.646 6.633
cgd1 3170.P.4177-4216 1 1 1 1 1 1 1 1 1 4 1 1 1 1 2.646 4.69
cgd6 520.P.300-327 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2.646 2.646
cgd2 410.P.680-744 1 1 1 2 1 1 1 1 1 1 1 2 1 1 2.646 3.606
cgd3 3620.P.935-981 1 1 1 1 1 1 0 0 1 3 1 1 1 1 2.449 3.742
cgd6 530.P.752-810 1 1 1 1 1 2 0 0 1 1 1 1 1 1 2.449 3
cgd3 1330.P.464-501 1 1 0 0 0 0 0 0 2 2 0 0 1 1 2.449 2.449
cgd6 520.P.942-1001 0 0 1 1 1 1 1 1 1 1 1 1 1 1 2.449 2.449
cgd6 760.P.999-1073 1 2 1 2 1 1 0 0 1 1 1 1 1 1 2.449 3.464
cgd8 2250.P.3970-4000 0 0 1 2 1 1 1 1 1 2 1 1 1 1 2.449 3.464
cgd8 4860.P.506-532 1 1 1 1 1 1 0 0 1 2 1 1 1 1 2.449 3
cgd7 1010.P.8072-8108 1 1 1 1 1 1 1 1 1 1 0 0 1 1 2.449 2.449
cgd6 5110.P.5014-5056 1 1 1 1 1 1 1 2 1 3 0 0 1 2 2.449 4.472
cgd6 520.P.1935-1984 1 1 1 1 1 1 1 1 1 2 1 1 0 0 2.449 3
cgd2 680.P.5030-5079 0 0 0 0 2 2 0 0 0 0 1 1 1 1 2.449 2.449
cgd8 2260.P.2694-2721 1 1 1 1 1 1 0 0 1 1 1 1 1 1 2.449 2.449
cgd8 660.P.1554-1715 0 0 1 1 0 0 0 0 0 0 2 2 0 0 2.236 2.236
cgd2 3870.P.4485-4548 1 1 1 1 0 0 0 0 0 0 1 1 1 1 2 2
cgd4 1340.P.815-878 1 1 0 0 1 1 1 1 1 1 0 0 0 0 2 2
cgd7 1010.P.10224-10288 1 1 1 1 0 0 0 0 1 1 0 0 1 1 2 2
cgd8 700.P.5284-5400 0 0 1 1 0 0 0 0 0 0 0 0 1 1 1.414 1.414
cgd7 1010.P.8357-8436 0 0 0 0 1 1 0 0 1 1 0 0 0 0 1.414 1.414
cgd6 610.P.1783-1819 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1
cgd6 4030.P.2123-2172 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1
Table 5.4: Results from BlooMine mining on 100 target regions around the genome of
C. parvum, across the Hadfield et al. dataset ordered by length Dn. The 90 target loci
were fully captured in a single read within at least one of the datasets. The target locus
name is formatted as {gene name}.P.{position}. Variation count cells are structured
as: target length variation target sequence variation. Distance (Dn) is
calculated as described in Section 5.2.2.
5.4 Discussion
The results presented in Section 5.3.1 indicate extensive within-host genetic diversity
of C. parvum across multiple loci. These results are consistent with those which have
been reported in experimental studies. In 2013 Grinberg et al. reported high levels
of within-host diversity amongst two clinical isolates of C. parvum, isolated from cases
of Cryptosporidiosis in New Zeland, across two known variable loci (HSP70 and gp60).
Their results indicated extreme within-host diversity at the the gp60 locus, demonstrating
the presence of 10 distinct alleles within the two isolates. This is supported by our results,
which highlights gp60 (cgd6 1080.P.108-164) as bearing high levels of within-host diver-
sity. As can be seen in table 5.4, the gp60 locus bears the fifth highest Dn by fragment
length variation, at 10.198. Troell et al. reported variation between single sequenced
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oocysts isolated from a single clinical sample, as well as variation in sporozoites within
single oocysts. The results from both of these studies indicated a consistent population
structure within a host, where a single target variant (allele) is seen to be dominant, rep-
resenting the vast majority of reads within the read set. This dominant variant is present
along with 1 or more subdominant variants. An example of this can be seen in Figure
4.10, where 82.5% (146 of 177) of the reads are represented by a single target fragment
length variant, with the remaining reads bearing 3 different target fragment length vari-
ants each represented by > 1 read. This observation is even more extreme when looking
at sequence variation, where figure 4.10 illustrates the presence of 15 discrete sequence
variants of the target cgd6 1080.P.108-164 (the gp60 VNTR locus) within the C. parvum
clinical isolate, UKP3, alone.
General clinical surveys do not demonstrate heterogeneity within clinical samples.
This may be explained by a lack of sensitivity to identify multiple discrete allelic popula-
tions within a sample using PCR alone, particularly in these instances where population
structure is characterised by a single highly dominant population and the fragment sizes
of the populations are so similar. It is probable that clinical surveys are detecting and
reporting the most abundant population, and the sub-dominant populations, in effect,
are being obscured by the dominant one. It has previously been reported that such PCR
based typing approaches commonly underestimate MOI within clinical samples [Zhong
et al., 2018]. This is particularly problematic in a clinical context, where mis-reporting
of the allelic profile of a clinical sample may alter the treatment decisions the clinician
may make.
The results of gp60 MOI analysis presented in Figure 5.5 clearly show relationships
between each isolate by the distribution of gp60 subtypes present within the sample. For
example, UKP4, UKP5 and UKP6 all present as having very similar MOI-signature, and
were isolated from the same cluster case, giving confidence in these results and indicating
that MOI-signature may be a novel method of high-sensitivity subtyping. This is also in-
dicated by the clustering that can be seen in 5.12, which shows that this dataset resolves
into a number of clades, each with complex structure, when clustering is performed using
gp60 fragment length MOI-signature rather than gp60 subtype alone. A comparison of
the gp60 MOI-signature tree (Figure 5.12) and the dominant allele sequence alignment
tree (Figure 5.15) indicate some notable differences. Isolates UKP4, 5, 6, 102, 103, 104,
118, 122, 133, & 134 are demonstrated as identical by sequence similarity of the dominant
allele, however, MOI-signature indicates significantly more complexity to the population
structure, with 9 distinct branches. In particular, UKP4, 5, & 6 appear to be relatively
distant within this tree, due to the presence of dissimilar sub-dominant allelic profiles.
Diversity in the yellow clade seen in Figure 5.12 is likely a result of alleles 71 and 53 only
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being represented as dominant by single isolates, UKP2 and UKP8 respectively, whereas
UKP7, 106, and 107 all bear dominant allele 59. This indicates difficulties associated
with clustering according to MOI-signature of isolates bearing rarer dominant alleles.
The MOI-signature tree generated with the tandem repeat locus cgd7 440.P.1066-
1129 shown in 5.14 indicates the presence of two major clades, split into 6 minor ones
(designated by colour). These two major clades are split by the fragment length of the
dominant allele, with the green clade bearing dominant allele 63, and the other clades
bearing varying dominant alleles. The green clade accounts for the majority of this dataset
(17/32 isolates). However, this clade is diverse, bearing a maximum vertical distance of
1.2. The MOI tree for cgd7 440.P.1066-1129 exhibits deeper roots at each coloured clade
than that of gp60 seen in Figure 5.12, indicating higher levels of diversity amongst sub-
dominant alleles than that of gp60. There are some key similarities between the trees
seen in Figures 5.12 and 5.14, markedly the membership and size of the largest (green)
clade. There are also similarities in the placement of rarer MOI-signatures (yellow clade)
which contain UKP8 and 106 in trees generated for both gp60 and cgd7 440. UKP129
is the only isolate which is mono-dominant (i.e. has only one allele present within the
MOI-signature) across both loci, bearing alleles 68 and 51 for gp60 and cgd7 440.P.1066-
1129 respectively. It is worth noting, however, that the MOI-signature generated using
the gp60 locus for this isolate was represented by only a single read, due to low coverage
at this region within this dataset.
Comparison of trees seen in Figures 5.12 and 5.15 highlight some differences in the
placement of certain isolates. The green clade is shown to be identical in both trees. The
placements on the rest of the tree follow a similar general structure, with the red and
blue clades clustering in a similar manner. However, members of the yellow and purple
clades do not cluster together. These differences are likely due to sequence variation,
which is not accounted for in the MOI-signature tree. The MOI-signature tree reveals
extensive structure in the red and green clades which is not revealed by the gp60 se-
quence tree, indicating that dominant populations within these samples bear an identical
gp60 subtype, but a great deal of variation exists amongst the sub-dominant populations.
Analysis of LD among allele pairs for both loci show extensive positive LD, indicating
high levels of non-random allelic association. Structure within Figures 5.10 and 5.8
indicate higher levels of positive LD between allele pairs which are closer in fragment
length. This suggests that MOI-signature variation may be as a result of repeat copy
number expansion or retraction, rather than as a result of multiple sources of infection,
or a non-clonal infective event, as we would not expect to see correlation between LD and
relative allele length were this the case. These results suggest a mechanism by which MOI
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can occur, wherein a single dominant population baring a single allele replicates and, due
to errors in DNA replication, variation is introduced into these regions by slipped strand
mispairing, resulting in the advent of a novel allele and therefore population. The results
support this mechanism of MOI diversity over non-clonal infection of a host. Further
work must be carried out to verify this hypothesis.
5.5 Conclusion
In this chapter, I have presented a detailed, and entirely in silico, analysis of Multiplicity
of Infection within a diverse Cryptosporidium parvum dataset isolated from clinical sam-
ples using BlooMine. Heterogeneity within these samples was extensive across two VNTR
loci (gp60 and cgd7 440.P.1066-1129), which supports the findings of experimental studies
into MOI within clinical sample of C. parvum [Grinberg and Widmer, 2016, Troell et al.,
2016]. I have also presented a novel typing methodology using the diversity of alleles at a
single locus within a clinical sample, termed MOI-signature typing. I demonstrated that
MOI-signature typing provides more detailed information about the diversity of popu-
lations of C. parvum within a clinical isolate than conventional ’dominant-allele’ typing
approaches, and therefore presents epidemiological surveys with a new dimension of data
with which to investigate transmission dynamics. Finally, I demonstrate that there is a
clear association between the incidence of certain pairs of alleles. In particular, alleles
which are closer in fragment size appear to be more likely to be in linkage disequilib-
rium, indicating that the method by which these incidences of MOI occur is variation
from a single clonal population, rather than infection of the host with multiple distict
populations. More work needs to be done to verify this hypothesis, and to detect these
MOI events experimentally. These results represent the most thorough investigation into
MOI that has been done for Cryptosporidium, and lays the groundwork for further re-
search into this under-investigated aspect of Cryptosporidium biology. Such projects are
essential in the development of preventative strategies, novel therapeutics, and our inter-
pretation of epidemiological surveys, and are therefore of great importance in the fight
against Cryptosporidiosis.
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Chapter 6
Conclusions and Future Work
6.1 Project Review
Due to the huge toll Cryptosporidiosis takes on global human health annually, the impor-
tance of efforts to improve our understanding of the transmission cycles of this parasite
cannot be overstated. Genome mining proves to be an essential tool in advancing our
understanding of this parasite. It allows us to formulate novel methods of detection and
transmission investigation, facilitating the development of novel prevention strategies
which are so essential for reducing the spread of this parasite and the disease it causes.
6.1.1 Generating Cryptosporidium Genomes from Clinical Sam-
ples
The problems associated with generating high quality whole-genome assemblies from clin-
ical samples of Cryptosporidium are largely due to the insufficient recovery of DNA from
these samples. This problem is due to a number of factors, such as small sample sizes,
low oocyst recovery rates, low DNA yield per oocyst, and extensive cleaning of oocysts
needed prior to extraction leading to oocyst loss. Consequently, DNA enrichment using
Multiple-Displacement Amplification (MDA) has been used to increase the amount of
genomic DNA available for sequencing.
In Chapter 2 I discuss how low levels of DNA isolated from clinical samples can lead
to extremely uneven depth of coverage across the genome, resulting in extensive misas-
sembly in Cryptosporidium whole genome assemblies. I then use the Gini coefficient as
a method of measuring the inequality of depth of coverage throughout the genome, and
present a novel extension of this coefficient to resolve the issues associated with data
granularity when calculating the Gini coefficient, termed Gini-granularity curves. These
curves are used to investigate the distribution of reads across a genome, and characterise
the nature of the inequality of coverage, i.e. whether there are large areas of read aggrega-
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tion, or very high levels of spiking. Furthermore, in Section 2.4 I demonstrate that using
MDA to enrich DNA for sequencing results in complex alterations of the distribution of
coverage plotted against GC content. Gini-granularity curves were used to indicate that
using MDA results in significant bias of large (> 10kb) portions of the genome, which
cannot be easily characterised by using other methods of analysis, such a word frequency
or GC content bias.
I demonstrate a method by which reliable, high-quality genome assemblies can be
generated using a pipeline to carry out de novo assembly and post-assembly improve-
ment. This pipeline was shown to be effective at resolving repetitive regions, which may
be investigated for utility as novel biomarkers to interrogate for diagnostic purposes.
The work presented in this chapter represents the first account of the wide scale
misassembly which can result from of uneven read coverage across Cryp-
tosporidium genomes (and subsequently the first attempt to resolve these issues)
[Morris et al., 2019b], and the first attempt to characterise the way in which
WGA affects the distribution of reads across the Cryptosporidium genome
[Morris et al., 2019a].
6.1.1.1 Elucidating the Criteria by which Sequences are Biased by WGA
Despite the investigation presented within this chapter, the criterion by which WGA
selectively amplified certain regions over others remains elusive. We can, with a large
degree of certainty, say that it biases large portions of the genome, which significantly
alters the way in which reads aggregate throughout a genome, and that this poses an
often obfuscated challenge to a bioinformatician. However, further investigations should
be carried out to elucidate the manner in which regions are biased, as it is my opinion
that it is not, as suggested in some articles, entirely random.
6.1.2 Identifying Novel Biomarkers Around the Genome of Cryp-
tosporidium
Tackling Cryptosporidiosis presents a number of issues to medical professionals. The pri-
mary issue is that the treatment is seldom effective in cases where the patient is immuno-
compromised. Furthermore, in these instances, Cryptosporidiosis is life-threatening. Em-
phasis has therefore been placed on tackling this disease at source and preventing its
spread. The development of prevention strategies are dependant on our ability to track
this disease and elucidate transmission cycles, which in turn necessitates the development
of highly sensitive, specific, and reliable subtyping schemes. The conventional method
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of Cryptosporidium subtyping is to interrogate the VNTR locus within a region coding
for a 60 Kda sporozoite surface protein: gp60 (gene cgd6 1080). This gp60 region has
been shown as highly polymorphic within C. parvum. However, there remain a number
of shortcomings of using this typing scheme:
 It is known to poorly differentiate C. hominis.
 Cryptosporidium has been reported to recombine at this locus [Widmer and Lee,
2010].
 As a single locus typing scheme, it lacks the reliability and resolution of multi-locus
typing.
These issues necessitate the development of novel typing schemes, driven by identifying
polymorphic regions around the genomes of Cryptosporidium.
In Chapter 3 I present VaNTA, a pipeline developed for the discovery of novel VNTR’s
in silico. It is used to identify novel VNTRs in coding regions around the genome of Cryp-
tosporidium and Plasmodium, and assess them for viability as biomarkers. A number
of VNTRs within Cryptosporidium were presented as comparable in their typing
power to the gp60 locus. Furthermore, we present a large number of VNTRs discov-
ered around the genome of Plasmodium falciparum which exhibit strong typing power.
VaNTA can be used to identify VNTRs within any organism, making it very versatile.
Consequently it will be made available for public use on the Galaxy platform, improving
usability and availability.
It is the intention that VNTR regions identified here will be used in Cryptosporidium
surveillance studies carried out by the Public Health Wales Cryptosporidium Reference
Unit, which will aid in the development of effective prevention strategies against Cryp-
tosporidiosis.
6.1.2.1 Experimental Validation of VNTRs Identified by VaNTA
Further work must be done to validate this biomarkers as appropriate for clinical ap-
plication. Small variations in fragment length can be difficult to detect experimentally,
necessitating further experimental evaluation. This will involve designing primers using
the flanking sequences of these VNTR regions (which are assessed for conservation by
VaNTA, for this purpose) and amplifying them using PCR. These PCR products should
then be sequenced and assessed for fragment length variation which can be detected using
conventional fragment length typing methodologies.
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6.1.3 Mining Reads for Sequences of Interest
The bottleneck between data generation and data analysis is a major problem in genomic
science. A primary reason for this bottleneck is that the technological progressions for
genome sequencing outstrip the progressions of genomic data analysis. This bottleneck
necessitates the development of tools which facilitate genome analysis in a cost and time
efficient way. Alignment-free sequence analysis presents a method by which genomes can
be analysed in a high-throughput and computationally efficient manner. Using alignment-
free sequence analysis, genome analysis can be performed on raw read data, obviating
the computationally expensive and time consuming task of genome assembly.
In Chapter 4 I present BlooMine, a tool developed to mine raw read sets(.fastq) for
query sequences. This tool utilises Bloom Filters, a highly efficient probabilistic data
structure, to perform set membership queries between kmer arrays generated from a
query sequence and a read. BlooMine proves highly reliable at pulling out reads
containing query sequences from a large simulated read set, despite variations
being introduced into the query sequences of these reads (see Section 4.7.1). Furthermore,
BlooMine was used to identify variations in the target locus within a read set,
which it achieved on the simulated dataset with high fidelity and sensitivity.
6.1.4 in silico Detection of Multiplicity of Infection in Cryp-
tosporidium
The effect Multiplicity of Infection has on clinically important factors such as virulence,
transmission, and clinical presentation are cryptic and poorly understood, leading Al-
izon et al. to remark ”Depending on the biological system, overall virulence1 can be
higher than the virulence of the most virulent parasite, lower than the virulence of the
least virulent parasite, or take some intermediate value between the two” [Alizon et al.,
2013]. This complex issue is made all the more difficult by the lack of reliable, high-
throughput approaches to investigate it. Most studies carried out to investigate MOI do
so using experimental techniques (detailed in Section 5.1) which are very labour inten-
sive and therefore scale poorly. There is consequently a great need for bioinformatic tools
which can carry out this kind of investigation in a reliable, sensitive, and scalable manner.
In Chapter 5 I use BlooMine to carry out an analysis of the MOI of Cryptosporidium
parvum across the 100 highest scoring VNTR loci identified by VaNTA in Chapter 3.
I then carry out further analysis of MOI at two loci: gp60 and cgd7 440.P.1066-1129.
1”Overall virulence” here is defined as the virulence experienced by the multiply infected host, which
is a complex product of the interaction between the individual genotypes of the pathogen which are
present in the host, and between the pathogen population and the host biological system.
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The results demonstrate that there is extensive sub-dominant population structure at
these two loci, indicating a high level of Cryptosporidium parvum population
complexity within a single host. Finally, I present a novel typing scheme, termed
MOI-signature typing. This typing scheme involves using in-host diversity at a single
locus to identify the relationship between clinical isolates. Using this scheme I show a
complex population structure within this C. parvum dataset (n = 36), which
is not achievable using conventional dominant allele typing schemes (such as
that used in gp60 subtyping). The characteristics of C. parvum population structure
are in accordance with experimental results [Grinberg et al., 2013, Troell et al., 2016].
A hypothesis is also presented, suggesting that the advent of MOI in a host is more
commonly as a result of divergence within the host than non-clonal infection. The re-
sults presented in this chapter are supported by epidemiological data, where available.
To my knowledge, these results represent the largest entirely in silico evalua-
tion of MOI carried out on clinical isolates of a unicellular eukaryotic parasite.
6.1.4.1 Experimental Validation of MOI-signature Typing
The discordance between clinical and in silico results of MOI detection has previously
been documented. However, it is possible that conventional methods of clinical typing
lack the sensitivity to elucidate sub-dominant populations of Cryptosporidium [Zhong
et al., 2018], since we have demonstrated that there is often an order of magnitude differ-
ence in abundance between the amount of DNA present (extrapolated from coverage over
individual alleles) for each allele (see Figures 5.5 and 5.6). Further work must therefore
be undertaken to validate the presence of these sub-populations experimentally, as these
in silico results, despite being supported indirectly by the observations of other teams
and of epidemiological collection data, are still predictions of putative sub-populations.
Care must be taken when evaluating MOI in samples which have been subjected to
DNA enrichment using WGA, as such enrichment may have an effect on the relative
abundances of sub-populations, or introduce pseudo-populations by incorrect amplifica-
tion. The hypothesis presented, suggesting MOI more commonly arises from variation
within a host rather than as a result of non-clonal infection also warrants further experi-
mental investigation. Finally, it is a possibility that errors introduced during sequencing
may exaggerate the level of MOI reported, therefore care should be taken when inter-
preting the results in the absence of experimental ones.
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6.2 Conclusion
Within this thesis, I have detailed the work carried out using the genomic sequencing
data available for Cryptosporidium to generate high-quality and reliable whole genome
assemblies, used these assemblies to prospect for VNTRs for use as novel biomarkers,
then used these biomarkers to illustrate that there is extensive Multiplicity of Infection
in clinical Cryptosporidiosis. The problems encountered and detailed here were resolved
using a variety of tools, some widely recognised and used (such as de novo assemblers like
spades, and aligners such as EMBOSS-water). However, some of these problems required
the development of entirely novel approaches and tools, which lead to the development of
VaNTA and BlooMine. The importance of developing such tools and applying them to
solve these biological problems cannot be understated, nor overlooked. The power of in
silico analysis will only increase as more ’omics data is generated with higher and higher
quality, and as computational power increases, meaning such tools will only increase in
their value and scope to resolve these problems and investigate biological phenomena in
a high-throughput manner. It is only by a thorough understanding of the transmission
of diseases such as Cryptosporidiosis, facilitated by such analyses and collaborations like
the one which lead to the development of this project, that we can hope to prevent their
spread and reduce the vast toll they have on human and animal health worldwide.
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UKP10 8.73 1.07 1.28 0.19 4366 2931
UKP11 7.41 0.9 1.17 0.24 4942 2284
UKP12 9.32 1.14 1.37 0.55 5627 2890
UKP13 9.02 1.1 1.33 0.26 6261 2612
UKP14 9.43 1.13 1.39 0.25 3156 3449
UKP15 9.4 1.14 1.38 0.11 1031 3723
UKP16 9.31 1.15 1.36 0.19 808 3740
WGA
UKP90 9.15 1.11 1.34 1.14 71 3724
UKP94 9.15 1.11 1.34 1.14 78 3763
UKP95 9.14 1.11 1.34 1.14 93 3696
UKP97 9.16 1.11 1.34 1.15 146 3794
UKP98 9.14 1.11 1.35 1.14 513 3516
UKP99 9.15 1.11 1.34 0.87 50 3775
UKP102 9.11 1.11 1.34 0.88 67 3742
UKP103 9.16 1.11 1.34 0.88 100 3734
UKP104 9.11 1.11 1.34 0.88 70 3738
UKP106 9.15 1.11 1.34 1.14 74 3744
UKP107 9.18 1.11 1.35 1.15 199 3671
UKP118 9.16 1.11 1.34 1.14 77 3777
UKP119 0.48 0.07 0.1 0.06 317 173
UKP120 9.15 1.11 1.34 1.14 83 3757
UKP121 9.15 1.11 1.34 1.14 72 3769
UKP122 9.14 1.11 1.34 1.14 104 3618
UKP123 5.44 0.69 0.86 0.68 1994 2140
UKP124 9.01 1.08 1.34 1.13 892 3571
UKP125 9.15 1.12 1.34 1.14 112 3782
UKP126 6.66 0.79 1.03 0.83 2226 2576
UKP127 9.13 1.11 1.35 1.14 264 3705
UKP128 9.14 1.11 1.34 1.14 89 3781
Continued on next page
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UKP129 9.15 1.11 1.34 1.14 177 3678
UKP130 9.12 1.11 1.34 1.14 89 3726
UKP131 9.14 1.11 1.34 1.14 64 3731
UKP132 3.01 0.41 0.54 0.38 1386 1197
UKP133 9.03 1.1 1.34 1.13 716 3637
UKP134 9.14 1.11 1.34 1.14 70 3777
UKP135 7.36 0.91 1.1 0.92 1368 2910
UKH51 9.08 1.12 1.33 1.14 50 3743
UKH55 9.09 1.11 1.33 1.14 52 3734
UKH56 9.08 1.11 1.33 1.14 55 3755
UKH57 9.09 1.11 1.33 1.14 82 3753
UKH58 8.75 1.06 1.28 1.09 1061 3550
UKH59 9.08 1.11 1.32 1.13 53 3755
UKH60 9.09 1.11 1.33 1.14 61 3748
UKH61 9.07 1.11 1.33 1.13 49 3749
UKH62 9.12 1.11 1.34 1.14 316 3771
UKH63 9.45 1.17 1.38 1.18 1299 3628
UKH64 9.45 1.17 1.38 1.18 1299 3628
UKH65 9.15 1.14 1.34 1.14 442 3744
UKH66 9.14 1.11 1.34 1.14 333 3762
UKH67 9.31 1.13 1.4 1.16 534 3704
UKH68 9.14 1.12 1.34 1.14 366 3757
UKH69 9.12 1.11 1.33 1.14 332 3772
UKH70 9.13 1.11 1.34 1.14 343 3764
UKH71 9.12 1.11 1.33 1.14 335 3773
UKH72 9.08 1.11 1.32 1.14 67 3752



















































































































































































































































































































































































































































































































































































































































































































































































































































































































Source code for a toolkit to calculate Gini and Gini-Granularity curves from coverage
files can be found at https://github.com/ArthurVM/Read-Distribution-Toolkit.
Source code for VaNTA is available from https://github.com/ArthurVM/VaNTA.
VaNTA was developed to run on laptops and personal computers, and therefore has
very low computational requirements. This iteration of VaNTA is developed to run on
UNIX systems via the command line. It will also be made available on the Galaxy plat-
form.
Source code for BlooMine can be found at https://github.com/ArthurVM/BlooMine.
BlooMine was developed and tested on a system running Ubuntu v18.04, with an Intel
core i7 9th Gen and 32Gb DDR3 RAM. BlooMine was developed to run on laptops and
personal computers, and therefore has very low computational requirements. In practical
(but not theoretical) terms, there is no lower bound memory requirement. Multithreading
is supported, and it is assumed that the user has access to at least 2 processing threads.
Therefore, the minimum processor requirement can be taken as a modern dual core
processor. BlooMine is developed to run on UNIX systems via the command line. It will
also be made available on the Galaxy platform.
.2 BlooMine Benchmarking
Benchmarking statistics carried out against conventional pipelines used for investigating
MOI are not provided due to the fact that BlooMine functions in a fundamentally different
manner to standard read alignment software, such as Bowtie2 and BWA, which drive
such approaches. Due to the often fairly strict ”acceptable nucleotide-identity rates”
utilised by such read aligners, using the simulated dataset which was used here would
have been an improper method of comparison. Consequently, the text focuses on the
fidelity of BlooMine in identifying target sequences with high levels of variance, rather
than comparisons against existing tools and pipelines which are poor analogues, and the
result of which would be too dependant on the type of dataset provided.
.3 Data Availability
The genome assemblies and annotations generated in Chapter 2 will be made available for
public access on GenBank. The list of all Tandem Repeats reported by VaNTA in Chapter
3 on both the P. falciparum and C. parvum datasets can be found at https://github.com/ArthurVM/VaNTA TRs.
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.4 Genome Sequencing
DNA extraction, purification and whole genome amplification (by MDA) of dataset 2
was carried out by myself at the Public Health Wales Cryptosporidium Reference unit
in Singleton Hospital - Swansea (CRU). Sequencing of dataset 2 was organised by the
CRU. One batch of 7 C. hominis genomes failed during sequencing, the reason for this
is unknown. All genomes were derived from samples taken during UK outbreaks of
Cryptosporidiosis between 2015-2018.
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The protozoan parasite Cryptosporidium is an important cause of diarrheal disease
(cryptosporidiosis) in humans and animals, with significant morbidity and mortality
especially in severely immunocompromised people and in young children in low-resource
settings. Due to the sexual life cycle of the parasite, transmission is complex. There
are no restrictions on sexual recombination between sub-populations, meaning that
large-scale genetic recombination may occur within a host, potentially confounding
epidemiological analysis. To clarify the relationships between infections in different
hosts, it is first necessary to correctly identify species and genotypes, but these
differentiations are not made by standard diagnostic tests and more sophisticated
molecular methods have been developed. For instance, multilocus genotyping has been
utilized to differentiate isolates within the major human pathogens, Cryptosporidium
parvum and Cryptosporidium hominis. This has allowed mixed populations with multiple
alleles to be identified: recombination events are considered to be the driving force
of increased variation and the emergence of new subtypes. As yet, whole genome
sequencing (WGS) is having limited impact on public health investigations, due in part
to insufficient numbers of oocysts and purity of DNA derived from clinical samples.
Moreover, because public health agencies have not prioritized parasites, validation has
not been performed on user-friendly data analysis pipelines suitable for public health
practitioners. Nonetheless, since the first whole genome assembly in 2004 there are now
numerous genomes of human and animal-derived cryptosporidia publically available,
spanning nine species. It has also been demonstrated that WGS from very low numbers
of oocysts is possible, through the use of amplification procedures. These data and
approaches are providing new insights into host-adapted infectivity, the presence and
frequency of multiple sub-populations of Cryptosporidium spp. within single clinical
samples, and transmission of infection. Analyses show that although whole genome
sequences do indeed contain many alleles, they are invariably dominated by a single
highly abundant allele. These insights are helping to better understand population
structures within hosts, which will be important to develop novel prevention strategies
in the fight against cryptosporidiosis.
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INTRODUCTION
The parasite Cryptosporidium is a protozoan that occurs
worldwide, and can cause the diarrheal disease cryptosporidiosis
in humans and animals (Figure 1). The life cycle of
Cryptosporidium (Figure 2a) (1) is completed within a single
host. Both the asexual phase, and the production of thin-walled
oocysts that enable autoinfection, mean the numbers of parasites
are increased from possibly single figures in the initial infection,
to result in clinically significant infections and the shedding
of vast numbers of oocysts in feces (2). These shed oocysts
have thick walls, conferring protection for the four infective
sporozoites contained within, and enabling long-term survival,
environmental transmission, and resistance to commonly used
disinfectants including chlorine (3, 4). This means that, in
addition to the variety of hosts that act as direct sources of
infection (Figure 1; Table 1), contaminated food, water, or
environmental vehicles are involved in transmission and need to
be considered and investigated for effective disease control and
prevention of outbreaks of cryptosporidiosis (5).
Human cryptosporidiosis is usually a gastrointestinal disease,
although there is some evidence for respiratory cryptosporidiosis
in some populations (6). Symptoms ranging from mild to
severe depending upon a number of factors, including the
host’s age, immune status, nutrition, genetics, and the site
of infection, as well as the infecting species and variant of
Cryptosporidium (7–9). Clinical symptoms include diarrhea,
abdominal pain, vomiting, nausea, and low-grade fever, which,
although prolonged (2 weeks is not unusual) are generally
self-limiting in immune competent hosts. However, infection
can be more problematic and even life-threatening in some
severely immunocompromised individuals, and in malnourished
young children (10). There are few options for treatment or
prevention. Recent studies have shown that in some low-resource
countries, where access to safe drinking water, sanitation,
FIGURE 1 | Transmission of Cryptosporidium spp. leading to human
cryptosporidiosis, arrow thickness represents likely global importance of
source hosts.
hygiene, and healthcare is often poor, Cryptosporidium is one
of the most important causes of moderate-to-severe diarrheal
disease and death in young children (11, 12). Furthermore,
long-term effects of infection such as malnutrition, growth,
and cognitive deficits have been described, highlighting the
socio-economic impact on the adverse outcomes of infection
(10). A vicious cycle of malnutrition and diarrhea can become
established with detrimental effects on these societies (13). For
these reasons,Cryptosporidiumwas included in theWorldHealth
Organization’s Neglected Diseases Initiative in 2004 (14), which
served to raise awareness of the need for international and
national investments in prevention and control.
Thirty-nine species of Cryptosporidium have been described
at the time of writing (Table 1), but not all cause human disease.
The vast majority of human cryptosporidiosis is caused by
the zoonotic species Cryptosporidium parvum or anthroponotic
Cryptosporidium hominis, with multiple variants that can cause
varying severity of symptoms. The diagnostic target of laboratory
tests, and those used to detect Cryptosporidium in water, is
the oocyst, using stained microscopy or immunologically-based
assays, or the sporozoite DNA. Routinely applied tests are
not able to differentiate species, and molecular methods are
needed to investigate true relationships between infections and
contaminants and thus elucidate the complex transmission of
Cryptosporidium. A range of samples need to be investigated,
from feces (e.g., stools, diapers, livestock dung, manure, slurry,
runoff, and wild life droppings), to contaminated water and food,
but these present challenges to detection and genotyping. At
present, amplification by culture is not an option in this context,
and finding oocyst targets, which may be in low concentration in
the sample matrix, can be a hit-and-miss affair. Recent advances
in molecular methods generally, and particularly in genomics,
have increased the amount of data available particularly on the
major pathogenic Cryptosporidium species (Table 1). Continued
generation and accessibility of genomic data will potentially
improve the public health response to cryptosporidiosis by
identifying new targets for incorporation into diagnostic and
genotyping assays (15). Putative virulence and host adaption
factors have been proposed (16), and potential chemotherapeutic




To identify Cryptosporidium species, genotyping was undertaken
initially using conventional PCR combined with either restriction
fragment length polymorphism (RFLP) or Sanger sequence
analysis, most commonly of the 18S rRNA gene (19). The 18S
rRNA gene includes conserved regions interspersed with highly
polymorphic regions and is currently considered to provide
the definitive sequences for discriminating Cryptosporidium
species. It is present in multiple copies (5 per sporozoite; 20
per oocyst) facilitating the development of sensitive assays,
which is especially important for testing samples such as water
where small (but potentially significant) numbers of oocysts
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FIGURE 2 | (a) The life cycle of Cryptosporidium (1). Oocysts (A) are ingested by the host, most likely as a mixed population of different genotypes; haploid
sporozoites (B) (variants are represented by red and blue) excyst and invade the brush border of epithelial cells; each sporozoite develops into a haploid trophozoite
with a prominent nucleus (C); the trophozoite undergoes merogony by mitosis to form a type I meront (D,E); up to eight haploid merozoites (F) are released, invade
(Continued)
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FIGURE 2 | another cell and undergo merogony again to form either further type I meronts (dotted line) or type II meronts (G), which release four haploid merozoites
(H) and form either microgamonts (I) that become multinucleate and mature to form multiple haploid microgametes (J) by mitosis, or a haploid macrogamont (K).
Microgamonts are released and potentially each fertilize a macrogamont to form a diploid zygote which undergoes sporogony by meiosis to produce either thin-walled
oocysts (L) containing four haploid sporozoites that can autoinfect the host (dotted line), or thick-walled oocysts (M) that are shed in the feces ready to transmit four
haploid sporozoites to a new host (the purple circle represents an oocyst that is the product of fertilization between the red and blue genotypes). (b) A simplified
schematic of genetic recombination in Cryptosporidium, potentially generating variation between sporozoites within oocysts. In a mixed infection population, different
fertilization scenarios potentially occur—between the same genotypes (resulting in identical daughter sporozoites) or between different genotypes, as in the example
shown, that result in a variety of outcomes depending on the random genetic exchange, or lack of, that occurs during meiosis. For simplicity only two example
chromosomes are shown with DNA from different genotypes represented by blue and red. The diploid zygote contains duplicate pairs of chromosomes, one set from
each parent cell; during interphase (In) the DNA in each chromosome is replicated to produce two identical sister chromatids held together with a centromere; in
prophase I (Pr I) the chromosomes start to condense and pair up with the homologous chromosome from the other parent cell, and cross-over can occur resulting in
an genetic exchange; during metaphase I (Me I) the paired chromosomes line up along the center of the cell and microtubules connect the centromeres to the
centrosomes (shown in green); during anaphase I (An I) each complete set of chromosomes (still paired as sister chromatids) are pulled toward each centrosome—the
chromosomes from either parent are randomly combined at this phase introducing a further opportunity for recombination (a blue and a red chromosome are drawn
to each centrosome in this example); in telophase I (Te I) the chromosomes start to unravel and cytokinesis starts to split the cell into two, resulting in two haploid cells;
in prophase II (Pr II) the chromosomes condense again; during metaphase II (Me II) the chromosomes line up along the center of the cells and microtubules connect
the centromeres to the centrosomes; this time during anaphase II (An II) the sister chromatids are separated and pulled apart toward the centrosomes, creating new
daughter chromosomes; finally in telophase II (Te II) the chromosomes unravel and cytokinesis starts to split the cells, which in the case of this example due to the
crossover event in prophase I, results in four genetically different haploid sporozoites. Depending upon whether random genetic exchanges take place between
chromosomes from different genotype parents (either in prophase I or anaphase I) the resulting haploid sporozoites can either be all different, two pairs of identical
sporozoites that are different from each parent, or two pairs of identical sporozoites that are the same as the two parents.
may be present. Species-level genotyping has provided improved
understanding of human epidemiology in some countries,
streamlined by the use of real-time PCR (see below). DNA
extraction methods from stool and gene targets have been
reviewed in detail by Khan et al. (17).
Beyond the species-level, Sanger sequencing part of the gp60
gene is most commonly used for further discriminating some
Cryptosporidium species, including C. parvum and C. hominis
(19–21). The gp60 gene is hypervariable both between and
within Cryptosporidium species, and the presence of a highly
variable serine repeat region in most species enables further
discrimination (19). For nomenclature of gp60 subtypes, the
reader is referred to a review of molecular epidemiologic tools
by Xiao and Feng (19). The use of this locus as a subtyping
marker has been questioned as it is associated with host cell
invasion, and therefore can be considered a virulence factor
under selective pressure. Nevertheless, as shown below, it may
still be an appropriate target for interrogation as a phenotype
determining biomarker. Another issue arises from the use of
a single locus; this may not be appropriate due to the genetic
recombination that occurs within Cryptosporidium populations
during the sexual stage of the life-cycle (Figure 2b). Whilst not
likely or expected between different species, this may occur in
populations of mixed subtypes of the same species (22–25). This
necessitates the investigation of multiple loci to reveal a more
accurate estimate of diversity and population structure (19, 26),
and would confer greater discrimination for characterization of
isolates (26, 27).
The reality is that genotyping tools are not currently
widespread in their application for public health purposes and in
most countries Cryptosporidium is under-diagnosed and isolates
are not characterized (28). In low-resource countries where
surveillance data are lacking, research studies have found that
C. hominis or human-adapted C. parvum subtypes predominate
(29, 30). C. parvum can also be the main species detected in
some urban settings with no animals close to residences, further
suggesting anthroponotic rather than zoonotic transmission (29).
These findings indicate that measures to improve sanitation
and hygiene would have greatest impact in these settings. Not
only is there a high prevalence of Cryptosporidium in these
populations, but there is also greater diversity within these
species, especially noticeable in C. hominis, than is seen in
industrialized countries (17, 31).
Genotyping in Cryptosporidium
Surveillance and Outbreaks
The aim of genotyping in the public health context is
to understand transmission and to improve the detection
resolution, investigation, and interpretation of waterborne,
zoonotic, person-to-person, and foodborne outbreaks. The
potential impact lies in:
• Identifying the Cryptosporidium species and subtypes that
most commonly cause human cryptosporidiosis, and their
demographic and temporal-spatial distribution
• Monitoring for the emergence of new species and subtypes in
human infection
• Improving detection, investigation, and interpretation
of outbreaks
• Increasing the sensitivity of epidemiological investigations to
identify links and risk factors, and identify the source of
outbreaks and contamination.
In most countries, routine surveillance captures Cryptosporidium
as an organism, but not species. Where genotyping is used to
inform public health, it is mainly in industrialized countries
but the framework varies. For example, in England and
Wales, clinical diagnostic laboratories have been sending
Cryptosporidium-positive stools for genotyping for many years,
both for molecular surveillance and for outbreak investigations,
and most diagnostic stools are genotyped (5, 32). In France,
testing for Cryptosporidium is not part of routine diagnostic
parasitological testing, but a national network of sentinel
laboratories was established to test for and genotype new and
outbreak cases of cryptosporidiosis (ANOFEL Cryptosporidium
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TABLE 1 | Cryptosporidium species, their major hosts, oocyst dimensions,















C. alticolis 5.4 × 4.9 Voles No No
C. apodemi 4.2 × 4.0 Mice No No
C. andersoni 7.4 × 5.5 Cattle Yes (rarely) PRJNA354069
C. avium 6.3 × 4.9 Birds No No
C. baileyi 6.2 × 4.6 Birds No PRJNA222835
C. bovis 4.9 × 4.6 Cattle Yes (rarely) No
C. canis 5.0 × 4.7 Canids Yes
(occasionally)
No





C. ditrichi 4.7 × 4.2 Mice Yes (rarely) No
C. ducismarci 5.0 × 4.8 Tortoises No No
C. erinacei 4.9 × 4.4 Hedgehogs Yes (rarely) No
C. fayeri 4.9 × 4.3 Marsupials Yes (rarely) No
C. felis 4.6 × 4.0 Felids Yes
(occasionally)
No
C. fragile 6.2 × 5.5 Toads No No
C. galli 8.3 × 6.3 Birds No No
C. homai Data not
available
Guinea Pigs No No











C. huwi 4.6 × 4.4 Fish No No
C. macropodum 5.4 × 4.9 Marsupials No No







C. microti 4.3 × 4.1 Voles No No
C. molnari 4.7 × 4.5 Fish No No
C. muris 7.0 × 5.0 Rodents Yes (rarely) PRJNA32283
PRJNA19553
C. occultus 5.2 × 4.9 Rodents Yes (rarely) No




































C. proliferans 7.7 × 5.3 Rodents,
maybe Equids
No No
C. proventriculi 7.4 × 5.7 Birds No No
C. rubeyi 4.7 × 4.3 Squirrels No No
C. ryanae 3.7 × 3.2 Cattle No No
C. scrofarum 5.2 × 4.8 Pigs Yes (rarely) No
C. serpentis 6.2 × 5.3 Reptiles No No
C. suis 4.6 × 4.2 Pigs Yes (rarely) No
C. testudinis 6.4 × 5.9 Tortoises No No
C. tyzzeri 4.6 × 4.2 Rodents Yes (rarely) No





C. varanii 4.8 × 4.7 Reptiles No No





C. wrairi 5.4 × 4.6 Guinea Pigs No No
C. xiaoi 3.9 × 3.4 Sheep, Goats No No
National Network, 2010). The Netherlands, Sweden and Scotland
also use sentinel laboratories to provide sporadic and outbreak
samples for genotyping in reference laboratories (28). In theUSA,
the Centers for Disease Control and Prevention is developing
CryptoNet, a molecular-based surveillance system aimed at the
systematic collection and molecular characterization of isolates
using 18S rDNA PCR-RFLP and gp60 sequencing (https://www.
cdc.gov/parasites/crypto/cryptonet.html). In Germany, Norway,
Spain, Ireland, Northern Ireland, Australia, and New Zealand,
Cryptosporidium genotyping has been used in epidemiological
research projects and/or for supporting outbreak investigations
(28, 33, 34), while the focus in Asia, Africa, and South
American countries has been on molecular epidemiological
research (29, 30, 35).
Molecular surveillance data in the United Kingdom (UK)
for example has shown that >95% of cases are caused by C.
hominis or C. parvum. Two seasonal peaks in cases occur, with C.
parvum consistently causing the majority of cases in spring and
C. hominis predominating in the autumn peak, with much higher
rates of foreign travel also reported during this second period
(32, 36–38). A similar temporal pattern has been reported in New
Zealand (39), but contrasts with the epidemiology in Ireland,
where there is no autumn peak and C. parvum predominates
all year (33, 40). This is likely due to the highly rural socio-
geography of Ireland and the greater potential of zoonotic
transmission, a feature also seen in rural regions of Great Britain
(36, 38). In the UK, the highest incidence of cryptosporidiosis is
in children under 5 years, with a second smaller peak in adults
in their 20s and 30s; in England and Wales in the period 2000 to
2003, C. hominis predominated in infants and the 30–39 year age
group (32), and in children <10 years and adults in the period
2004 to 2006 (37), suggesting transmission between children and
caregivers. In Ireland, where C. parvum predominates, the adult
peak does not appear but this may be a testing bias (33, 40).
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Although the sentinel surveillance in France is not wholly
representative of the French population due to the structure of
the network resulting in the inclusion of a higher proportion
of hospitalized cases (70%), particularly over-representing the
proportion of HIV-infected patients, certain trends are noticeable
(ANOFEL Cryptosporidium National Network, 2010). There
appears to only be a late summer/autumn peak each year, but the
case numbers per month were too low to determine any species-
related seasonality. However, C. parvum was more prevalent
each year compared to C. hominis (54.2 vs. 36.5%) and with
the remaining 9.4% representing other species (particularly C.
felis). The seemingly high number of unusual species were mainly
found in the over-represented immunocompromised patients
(82.8%), which may explain their higher prevalence than in the
UK for example.
In the Netherlands, only an autumn peak in case numbers
is present in surveillance data, and the predominant species
infecting people does not seem to be stable between years. One
study undertaken between 2003 and 2005 reported a higher
prevalence of C. hominis (70.3%) than C. parvum (18.7%), with
9.9% cases having both species, and a single case of C. felis (41).
The infecting species was significantly associated with patient
age, with children (aged 0–9 years) more frequently infected with
C. hominis and adults (over 25 years old) more frequently with
C. parvum (41). However, over a 3-year study from April 2013,
C. parvum was most prevalent in years one and two, but in
year three (April 2015 to March 2016) C. hominis predominated
and cases did not decline toward the winter as they had done
in previous years (42). Whether these apparent shifts were a
function of fluctuating participation in the sentinel scheme or
another reason is not known. In England and Wales apparent
shifts have also been seen; from 2000 to 2003 the ratio of C.
parvum:C. hominis nationally was close to 1, but in the period
2004–2006 it was 1:1.5, most noticeable in 2005 when it was
1:2.3 and major C. hominis outbreaks may have influenced the
distribution (37). The UK and the Netherlands both reported
an excess in cases of C. hominis with similar epidemiology in
the latter part of 2015, and despite gp60 sequencing identifying
subtype IbA10G2 and enhanced surveillance, no explanation was
found. This was the second time an international C. hominis
excess had been reported; in the late summer of 2012 the
Netherlands, UK, and Germany reported similarly unexplained
increases (43).
In the United States (US) national cryptosporidiosis
surveillance through CryptoNet is in its infancy, but there
seems to be a high diversity of Cryptosporidium species and
subtypes causing human cryptosporidiosis compared to other
industrialized nations (19). While C. hominis and C. parvum
cause the majority of cases, unusual species such as C. ubiquitum
and the chipmunk genotype are also seen, particularly in
rural areas and may suggest an important role of wildlife in
transmission, either directly or through drinking untreated water
(19). While general surveillance of Cryptosporidium species and
genotypes in the US is still fairly new, outbreak surveillance
has been carried out for many years through the National
Outbreak Reporting System (NORS). Analysis of 444 outbreaks
of cryptosporidiosis between 2009 and 2017 demonstrated most
were in the autumn and caused mainly by waterborne and
person-person transmission (44). Molecular data are available
for some of the outbreaks on the NORS website https://wwwn.
cdc.gov/norsdashboard/. Genotyping data for 131/178 (74%)
outbreaks in the same time period in England and Wales
showed 69 were caused by C. parvum (which caused all animal
and environmental contact and food-borne outbreaks, and a
minority of recreational water outbreaks), 60 were caused by
C. hominis (most of the recreational water and all person-to-
person spread outbreaks) and in two outbreaks both species
were identified (5). Both C. parvum and C. hominis caused
drinking waterborne outbreaks. Gp60 sequencing established
linkage between cases and suspected sources in nine animal
contact, three swimming pool, and one drinking water outbreaks
(5). Thus, the public health benefits of identifying infecting
species and subtypes lie in the ability to identify and strengthen
epidemiologic links between cases, and in indicating possible
exposures and sources to inform outbreak management (5).
However, the ability to differentiate zoonotic and anthroponotic
C. parvum routinely in all cases would be useful.
Identification by sequencing has established that unusual
species of Cryptosporidium, previously considered without
zoonotic potential, can infect people. Enhanced surveillance
has provided some understanding of the transmission of these
infections. In the UK, cases with unusual species often reported
zoonotic exposures; contact with unwell pets was a significant
association, and in particular, contact with cats was reported
by significantly more cases with C. felis (45). Genotyping C.
ubiquitum from patients in the US revealed mainly the rodent-
adapted subtype families (XIIb-XIId) in contrast to the UK
where infections weremainly the ruminant-adapted XIIa subtype
family (19, 46).
The potential for outbreaks is not limited to C. parvum
and C. hominis. In 2007 Cryptosporidium cuniculus (previously
rabbit genotype) was first identified in a patient during routine
molecular surveillance in the UK (47). The following year
an investigation into a drinking water quality incident in
England established that oocysts detected in treated water
were C. cuniculus. Soon afterwards, primary and secondary
C. cuniculus cases appeared in the supplied local population,
with the same gp60 subtype, VaA18 (48). Importantly, matching
the Cryptosporidium isolated from the drinking water, the
remains of a rabbit discovered in a chlorine contact tank,
and the case samples provided strong evidence for waterborne
transmission. This was the first outbreak reported to have
caused cryptosporidiosis where the etiological agent was a
species other than C. parvum or C. hominis, and established C.
cuniculus as a human pathogen. It re-enforced the importance
of protecting water supplies not only from livestock and sewage
contamination, but also from wildlife.
Sequencing of the gp60 gene has identified changes in the
circulation of predominant subtypes, and the emergence of
virulent subtypes. C. hominis IbA10G2 continues to predominate
in northern Europe, but in the US in 2007, 40 of 57 sporadic cases
from four states were a rare subtype, IaA28R4, with IbA10G2
accounting for just eight cases (49). Since 2013, IaA28R4 has
been displaced by IfA12G1R5 as the predominant C. hominis
Frontiers in Public Health | www.frontiersin.org 6 December 2019 | Volume 7 | Article 360
Morris et al. Sequencing Cryptosporidium for Public Health
genotype in the US associated with both sporadic and outbreak
cases (19). In Africa and Asia there is greater variation in
C. hominis subtypes. For example, in Bangladesh where C.
hominis is the most common species (>95% of cases) and the
seasonality demonstrates a summer peak corresponding to the
monsoon, gp60 analysis revealed 13 different subtypes over a
2 year period (31). Some, for example IaA18R3 and IbA9G3
were present year on year, but other subtypes predominated in
some years and disappeared in subsequent years (e.g., IdA15G1
was very common in 2015, but not in 2016 when IaA19R3 and
IeA11G3T3 were dominant), indicating a dynamic and frequent
transmission (31).
In Europe there is more variation among C. parvum than
C. hominis, although IIaA15G2R1 and IIaA17G1R1 are often
(but not always) the most common (5, 19, 50). Genotyping
has increased our capacity to detect, investigate and interpret
outbreaks. For example, in 2012, C. parvum IIaA15G2R1 was
used as part of the case definition in an analytical study to
investigate a large outbreak (>300 cases) across England and
Scotland. A statistically significant association was identified
with consumption of pre-cut, bagged mixed salad leaves from
a specific national retailer (51). Also in 2012, an outbreak in
schoolchildren was associated with a visit to a holiday farm in
Norway (52). Genotyping of isolates from cases and potential
animal sources on the farm revealed the same rare subtype of
C. parvum, IIaA19G1R1, in the cases, lambs and goat kids (52).
The same holiday farm was also involved in a previous outbreak
in 2009 and the same subtype was identified retrospectively,
suggesting that in the absence of newly introduced subtypes,
existing subtypes can be stable and circulate on the farms for
many years (52).
Although gp60 sequencing has played an important role in
refining epidemiological investigations, it is somewhat surprising
that there is no standardized multilocus genotyping scheme for
Cryptosporidium surveillance and outbreaks. Additionally, the
lack of suitable markers has hampered our understanding of
the main transmission pathway (zoonotic or anthroponotic) of
Cryptosporidium species and subtypes. As discussed in this paper,
genomics has an important role to play in the identification
of new markers and the development of a MLG scheme, and
the aspiration is that application would eventually become
nationally systematic.
Multilocus Genotyping
Currently multilocus genotyping (MLG) is mainly applied to
study the population structure of Cryptosporidium spp. with
few reports describing its utility in surveillance or outbreaks.
One example is an investigation into a Swedish swimming
pool outbreak in 2002, where multilocus genotyping revealed
two concurrent C. parvum outbreaks, with different subtypes
linked to the use of either the indoor or outdoor pool,
indicating multiple contamination events (53). In England, the
epidemiological association of C. parvum cases with a drinking
water supply was strengthened by MLG (54). However, more
often investigations have explored the population structure and
biology of Cryptosporidium.
In 2015, Widmer and Caccio investigated the relationship
between sequence and length polymorphism within a set of
biomarkers in the Cryptosporidium genome. They compared
genetic distances of sequence and length polymorphism, finding
that there was a weak correlation between the two distance
measures. Their results also indicated that the resolution of
Cryptosporidium population structure was dependent on the
genotyping method used (55). Differences in varying extents of
host-associated (56, 57) and geographical segregation (24, 58–
60), and the extent of panmixia vs. clonality, depending on
the population studied (21), have been reported. For example,
in Spain, C. parvum in cattle herds was reported to show a
panmitic population structure contrasting with sheep where C.
parvum populations appeared more clonal (19, 61, 62). This may
have been a function of the predominance of C. parvum gp60
subtype family (IId) in sheep in the study region of Northeastern
Spain (63) as IId has been reported to be clonal in other
regions/countries (64).
Pamixia in Cryptosporidium spp. may reflect the increased
potential for genetic recombination between more diverse
isolates than is available in these supposed clonal populations of
parasites. The presence ofmixed populations withmultiple alleles
is the driving force of increased variation and the emergence
of new subtypes due to recombination events (65–67). In some
studies, for example in Scotland C. hominis populations have
shown clonality (58), but in a cohort of children in Peru,
genetic recombination was detected in some C. hominis IbA10G2
samples using MLST of 32 polymorphic loci, despite the overall
clonality of the C. hominis population (65).
However, with the vast majority of C. hominis isolates in many
areas, including northern Europe and Australia, demonstrating
the dominant IbA10G2 (21) the potential for recombination
with other more diverse subtypes may be reduced through lack
of exposure in those regions. In contrast, the wide variety of
different C. parvum subtypes usually present in local geographic
areas make mixed populations more likely. This has been
suggested in a study of the global population structures of
both Cryptosporidium species, where samples from Uganda
showed similar panmitic population structures, contrasting with
C. hominis samples from the United Kingdom and C. parvum
from New Zealand which showed much more clonal population
structures (68). The authors suggest that both C. parvum and
C. hominis population structures appear to be shaped by local
or host-related factors rather than being species-specific (68).
This was borne out by a study in Sweden that applied a nine-
locus SNP-based method to differentiate C. hominis IbA10G2
and grouped 44 isolates, from 12 countries (including 7 non-
European), into 10 MLSTs with known epidemiologically-linked
samples clustering together; geographical clustering was not
obvious, however the numbers of isolates from each country were
small (69). In the USA, the emergence and spread of C. hominis
IaA28R4 was investigated by sequencing eight loci (67). Of 95
C. hominis samples (62 IaA28R4 samples) from four states, the
sequence diversity identified two clear sub-populations separated
geographically between Ohio and three southwestern states,
and suggested that the Ohio subpopulation was a descendant
of the subpopulation in the southwestern states. Furthermore,
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genetic recombination was seen to occur in IaA28R4 isolates and
was likely an important factor in its emergence (67), a finding
supported by a comparative study of the genome along with the
previously dominant IbA10G2 subtype (70).
For disease surveillance and outbreak investigations, there is
a need to establish a common multilocus genotyping scheme
to track the sources and spread of infection. In a review
published in 2012, Robinson and Chalmers reported that
different combinations of loci and methods of analysis had
been used, with very few groups using comparable loci (27).
For public health purposes it is desirable to have consensus
to enable cross-boundary comparisons and investigations and
track international spread. An initiative funded by EU COST
Action FA1408 “A European Network for Foodborne Parasites:
Euro-FBP” (http://www.euro-fbp.org) enabled a workshop to
be held between 23 scientists and experts in public and
animal health from 12 European countries and the USA on
Cryptosporidium genotyping (71). The participants discussed
the need for, and potential directions of, a standardized typing
scheme specifically for surveillance and outbreak investigations.
There was general agreement that a robust multilocus genotyping
scheme should be developed through collaborative laboratory
studies, to standardize a method for meaningful interpretation of
genotype occurrence and distribution trends, and where possible
incorporate into national surveillance programs (71). To achieve
this multiple markers spread, sufficiently across the genome, are
required. The recent generation of genome data facilitates the
identification of markers that show potential to be combined
for MLG investigations specifically for surveillance and outbreak
investigations (15).
WHOLE GENOME SEQUENCING
While we aspire to using WGS routinely in public health
investigations of Cryptosporidium cases in the way it is applied to
some bacterial pathogens (72–74), the reality is that this is still a
way off. Direct sequencing would provide timely investigation of
public health incidents, but it poses a challenge for this parasite;
it is difficult to culture and bioinformatics pipelines have not
been validated for public health purposes as Cryptosporidium has
suffered from lack of prioritization in genomics programs.
The first technical problem is the amount of DNA that is
required. Although this varies depending on the technology
used, for example, the Nextera XT DNA kits that have been
used in several publications require 1 ng of DNA, and as each
oocyst contains 40 fg of DNA it means that 2.5 × 104 oocysts
are required without losses and in a practical volume (75). To
generate sufficient DNA, oocysts may be propagated through
animals, but Cryptosporidium populations have been shown
to change through natural host-based preferential selection of
individual subtypes or further recombination into new subtypes.
For example, the “isolate” that provided the first reference C.
hominis genome in 2004 (TU502) was subsequently serially
propagated in gnotobiotic pigs over many years resulting in a
different subtype in 2012, which was likely due to the original
population being overgrown by another contaminating isolate
(76). Additionally, the availability of host animals appropriate to
the Cryptosporidium species in question (Table 1), and the ethics,
time and cost resources that are associated with propagation are
prohibitive. As propagating oocysts is not a practical solution,
obtaining enough clinical sample is the next hurdle, as the volume
of stools often submitted is very small. Purity is also a challenge
because feces is the starting point, so Cryptosporidium DNA is
overshadowed by non-target DNA from the biome and host.
Lack of purity has been overcome by the combination of several
techniques including harvesting by flotation, further purifying
by immunomagnetic separation and using the natural chlorine
resistance of Cryptosporidium oocysts to surface-sterilize them
with bleach (75, 77).
The sufficiency of available Cryptosporidium DNA has
also been addressed through the use of whole genome
amplification (WGA) techniques, which now mean that very
small amounts of DNA, even from single oocysts, can be used
for genome sequencing (77, 78). Guo et al. used WGA to
enrichCryptosporidiumDNA from six discrete species/genotypes
extracted from 24 human and animal fecal samples (77).
The results were encouraging, showing that Cryptosporidium
DNA was significantly enriched, allowing for coverage of
> 94% of the genome (77). This ability to whole genome
sequence from very low numbers of oocysts is a development
that may help when investigating environmental samples and
other transmission pathways. Additionally, it may also alleviate
problems encountered when whole genome sequencing a mixed
population of oocysts. The concern that WGA could result in
higher numbers of errors introduced into the genome sequence
due to the fidelity of the enzymes used is also unfounded.
The presence of four sporozoite genomes in a single oocyst
helps, as any errors introduced in the first cycle are unlikely
to occur at exactly the same place in more than one genome,
so subsequent copies from the other genomes (containing the
correct sequence) should overshadow any errors. AlthoughWGS
technology has developed and some of the technical hurdles
have been overcome to enable direct sequencing (75, 77, 78),
we are still not at a point where it can be used to inform
in real-time for meaningful surveillance or during outbreak
investigations. Aside from technical and resource issues, the
lack of user-friendly, validated pipelines specifically designed
to generate data in a form that is useful to public health
practitioners during the management of incidents, make direct
whole genome sequencing currently impractical. Nevertheless,
genomic data are being used for biomarker discovery and to
understand genetic diversity in parasite populations in different
settings. These developments are described below, and arise from
the progression of Cryptosporidium whole genome sequencing
and assembly over the last two decades.
Progression of Whole Genome Sequencing
and Assembly
Attempts to sequence the genome of Cryptosporidium began
in the early 2000s. Initial attempts involved cloning sheared
fragments into plasmid vectors and Sanger sequencing. This
approach resulted in > 9x coverage of the genome and yielded
a fragmented assembly of 221 contigs of length > 5 kbp (79).
A more advanced sequencing project was undertaken to resolve
gaps, using large C. parvum fragments contained within lambda
DASH II libraries, and sequence missing DNA using a primer
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walk strategy (79). The completed genome of C. parvum (Iowa
II) along with a preliminary annotation was first published in
2004 by Abrahamsen et al. (80) who passaged oocysts through
an animal donor to produce enough parasitic material for the
extraction and purification of sufficient amounts of DNA. A
random shotgun sequencing approach was used, which yielded
a complete genome with coverage of 13x over 18 large contigs
(80) and was shortly followed by the publication of the first
draft genome of C. hominis (TU502) in late 2004. However, this
C. hominis genome proved to be much more fragmented than
that of C. parvum, resulting in a sequence consisting of 1,422
contigs (81).
In 2015, the C. parvum (Iowa II) reference genome was
reassembled and reannotated, and a new C. hominis reference
genome (UdeA01) published (82). The updated assembly
resolved all eight chromosomes from the 18 scaffolds in the
previous genome, representing the first chromosome level
assembly of C. parvum. The reannotation effort increased
the number of putative genes from 3807 to 3865 for
C. parvum Iowa II, and predicted the presence of 3819
genes in C. hominis UdeA01 (82). In 2016, Ifeonu et al.
reassembled and reannotated the C. hominis TU502 genome,
along with producing new draft genomes of human isolated
C. hominis (UKH1) and C. meleagridis (UKMEL1) along with
the avian species Cryptosporidium baileyi (TAMU-09Q1) (83).
The C. hominis TU502 genome proved to be a considerable
improvement on the previous 2004 version, being much more
complete, and reducing the number of contigs down to 119.
Annotation was facilitated by the RNAseq data generated from
the oocyst stage of both C. hominis and C. baileyi, predicting the
presence of 3745 protein coding genes in C. hominis TU502 and
3765 in C. hominis UKH1 (83).
As can be seen in Table 2, there is little difference between
the genomes of C. parvum and C. hominis. They exhibit 95–
97% DNA sequence identity; with 11 protein-coding sequences
identified only in C. hominis and 5 in C. parvum, and no large
indels or rearrangements apparent (84). The high conservation
in the C. hominis genomes generated from European samples
compared to the much more polymorphic C. parvum does not
appear to be expressed in general observations on structure
and base representation as illustrated in Table 2, suggesting
that phenotypic differences are potentially due to more subtle
sequence divergence (SNPs and Indels) and gene expression.
This further illustrates the importance of large-scale sequence
comparison of Cryptosporidium species to elucidate potentially
exploitable variation. Widmer et al. identified a number of highly
divergent genes by comparison of the genomes ofC. parvum gp60
subtype IIc and the Iowa II reference (85). Further investigation
reveals that genomic evolution was largely reductive, resulting
in Cryptosporidium depending mainly on host cells for basic
nutrients (86).
As more genomes are becoming available at an ever-
increasing rate, researchers are able to explore further the
biology and evolution of Cryptosporidium. Recently, Nader et al.
(87) used 21 whole genome sequences to show the existence
of two subspecies lineages of C. parvum (C. parvum parvum
and C. parvum anthroponosum) with different host-adapted
infectivity. Additionally, they identified some of the historic
genetic exchanges that have occurred between these lineages
and C. hominis during the evolution of these different species
and subspecies, even suggesting rough time-lines for when these
events occurred (87, 88).
In an important epidemiological development, Gilchrist et al.
(31) used the methods described by Hadfield et al. (75), to study
the genetic diversity of C. hominis in slum dwelling infants in
Dhaka, Bangladesh, over a 2-year period. As mentioned above,
they found that C. hominis was more abundant during the
monsoon periods and showed high levels of diversity at gp60
locus. Furthermore, WGS revealed extensive SNP diversity, and
very high levels of variation at seven distinct loci. They also
detected high levels of recombination within the C. hominis
populations, evidenced by linkage disequilibrium decay. The
genetic diversity of C. hominis encountered in the Bangladesh
study was found to be far greater than that seen in northern
Europe, where the predominant C. hominis IbA10G2 subtype
is highly conserved at the genome level (50, 71). This study
reveals the importance of high-throughput, wide scale genomic
sequencing and analysis in elucidating the complex population
structure of the parasite worldwide (31).
In another study, WGS was also used for a comparative
genomic analysis between two subtypes of C. hominis that
have been dominant in the US at various times, IbA10G2
and IaA28R4, and C. parvum (70). Their genome comparison
revealed evidence of genetic recombination in the two C. hominis
subtypes, and also some unique genetic differences between
C. hominis and C. parvum, and multigene families that may
contribute to the host variation between these two species (70).
Genome Availability
The advent of the new techniques to facilitate the DNA
extraction, enrichment, sequencing, and assembly of high
qualityCryptosporidium genomes from clinical samples, provides
TABLE 2 | The progression of C. hominis and C. parvum whole genome assembly from initial attempts in 2004 to the completed genomes in 2015 and 2016 (80–83).










Genome length 9.10 Mbp 9.16 Mbp 9.05 Mbp 9.10 Mbp 9.10 Mbp
Coding genes (% genome) 3807 (75.3%) 3994 (69%) 3819 (75.4%) 3865 (75.7%) 3745 (77.8%)
GC content 0.3 0.32 0.32 0.32 0.3
Introns 0.05 0.05-0.20 0.109 0.108 not reported
Fragments 18 1422 8 8 119
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FIGURE 3 | A comparison of the coverage over chromosome 1 of C. parvum Iowa II (top track) and the clinical isolate UKP3 (bottom track), showing the highly uneven
coverage typically exhibited from many clinical isolates. Reads were mapped using Bowtie v2.3.3.1 (93) and visualized using Integrative Genomics Viewer v2.4.16 (94).
an opportunity to greatly expand the number of genomes
available. An EU funded collaboration (Aquavalens project,
www.aquavalens.org) between several institutions generated 27
assemblies of C. parvum, C. hominis, Cryptosporidium viatorum,
C. ubiquitum, C. cuniculus, and C. meleagridis directly from
clinical isolates using the DNA extraction and purification
protocol described by Hadfield et al. (75) and Nader et al.
(87). Under another EU funded project, COMPARE (https://
www.compare-europe.eu/), 31 new C. parvum and 19 new
C. hominis genome assemblies were generated from clinical
isolates, using the DNA extraction and purification protocol
described by Hadfield et al. (75), and the DNA enrichment
protocol described by Guo et al. (77). A further 14 C. hominis
genomes, representing 9 different gp60 subtypes, have also been
published (89) and are available as a Bioproject (PRJNA307563)
on the National Center for Biotechnology Information (NCBI)
online databases. Currently, whole genome assemblies of isolates
from human and animal derived Cryptosporidium spanning 9
species, are available as Bioprojects on NCBI databases (see
Table 1), but this number is rapidly increasing as methods
and technology become more available. The Cryptosporidium
genomics resource CryptoDB (http://cryptodb.org/), provides
access to species including C. hominis, C. parvum, other zoonotic
species including C. meleagridis, and host-adapted species rarely
found in humans (Cryptosporidium muris, Cryptosporidium
andersoni, C. baileyi, and Cryptosporidium tyzzeri) and provides
analytical tools to mine and compare the genomes sequences
and their functionality (90, 91). A number of unassembled,
unprocessed raw read sequences are also publically available via
online repositories such as GenBank and the Welcome Trust
Sanger Institute FTP servers.
Sequencing Using Long-Read Technology
Recently, there have been attempts to generate Cryptosporidium
sequences using long-read technology, such as MinION by
Oxford Nanopore, and Pacific Biosciences. There exist a few
draft genomes from long reads generated by PacBio, but most
are yet unpublished. However, a C. parvum PacBio sequence is
available on the Welcome Trust Sanger Institute FTP servers
(ftp://ftp.sanger.ac.uk/project/pathogens/Cryptosporidium) that
was generated to map shorter Illumina reads to during the study
in Dhaka that explored the genetic diversity of C. hominis (31).
Currently, there have been no successful attempts at sequencing
the genome using the MinION platform published. This is likely
due to the large amount of DNA required to generate such reads
using this particular technology, which is a known difficulty
associated with Cryptosporidium genomic sequencing.
Pitfalls in Genome Assembly
Morris et al. have outlined difficulties associated with generating
reliable and accurate genome assemblies from clinical isolates
of Cryptosporidium (92). They demonstrated that the issues
surrounding extracting sufficient DNA from clinical isolates
resulted in highly uneven depth of coverage across the genome
(for an example, see Figure 3) which can be seen in sequences
generated from clinical isolates by a number of research teams.
This, in tandem with the large number of low complexity regions
within the Cryptosporidium genome, results in widespread
genomemisassembly when using the Spades assembler (95). Peng
et al. further proposed an approach to generating reliable draft
assemblies from clinical samples, and demonstrated how accurate
resolution of low complexity regions are essential for biomarker
discovery using the Iterative De-Bruijn Assembler (IDBA) (96).
Assembly of C. parvum and C. hominis is facilitated by high
quality reference sequences (C. parvum IowaII and C. hominis
UdeA01) which allow for reference-guided assembly. This,
however, is not the case for other species of Cryptosporidium. It
is therefore important to consider whether a reference guided
assembly should be attempted, and what reference genome to
use. The application of an inappropriate reference sequence may
result genome assembly errors.
APPLICATIONS, FUTURE ISSUES, AND
RESEARCH DIRECTIONS
With the recent expansion in the number of available raw read
archives and genome assemblies generated from clinical samples,
further in silico investigation can be carried out in an attempt to
resolve a number of biological questions, such as:
• Can biomarkers differentiate genetic lineages of
Cryptosporidium spp. virulence or pathogenicity, and
therefore act as targets for diagnostic interrogation or
novel therapeutics?
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• How much variability exists within intergenic regions in
species of Cryptosporidium?
• To what extent do multiple sub-populations of
Cryptosporidium spp. exist within an infected host
and in single clinical samples and impact of these
during onward transmission and even the evolution of
the parasite?
Biomarker Discovery and Analysis
The state ofCryptosporidium genotyping is far from resolved, and
there is still a large amount of work to be done regarding the
discovery, assessment, and selection of suitable biomarkers and
genotyping conventions. Subsequent to the increasing availability
of genomes is a bottle-neck in the analysis of these data, and there
is a need to develop time-efficient, computationally inexpensive
and high-throughput (automated) methods of genome analysis.
“In house” pipelines have been used for biomarker detection
and analysis. A typical example was reported by Perez-Cordon
et al. (15), who used Tandem Repeats Finder (TRF) (97) to
detect Variable Number Tandem Repeat (VNTR) regions within
the genome of Cryptosporidium parvum Iowa II isolate and
aligned them to homologues within a dataset of genomes
generated by Hadfield et al. (75). This pipeline consisted of three
primary steps:
1. Tandem Repeat (TR) identification in a reference genome.
2. Discovery of the TR’s around the genome of a dataset of
assembled genomes.
3. Assessment of these TR’s for variation and subsequent viability
as Biomarkers.
Using this pipeline, bioinformatic analysis of the Hadfield dataset
alone has yielded a large number of novel VNTR regions (15),
some of which compare favorably to the commonly used gp60
marker in their ability to resolve discrete subtypes of C. parvum.
Automating pipelines, can utilize the increasing amounts of
whole genome sequence data available for Cryptosporidium
allowing for the discovery of novel VNTRs in a high-
throughput manner.
In addition to novel VNTR markers, genome analysis of
other Cryptosporidium species and genotypes can allow for the
redescription of known markers in these for the development
of new subtyping tools. One example, is with the zoonotic
species Cryptosporidium ubiquitum, where the homolog of gp60
was diverse from those of C. hominis and C. parvum so could
not be used to differentiate isolates (46). Li et al. used whole
genome sequence data to identify and develop a gp60 subtyping
tool that allowed the differentiation and showed apparent host-
adaptation (46). Another example, described the development
from whole genome sequencing data of a two marker subtyping
tool (gp60 and a mucin protein gene) for the zoonotic chipmunk
genotype I (98).
When developing genotyping assays, it is important that
biomarkers are selected so as not to influence the outcome of
the analysis. For example, markers must be distant enough from
each other on the same chromosome or spread over the eight
chromosomes to ensure genetic linkage does not occur, and
markers must give high enough discrimination when combined
to be appropriate for the application in question, such as
demonstrating epidemiological relationships (27, 84).
Multiplicity of Infection in Cryptosporidium
It is both biologically plausible (due to unrestricted sexual
recombination between sub-populations), and there is strong
evidence (described below) that infections can arise from,
and give rise to, multiple sub-populations of Cryptosporidium
spp. which will be present in individual hosts (termed here
multiplicity of infection—MOI) and thus clinical samples. This
is driven by meiotic division in the zygote resulting in potential
re-assortment of chromosomes (Figure 2b). As a result, the
genomes of the haploid sporozoites within an oocyst may
differ from each other and the parent sporozoites. Grinberg
and Widmer demonstrated the common occurrence of MOI
and provided evidence that the degree of MOI may depend
on prevailing transmission patterns within geographical regions
(25). The current approaches of Sanger sequencing results
in the resolution of a single allele at each locus for the
population, which, if MOI is present, would in effect simply
represent the most populous sequence variant at each locus
within the assembly. Grinberg and Widmer illustrated this
from three hypothetical infections (25), but the potential extent
for MOI is theoretically even greater (Figure 2b). This may
confound epidemiological analysis, which generally relies on
the assumption that large-scale genetic recombination does not
occur within a host, and that a single host exhibits a single,
clonal population. Furthermore, it has been suggested that MOI
is a driving force behind the evolution of virulence, and has a
complex relationship with both the virulence experienced by the
host, and transmission (99, 100). It is therefore essential thatMOI
is well-understood and accounted for in order to develop novel
prevention strategies in the fight against cryptosporidiosis and
other parasitic diseases. The investigation into the impact of MOI
relies on the accurate and reliable detection and discrimination of
discrete populations of parasites, not readily achieved by current
genotyping approaches. There are a few major alternatives to
achieve this:
• Cloning and sequencing key loci to detect variation.
• Isolating and sequencing single oocysts from clinical samples.
• Comparing length polymorphism at multiple loci.
• Investigating sequence variation among reads within
short read archives generated by Next Generation
Sequencing (NGS).
These approaches investigate MOI from very different angles:
variable locus cloning and single cell sequences from an
experimental angle, and length polymorphism and sequence
variation within reads from an in silico angle. This lends them
unique challenges to overcome. By cloning PCR amplicons of
selected loci (gp60 and hsp70) and utilizing Next Generation
Sequencing (NGS), Grinberg et al. reported the presence of
numerous sub-populations within single isolates of C. parvum.
They demonstrated the presence of two hsp70 and 10 gp60 alleles
within their two isolate dataset. Furthermore, they reported that
in both isolates there was a dominant allele, which represented
the majority of the amplicons sequenced (101). Single oocysts
were isolated and sequenced by Troell et al. (78) with a
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view to elucidate these putative intra-isolate sub-populations.
Sequencing 10 oocysts individually resulted in assemblies of
49.4–91.8% of the size of the C. parvum Iowa II reference
genome. By pooling the reads from all 10 oocysts, they generated
a 94.4% complete genome. Variation at multiple loci was
detected between the assembled genomes, verifying the presence
of discrete populations within the “isolate” (78). Analysis of
fragment length polymorphism can highlight MOI, however, due
to PCR-based amplification of the fragments, minority variants
are largely undetectable (25). To compare the results obtained
from Sanger sequencing and NGS, Zahedi et al. investigated
gp60 amplicons from 11 C. hominis, 22 C. parvum, and 8 C.
cuniculus animal samples from Australia and China (102). They
demonstrated that NGS ismore effective at resolving the presence
of multiple populations of Cryptosporidium within a sample,
and the extent of MOI. There was concordance between the
subtypes identified by both platforms, but additional subtypes
were identified using NGS on C. parvum and C. cuniculus gp60
amplicons, but not C. hominis.
The major issue with the experimental approaches detailed
above is that they are expensive, extremely labor intensive and
time consuming, leading to poor scalability. This leads to a
major problem in generating sufficient data with which to begin
to unravel the role of these parasite sub-populations, and to
understand their overall impact on global public health. It is
expected that they will have roles in affecting transmission
by reducing host-fitness (virulence), and in generating novel
subtypes via sexual recombination. There is therefore a great need
to develop strategies which allow us to carry out investigations in
a high-throughput manner, utilizing the wealth of raw genomic
data is available for Cryptosporidium and other related parasites.
Using biomarkers discovered from the analysis of the increasing
number of high quality genomes, the opportunity arises to start
to investigate MOI using in silico techniques, by mining raw
read sets sequenced from clinical samples for information, which
may have been previously unattainable. This approach involves
three stages:
1. Identification of target regions for read interrogation. It is
essential to select target regions, which are likely to show
variation in-host, and it is therefore wise to select loci which
show large amounts of variation between hosts.
2. Identification of reads within a single-host read set which have
captured the target region.
3. Assessment of variation of the target sequence amongst reads
which were identified in step 2.
A high level of variation within a single-host read set indicates
the presence of multiple populations. Preliminary analysis of
the Hadfield et al. dataset (75) indicated extensive variation
at multiple tandem repeat loci around the Cryptosporidium
genome, indicating highly complex in-host population structure.
Results for variance mining at the gp60 locus can be seen in
Figure 4, which shows high levels of fragment length variation.
However, there is invariably a single allele which appears to be
FIGURE 4 | The distribution of fragment lengths at the gp60 locus mined from raw read sets generated from human clinical samples of UK isolated C. parvum by
Hadfield et al. (75). Fragment lengths are given in the legend. n refers to the number of reads which fully captured the gp60 region, and are therefore presented in
the data.
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most frequently exhibited within reads, and therefore considered
dominant. This is in agreement with the findings reported by
others, which show similar population structure (78, 101). There
is, however, a disparity in the extent of MOI in Cryptosporidium
between laboratory evidence by fragment sizing of key loci, and
by mining NGS data. This is potentially due to the limited
sensitivity of such approaches to identify multiple alleles of
similar fragment size. Furthermore, PCR may preferentially
amplify more abundant alleles, resulting in the less abundant
alleles being obscured, as shown by Grinberg et al. who initially
only identified the predominant alleles in their samples by PCR
and Sanger sequencing (101). It may also be the case that such
studies were not designed to detect multiple alleles within a
single sample, and therefore underestimate the incidence of
MOI. Consequently, care should be taken when interpreting
entirely in silico results in the absence of experimental data. Due
to MOI being a new area of investigation in Cryptosporidium
research, the reliability of in silico approaches to elucidate in-
host population diversity is still unclear, particularly in the
light of studies indicating extensive contamination of samples
(77). Preliminary results, however, appear to make predictions
which are in accordance with experimental and epidemiological
evidence, giving confidence in such data.
Natural transmission studies from analyzing secondary
infections and those in farm settings has shown that dominant
subtypes can be stable for many years or they can vary from
year to year. For example, the outbreaks among visiting children
on a holiday farm in Norway showed the same gp60 subtype,
IIaA19G1R1, was still circulating over several years and an
investigation into secondary transmission within households
after the children returned home also found the same subtype
(103). While there was no evidence at the gp60 gene of mixed
populations in this example, in farm settings it is common
for multiple subtypes to be present (104, 105). During a
study of household transmission in a rural and urban setting
in Bangladesh, a wide variety of gp60 subtypes were found,
particularly in the urban setting, but often there were concurrent
infections with the same subtype within households and
therefore it was mostly impossible to know the directionality of
transmission (106). Where there were different subtypes within
households it is unclear whether these stemmed from external
sources rather than secondary transmission within the household
(106). However, despite these studies there is a lack of data
from mixed natural infections and the changes or dominance of
subtypes that may occur during onward transmission, something
that warrants further investigation using multilocus tools or
whole genome data. Cama et al. used MLST to characterize
differences in Iowa reference C. parvum isolates that had been
maintained in different laboratories and described differences
that were likely the results of passages through calves infected
with exogenous C. parvum (107). This genetic drift in reference
isolates was also seen with the TU502 reference C. hominis isolate
between 2005 and 2012 following multiple animal passages (76).
Therefore, the implications of MOI for surveillance and outbreak
investigations are uncertain. As drift may happen in the longer
term but not necessarily in the short term, detecting an outbreak
“type” is reasonable, but equally it could be that two cases with
apparently different subtypes are still actually linked if there is
bias in the detection of dominant alleles.
CONCLUSIONS
WGS holds tantalizing promise for better understanding the
transmission of cryptosporidosis, but there are still good reasons
as to why it is not used routinely for diagnostics in a clinical
setting. These include issues with extracting high quality pure
DNA from clinical samples and issues with uneven depth of
read coverage that leads to gaps in the assembled genome
sequence. This later issue has important implications for cost:
reducing costs by sequencing at a low depth of coverage is
problematic, because it will increase the size and frequency of
gaps in the assembled genome sequences. Nonetheless, while
WGS is not yet on the horizon as method for routine clinical
genotyping, it is indirectly having an important influence on
clinical diagnostics. For instance, WGS is being used to guide
and inform the development of MLST schemes, such as those
based on VNTRs and fragment sizing. It is providing key insights
into the evolutionary development ofCryptosporidium, including
the discovery of new subspecies. Perhaps most important in
terms of understanding the transmission of the disease, WGS
is providing key insights into MOI. While evidence for MOI
is occasionally found using fragment sizing, preliminary WGS
analysis shows that is it is much more prevalent than the
evidence from fragment sizing might suggest. WGS shows that
although clinical samples do indeed contain multiple alleles,
a single highly abundant allele usually dominates the data
sets. It is highly likely that only the dominant allele that is
detected via fragment sizing, with the other alleles remaining
undetected. Resolution of these multiple populations is a
stepping-stone to understanding the driving factors behind the
evolution of virulence, and how new subtypes and genotypes arise
in Cryptosporidium.
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Abstract: Cryptosporidium is a protozoan parasite that causes a diarrhoeal disease in humans, and which may be spread
by swimming pools or infected municipal water supplies. It can be a serious health risk for individuals with
weakened immune systems. Genomics has the potential to help control this pathogen, but until recently, it has
not been possible to perform whole genome sequencing directly from human stool samples. This is no longer
the case, and there are now at least a dozen high quality genomes available via resources like CryptoDB and
NCBI, with other isolates being sequenced. The analysis of these genomes will improve current approaches
for tracking sources of contamination and routes of transmission by allowing the identification of biomarkers,
such as multiple-locus variable tandem repeat regions (VNTRs). However, problems remain due to highly
uneven sequence coverage, which causes serious errors and artefacts in the genome assemblies produced by a
number of popular assemblers. Here we discuss these assembly issues, and describe our strategy to generate
genome assemblies of sufficient quality to enable the discovery of new VNTR biomarkers.
1 INTRODUCTION
Cryptosporidium is an Apicomplexan parasite caus-
ing gastrointestinal disease (Cryptosporidiosis) in hu-
mans and animals. In the developing world, Cryp-
tosporidium is one of the main causes of childhood
morbidity. A recent large-scale study has evalu-
ated the aetiology, burden and clinical syndromes
of moderate-to severe diarrhoea across seven sites
in sub-Saharan Africa and South Asia. It identified
Cryptosporidium as contributing to approximately
202,000 deaths per year in children less than 24
months old (Sow et al., 2016). In the UK, C. parvum
and C. hominis cause most cases of Cryptosporidio-
sis. While self-limiting after prolonged duration of
symptoms (2-3 weeks) in immunocompetent hosts,
severely immunocompromised patients suffer severe,
sometimes life threatening disease. C.parvum has a
small, very compact genome, with the IowaII (Abra-
hamsen et al., 2004) reference exhibiting a 9.1Mb
genome, bearing 3,865 genes, of which 89.1% are in-
tronless.
The sequencing and assembly of whole or partial
genomes has become an essential tool in modern sci-
ence, facilitating research in every area of biology.
A primary concern for Cryptosporidium is extract-
ing from clinical samples sufficient amounts of high
quality, low contaminant DNA for sequencing. With-
out this, sequencing may result in low coverage se-
quence, variable sequencing depth and poor quality
genome assemblies. In the area of Cryptosporidio-
sis the impact of genomics has been limited by the
need to propagate the parasite in animals to gener-
ate enough oocysts from which to extract DNA of
sufficient quantity and purity for analysis (Abraham-
sen et al., 2004). In 2015 this problem was over-
come through an approach that now allows genomic
Cryptosporidium DNA suitable for whole genome se-
quencing to be prepared directly from human stool
samples (Hadfield et al., 2015). Hadfield et al. (2015)
applied their method to the whole genome sequencing
of eight C. parvum and C. hominis isolates. Presently,
the Cryptosporidium genomics resource, CryptoDB
(Puiu et al., 2004), currently gives access to 13 com-
plete genomes, with a total of 10 available from the
NCBI.
Currently clinical diagnosis of Cryptosporidium
relies on conventional genotyping tests. The availabil-
ity of whole Cryptosporidium genome sequences pro-
vides much higher resolution information for geno-
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typing. In addition, the genomes can be used to study
a wide array of aspects of pathogen biology, such as
identity, taxonomy in relation to other pathogens, sen-
sitivity or resistance to drugs, development of novel
therapeutic agents, virulence, and epidemiology. Our
interest is to build on current genotyping tests by de-
veloping a standardised multi-locus typing scheme.
This will allow sources of contamination and routes
of transmission to be characterized and compared in a
cost- and time-efficient manner (Perez-Cordon et al.,
2016; Chalmers et al., 2017). Here variable-number
of tandem-repeats (VNTR) are used, with recent in-
vestigations concluding that additional loci need to
be identified and validated (Chalmers et al., 2017).
Our work is building on that of Perez-Cordon et al.
(2016), who used Tandem Repeats Finder (Benson,
1999) to identify polymorphic VNTR’s around the
genome of C. parvum, and analysed them for vari-
ation across the eight genomes sequenced by Had-
field et al. (2015). We aim to use whole genome
sequencing of additional isolates and species to help
achieve this goal, but this work is hapered by the
quality of available genome sequences (Perez-Cordon
et al., 2016).
This paper is structured as follows. First, we ex-
plain the quality issues associated with genome se-
quences extracted from clinical stool samples. Then
we describe our methods, including the data sets used,
a novel metric we use to measure the distribution of
read depth in a set of sequenced reads, and the process
of assembly with the identification of misassemblies.
In the results and discussion sections, we summarise
properties of the sequenced reads, show how they can
lead to misassemblies, and give evidence of the types
of misassembly we encounter. We also describe how
our novel metric can explain some of these assembly
errors. Finally, we conclude with a brief outline the
strategy we use to generate genome assemblies of suf-
ficient quality to use for the discovery of novel VN-
TRs.
2 THE PROBLEM
Although it is possible to derive high quality Cryp-
tosporidium DNA by culturing the parasite in donor
animals (Abrahamsen et al., 2004), this is expensive
and time consuming, and is not appropriate for clin-
ical samples, where maintaining sequence identity is
essential. Sequencing Cryptosporidium from clinical
samples suffers from three major problems:
• The yield of oocysts from clinical samples is low.
• The oocysts are extracted directly from faeces, ne-
cessitating extensive cleaning and purification be-
fore DNA extraction.
• The DNA yield per oocyst is low.
These three problems commonly result in se-
quenced data sets with very uneven depth of coverage,
which makes assembly and analysis difficult. Un-
even sequencing depth has been identified in datasets
obtained from published and unpublished paired end
read libraries generated by different groups, and
which were prepared using the standard Nextera XT
DNA sample preparation kit. Uneven sequencing
depth may lead to genome misassembly, and we have
identified this an issue with a number of popular de
novo assemblers. Poor quality genome assemblies
can find their way into public repositories of genome
sequence and this can confound the development of
novel prevention strategies, therapeutics, and diag-
nostic approaches.
3 METHOD
Our initial choice of assembly software was to use
SPAdes (Bankevich et al., 2012), following the Had-
field et al. (2015) paper. However, after aligning the
assembled genomes to the reference genome, and vi-
sualising genome features such as genes and VNTRs,
a number of issues became apparent (see Figure 4)
such as the transfer of large sequence fragments be-
tween chromosomes. We assumed this was a compu-
tational artefact, rather than a true biological signal,
and therefore we have investigated the assembly pro-
cess in the following manner.
3.1 Dataset
We used the dataset presented by Hadfield et al. (Had-
field et al., 2015), consisting of 7 UK isolates of
Cryptosporidium parvum and 3 UK isolates of Cryp-
tosporidium hominis: UKP2 to UKP8 & UKH3 to
UKH5. An updated C. parvum IowaII reference as-
sembly was utilised, which included all 8 chromo-
somes resolved, rather than the 18 fragment IowaII
assembly (Abrahamsen et al., 2004) that was used
by Hadfield et al. This dataset was used because
they currently represent the largest collection of pub-
lished Cryptosporidium draft genomes from clinical
isolates.
For the purpose of identifying a correlation be-
tween genes transferred to chimeric regions and Gini,
unpublished isolates consisting of 29 UK C. parvum
and 19 UK C. hominis isolates where also used.
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Figure 1: Coverage across chromosome 7 of the C.parvum UKP3 (top track) and IowaII reference (bottom track) genomes to
illustrate the extreme coverage inequality of the UKP3 isolate genome (UKP3 Gini = 0.5489, IowaII Gini = 0.112). Image
produced using IGV. Note that the IowaII DNA sequences were derived from an animal model, and have low or ”normal”
read depth variation, whereas UKP3 is more typical of DNA sequences extracted from clinical samples.
3.2 Sequenced Read Analysis
The reads were mapped to a reference genome (C.
parvum IowaII for C. parvum and C. hominis TU502
(Xu et al., 2004) for C. hominis) using Bowtie2
v2.3.3.1. (Langmead et al., 2009) Coverage analy-
sis was then performed using Samtools v1.5 (Li and
Durbin, 2009).
Figure 2: Graphical representation of the Gini coefficient.
In this graph, the Gini coefficient can be calculated as
A/(A+B), which represented area under the Lorenz curve
(blue) inversely proportional to the line of equality (red).
The green dotted lines denote the percentage of reads which
cover 80% of a genome used to generate the Lorenz curve
(poor coverage depth equality) as compared to a perfect dis-
tribution of reads.
Read depth was calculated using the ’depth’ tool
within the samtools package. The Gini coefficient is a
measure used to identify inequality in the distribution
of a quantifiable metric. It is commonly used in eco-
nomics to measure income inequality within a pop-
ulation, where it is represented by a value between
0 and 1, with 0 representing perfectly even distribu-
tion, and higher values representing higher inequality
of distribution. Here we have applied this coefficient
to measure inequality of depth of coverage across a
genome. For each of the 10 Hadfield genomes, we
calculated the Gini coefficient of read depth. The Gini
coefficient is defined using the following equation:
G = A/(A+B)
where A is the area under the line of equality, and
B the area under the Lorenz curve, on the graph of
distribution inequality (see Figure 2). The green dot-
ted lines (marked at 80% on the x axis) in Figure 2
gives an example of how, in the dataset used to gener-
ate the Lorenz curve, 80% of the genome is covered
by only 40% of reads (the value at the position of col-
lision of the green dotted line on the y axis), whereas
in a perfect distribution it would be covered by 80%
of reads.
The algorithm for calculating a genome’s Gini co-
efficient of read depth coverage involves first calcu-
lating the mean depth of coverage of 1Kb windows
over the genome. These windows are ordered accord-
ing to their depth of coverage values, and these values
rescaled between 0 and 100. This ordered set of read
depth values is used to generate the Lorenz curve, L,
where the value at every position i on the curve rep-
resents the sum of all values at positions ≤ i. A line
of equality, E, was generated to represent perfectly
even distribution of reads across a genome. The dif-
ference between the values at each position on E and
L is then calculated and the summed inverse propor-
tional difference (The Gini coefficient) of these values















where n refers to the number of windows (read
depth values) across the genome, xi is a depth of cov-
erage value at position i on the line of equality E, and
x j is the value at position j on the Lorenz curve L.
The Gini coefficient for each genome represents
the unevenness of read depth across the genome se-
quence (an example of uneven coverage across chro-
mosome 7 of UKP3 as compared to Iowa II can be
seen in Figure 1).
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3.3 De novo Assembly
First de novo assembly was undertaken in the same
manner as those reported by Hadfield et al. (2015).
SPAdes v3.7.1 (Bankevich et al., 2012) de novo as-
sembler was used to construct scaffolds from paired
end read files. Kmer sizes of 23, 33, 55, 65, 77 & 89
were used in the assembly, with 1 iteration used for er-
ror correction, repeat resolution was enabled and the
coverage cut off set to ’off’. Various kmer sizes, cov-
erage cut-offs, repeat masking, and a reference guided
assembly approach were used in an attempt to im-
prove assembly quality.
A second de novo assembly was undertaken using
velvet v1.2.10 de novo assembler (Zerbino and Bir-
ney, 2008) on paired end read files using a maximum
kmer length of 31, coverage cut-off set to auto, cover-
age mask set to 2, and the ’-short’ parameter enabled.
A third assembly was undertaken using IDBA-UD
(Peng et al., 2012), to resolve low coverage regions
whilst attempting to prevent generation of chimeric
fragments during assembly and scaffolding.
Figure 3: The workflow for assembly, adapted from that
used by Hadfield et al. for the assembly of genomes with
high coverage depth inequality.
3.4 Post Assembly Processing
The assemblies were improved using the Post Assem-
bly Genome Improvement toolkit (PAGIT) (Swain
et al., 2012): a pipeline consisting of four standalone
tools with the aim of improving the quality of genome
assemblies. The tools are, in suggested order of exe-
cution: ABACAS (Assefa et al., 2009), IMAGE (Tsai
et al., 2010), ICORN (Otto et al., 2010), & RATT
(Otto et al., 2011).
The workflow of this assembly pipeline can be
found in Figure 3.
3.4.1 ABACAS: Algorithm based Automatic
Contiguation of Assembled Sequences
ABACAS is a contig-ordering and orientation tool
which is driven by alignment of the draft genome
against a suitable reference. Suitability of the ref-
erence is defined by amino acid similarity of at
least 40%. Alignment is performed by NUCmer or
PROmer from the MUMmer package (Kurtz et al.,
2004): a tool designed for large scale genome align-
ment. Contigs from the draft assembly are positioned
according to alignment to the reference genome, with
spaces between the contigs being filled with ’N’s,
generating a scaffold of the draft assembly.
ABACAS was executed using the updated (All 8
chromosomes resolved) C.parvum IowaII (Abraham-
sen et al., 2004) reference genome with default pa-
rameters.
3.4.2 IMAGE: Iterative Mapping and Assembly
for Gap Extension
IMAGE uses Illumina paired end reads to extend con-
tigs by closing gaps within the scaffolds of the draft
genome assembly. IMAGE uses read pairs where one
read aligns to the end of a contig and the other read
overhangs beyond the end of the contig into the gap.
This gap can then be partially closed using the over-
hanging sequence and by extending the contig.
IMAGE was run in groups of three iterations at
kmer sizes of 91, 81, 71, 61, 51, 41, & 31, totalling
21 iterations. Scaffolding was then performed with
a minimum contig size of 500, joining contigs with
gaps of 300 N’s.
3.4.3 ICORN: Iterative Correction of Reference
Nucleotides
ICORN was developed to identify small errors in the
nucleotide sequence of the draft genome, such as
those which may occur due to low base quality scores.
It was designed to correct small erroneous indels, and
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is not suitable for, or capable of, correcting larger in-
dels or misassemblies.
ICORN was run using 8 iterations and a fragment
size of 300.
3.4.4 RATT: Rapid Annotation Transfer Tool
RATT is an annotation transfer too used to infer or-
thology/homology between a reference genome and a
draft assembly. This is achieved by utilising NUCmer
from the MUMmer package to identify shared syn-
teny between annotated features within the reference
genome, and sequence within the draft assembly. An-
notation files (EMBL format) are produced which
contain regions which are inferred to be common fea-
tures. The regions are filtered and transferred depen-
dant on whether the transfer is between strains (Strain,
similarity rate of 50-94%), species (Species, similar-
ity rate of 95-99%), or different assemblies (Assem-
bly, similarity rate of >=99%).
RATT was run using IowaII annotations in EMBL
format, downloaded from CryptoDB, as a reference.
The Strain parameter was used to transfer feature
annotations to the draft assembly.
3.5 Analysis of Draft Genomes
VNTR’s around the reference and draft genomes
were identified for the purpose of VNTR comparison
and polymorphism analysis. Tandem Repeats Finder
v4.09 (Benson, 1999) was used to identify VNTR’s
around the C. parvum IowaII reference genome using
a matching weight of 2, mismatch and indel penal-
ties of 5, match and indel probabilities of 80 and 10
respectively, minimum score of 50 and maximum pe-
riod size of 15. The number of VNTR’s per gene is
included as a heat map in Figure 4.
3.6 Identification of Misassembly
The draft genomes were analysed in two ways (1)
by transferring gene annotations from the reference
genome to the drafts using RATT, and (2) by align-
ing the contigs (from IDBA-UD) or scaffolds (from
SPAdes/Velvet) from the draft assemblies to the
IowaII reference genome. RATT was used to identify
the number of genes which were transferred between
genomes: it provided a convenient way of identify-
ing putative chimeric regions i.e. regions on a draft
chromosome that contained genes from 2 or more ref-
erence chromosomes. NUCmer was then used to in-
vestigate these putative chimeric regions by perform-
ing whole genome alignments. NUCmer (from the
MUMmer package (Kurtz et al., 2004)) was used with
a minimum length of match set to 100, preventing the
report of small regions of similarity, a maximum gap
of 90, and a minimum cluster length of 65.
3.7 Quality Assessment with Gini
The Gini coefficient for each isolate was calculated
and plotted against the number of genes transferred to
chimeric regions (detailed in section 3.6). The coeffi-
cient of determination (R2) was used to calculate the
amount of variance in the number of genes transferred
to chimeric regions explained by the Gini coefficient.
3.8 Data Visualisation
The C.parvum assemblies (UKP2-8) were visualised
alongside the C.parvum IowaII reference genome us-
ing the Circos package v0.69 (Krzywinski et al.,
2009). Mapped reads were visualised using Integra-
tive Genomics Viewer v2.4.16 (Thorvaldsdóttir et al.,
2013).
4 RESULTS
Statistics from the sequencing of the Hadfield et al.
genomes can be found in Table 1. The Gini coefficient
values are high (>0.25) in five of the ten paired end
read libraries. See Figure 1 for an example of how the
Gini value corresponds to actual read depth variation
within UKP3 and IowaII. Apart from the variation in
read depth, the sets of sequences generally appear to
be of good quality, with high genome coverage, and
little sign of contamination.
Table 2 shows the results of assembly using
SPAdes. The results from assembly with Velvet were
comparable to that of SPAdes, and therefore are not
shown here. Table 3 shows the results of assembly us-
ing IDBA-UD. The results shown in these tables in-
dicate that SPAdes produced assemblies with longer
and fewer contigs than IDBA-UD, highlighting the
differences between the assembly approaches adopted
by the assemblers.
Both the assemblies were then run through the
PAGIT pipeline to make the improvements described
in the methods section, including gap closing and the
transfer of gene annotations. The results can be found
in Tables 2 and 3. The SPAdes assemblies required
fewer gaps to be closed by IMAGE. The mean per-
centage of genes transferred by RATT to the improved
SPAdes assemblies is >99%. The mean percentage of
genes transferred to chimeric regions is 10.6%.
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Table 1: Bowtie2 mapping statistics for C. parvum and C.
hominis reads generated by Hadfield et al.. The Gini coef-
ficient is included in this table as an indication of uneven
























UKH3†305.02 0.903 0.98 34.71 0.1634
UKH4†1828.87 0.845 0.96 209.17 0.4935
UKH5†1765.46 0.809 0.96 201.92 0.2895
UKP2* 426.69 0.819 1.00 46.84 0.2121
UKP3* 1514.83 0.889 0.99 166.42 0.5489
UKP4* 1751.98 0.891 0.99 192.48 0.4693
UKP5* 244.53 0.846 0.99 26.86 0.2895
UKP6* 954.18 0.816 0.99 104.83 0.2106
UKP7* 708.61 0.891 0.99 77.85 0.5494
UKP8* 1587.38 0.837 0.98 174.39 0.5570
Table 2: The assembly statistics (SPAdes and post-PAGIT)
include the number of scaffolds (No.), scaffold N50 metric,
scaffold mean length (Av.), and the total size of the final
assembly. Gene annotations were transferred by RATT out
of a total of 3805 gene annotations in the reference assem-
bly. Genes erroneously transferred refers to genes trans-
ferred to regions which have been identified as chimeric
(and therefore misassemblies). Within C. hominis, the er-
roneous transfers are putative, due to differences between




















UKH3 168 149.9 54.0 9293 12 3792 (401)
UKH4 522 57.4 17.5 9594 95 3791 (467)
UKH5 463 54.6 19.6 9357 92 3787 (496)
UKP2 157 216.0 58.2 9254 23 3720 (356)
UKP3 270 109.8 33.7 9336 23 3688 (453)
UKP4 235 175.2 38.7 9226 22 3770 (349)
UKP5 447 70.7 20.3 9271 51 3800 (430)
UKP6 689 332.6 14.1 9826 13 3731 (96)
UKP7 521 62.6 17.3 9257 19 3797 (475)
UKP8 369 93.0 24.7 9473 26 3803 (518)
Table 3 shows the results of assembly using
IDBA-UD, and subsequent improvement and anno-
tation using PAGIT. These genomes benefited greatly
from gap closure by IMAGE over those produced by
SPAdes (see Tables 2 and 3), since gaps in intra-
genic repetitive regions were much more common,
potentially confounding VNTR analysis. The mean
percentage of genes transferred by RATT to the im-
proved IDBA-UD assemblies is 98%. The mean per-
centage of genes transferred to chimeric regions is
Table 3: Statistics for draft genomes assembled using





















UKH3 419 52.9 21.5 9102 104 3757 (0)
UKH4 627 39.7 14.3 9212 229 3688 (44)
UKH5 619 38.7 14.5 9197 247 3699 (32)
UKP2 360 63.9 25.2 9143 241 3776 (0)
UKP3 563 47.8 16.0 9168 312 3767 (1)
UKP4 509 53.7 17.7 9154 292 3772 (0)
UKP5 1830 11.2 4.8 9273 1791 3552 (1)
UKP6 768 51.4 12.1 9135 105 3702 (2)
UKP7 829 32.0 10.7 9184 288 3775 (6)
UKP8 614 40.7 14.7 9177 293 3756 (0)
0.2%. In the IDBA-UD assemblies, the C. hominis
genomes performed slightly worse, with 0, 44, and
32 genes transferred to chimeric regions respectively
across UKH3, UKH4, and UKH5.
The dramatic decrease in the number of genes
transferred to chimeric regions indicates significantly
fewer misassemblies in improved genomes generated
by IDBA-UD than in those of SPAdes, marking a sig-
nificant improvement. This indicates the effectiveness
of using ABACAS to identify gaps within the IDBA-
UD assemblies, and IMAGE to close them, which
SPAdes would resolve during assembly.
NUCmer, from the MUMMER package was used
to identify misassembly, as detailed in section 3.5.
Figure 4 shows the extent of misassembly in the iso-
late genomes, denoted by coloured bars correspond-
ing to which chromosomes regions belong to accord-
ing to NUCmer. Extensive misassembly was iden-
tified in all of the genomes, to varying degrees. The
most consistently misassembled chromosome is chro-
mosome 7, with a consistent chromosome 8 mis-
assembly. The most misassembled isolates where
UKP3 and UKP8, with 8 misassemblies of larger than
10kb. These two isolates have very high Gini scores
(see Table 1), of 0.5489 and 0.5570 respectively.
Figure 5 illustrates a moderate correlation (R2 =
0.41) between the Gini coefficient and number of mis-
placed genes within misassembled chromosomal re-
gions across 45 isolates of C. parvum and C. hominis.
Table 4 shows the number of VNTR regions that
were missing from the IBDA-UD assemblies before
and after gap closure with IMAGE. These results
show that a large amount of VNTR regions were re-
solved using IMAGE, indicating the importance of
post-assembly genome improvement in the genera-
tion of accurate and reliable genome assemblies.
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Table 4: The number of VNTR regions missing within the















Figure 4 shows putatively misassembled regions
(translocations) within the C.parvum UKP2-8 (Had-
field et al., 2015) PAGIT-improved SPAdes assem-
blies. A heatmap showing the number of VNTR’s per
coding sequence (CDS) is included. Every genome
assembly within the dataset exhibits significant mis-
assembly across all chromosomes, particularly at the
terminal end.
5 DISCUSSION
Table 1 indicates high depth of coverage inequal-
ity throughout the genomes, represented by relatively
high Gini coefficient values in comparison to that ex-
hibited by Iowa II (0.112), which the mean depth and
breadth of coverage (fraction of the reference cov-
ered) will not indicate. This appears to be a com-
mon issue when sequencing Cryptosporidium from
human clinical samples. Paired end read libraries ac-
cessed from GenBank, sequenced by the Welcome
Trust Sanger Institute (Bioproject PRJEB3213), and
those published by Troell et al. (2016) (Biopro-
ject PRJNA308172), who was attempting to gener-
ate whole genome sequences from single cells using
whole genome amplification (Troell et al., 2016), also
suffered from very high Gini coefficients, indicating
that this problem is not restricted to a single research
team. Figure 5 indicates that there is some correla-
tion between the Gini coefficient and the amount of
misassembly within genomes assembled by SPAdes.
Although this correlation is weak (R2 = 0.41).
Whole genome alignments were used to iden-
tify in silico translocation events (considered putative
misassemblies), as detailed in section 3.5. Figure 4 il-
lustrates that translocation occurred in a similar fash-
ion throughout each of the assemblies, with the same
areas being merged into similar chimeric genomes,
as can be seen in chromosome 7, where the initial
120kb region has merged into the end of chromosome
8 throughout all of the genomes. It is interesting to
note that only on UKP3 was a 70kb area from chro-
mosome 5 seen starting at 500kb on chromosome 7.
Similarly only in UKP8 was a unique 70kb translo-
cated region seen in chromosome 7 from chromosome
3. These two genomes bear high Gini coefficients,
as detailed in Table 1, which may contribute to this.
A peculiarity of these misassemblies is the observed
trend of chimeric chromosomes being a result of the
native chromosome being flanked upstream by 80kb
of the downstream extreme portion of the subsequent
chromosome. This is illustrated very clearly in Figure
4.
Taxonomic evaluation carried out by Hadfield et
al. utilising the gp60 marker show that there are five
gp60 subtypes within the C. parvum dataset. This
variation within the Hadfield C. parvum isolates is
supported by Perez-Cordon et al. (Perez-Cordon
et al., 2016) which shows clear variation across 28
VNTR loci, suggesting a number of genetic lineages.
The very low likelihood of similar translocation oc-
curring across different populations of C. parvum in-
dicates that these events are as a result of misassembly
by SPAdes, rather than a biological observations.
Examination of one such chimeric contig (the
chr8-chr7 chimeric region at 0-0.14Mb of UKP3 on
Figure 4) revealed that the region has very low depth
of coverage, with no single read spanning the chromo-
somal fragments. Moreover, the sequences from dif-
ferent chromosomes are joined using a simple ”AT”
repetitive region with only three reads spanning the
repeat region and no reads pairing across it (see Fig-
ure 6). This was observed in a number of other
chimeric interface regions. Due to the low complex-
ity, high repeat rich nature of the Cryptosporidium
genome, coupled with the difficulties associated with
DNA extraction and sequencing of this parasite, there
is insufficient evidence to suggest that this represents
true biological variation. Instead, it may be attributed
to a misassembly by the Spades software. This kind
of assembly error was also typical of the assemblies
produced by using Velvet de novo assembler.
Unlike SPAdes, the IDBA assembler leaves these
sequence fragments unjoined, with the result that sig-
nificantly less chimeric regions are seen in the IDBA
assemblies. This is because IDBA is designed for the
task of assembling genomes of highly uneven depth of
coverage. Although IDBA-UD did not create so many
chimeric contigs, the low complexity regions were of-
ten left unassembled, with the result that CDS regions
contained gaps. Unfortunately, these gaps often in-
cluded the VNTRs that we require for our multi-locus
subtyping scheme.
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Figure 4: Misassembled regions on each SPAdes assembled Hadfield et al. C.parvum genome. Regions are colour coordinated
by which chromosome of the C.parvum IowaII reference genome (represented by the outer track) they map to. From outermost
to innermost, the inner tracks represent the genomes of each isolate from UKP2-8. The innermost track (UKP8) also includes
a linkage map showing precisely where the regions map to in the IowaII reference genome. The second from outer track
shows a heatmap of genes bearing Tandem Repeats (TRs), from light yellow denoting a single VNTR within the gene to dark
red indicating many TRs within the gene. TRs were identified using Tandem Repeats Finder (see section 3.5).
Both SPAdes and Velvet (data from Velvet not
shown) produced full, ungapped CDS regions (see
Table 2). Thus the IDBA assemblies were not suit-
able for VNTR analysis and further biomarker iden-
tification without significant improvement. PAGIT
was used to improve the genomes from all assemblers
(see section 3.4), and this improved the resolution of
low complexity regions within the IDBA-UD assem-
blies. Within PAGIT, ABACAS performs scaffolding
on the genome assemblies and introduces gaps across
the unassembled regions, the IMAGE tool then per-
forms gap closure on these regions, resulting in high
quality intragenic VNTR’s for biomarker analysis.
An example of a region resolved by IMAGE can
be seen in Figure 7, which shows a multiple align-
ment of the cgd5 350 gene from each of the Had-
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Figure 5: The percentage of genes transferred to chimeric
(misassembled) regions against Gini coefficient of coverage
for 45 isolates of C.parvum and C.hominis. R2 = 0.41
field C. parvum assemblies. This region exhibits 4
distinct alleles, and can therefore be used to define
specific genotypes: an essential tool of clinical diag-
nostics. The number of gaps closed within the IDBA-
UD assemblies was significantly higher than within
the SPAdes assemblies. This difference in gaps closed
was expected, as IDBA-UD was designed for the pur-
pose of assembling genomes which suffer from poor
depth of coverage equality, and is therefore more con-
servative in extending reads across regions with shal-
low coverage.
The C.parvum assemblies produced by IDBA-
UD and PAGIT exhibited very few misassemblies
compared to the SPAdes assemblies. However,
the C.hominis genomes suffered from a greater
amount of putative misassemblies within the IDBA-
UD genomes, as measured by the number of genes
being transferred between chromosomes. Note that,
genes are transferred from the C.parvum IowaII ref-
erence genome, which is as different, albeit similar
species, and so some biological changes may be ex-
pected. Further analysis is required to fully elimi-
nate assembly error as a cause of these chromosomal
translocations. Table 4 shows that IMAGE is essen-
tial within this workflow for the resolution of repet-
itive regions which are not resolved during assembly
with IDBA-UD. The results show a five to six-fold de-
crease in the number of VNTR regions missing within
the assemblies.
6 CONCLUSION
In this paper we have performed a detailed analy-
sis of 10 Cryptosporidium genomes assembled with
3 popular assemblers. In summary, the results indi-
cate that assembly with IDBA-UD followed by im-
provement with PAGIT (with particular emphasis on
IMAGE) is an effective and reliable way of assem-
bling high quality draft genomes generated using the
protocol detailed by Hadfield et al. (2015). Due to
the protocol required to extract DNA from clinical
samples, these genome sequences often have highly
uneven sequencing depth even if the coverage across
the genome sequence is relatively high. To investi-
gate sequencing depth, we have developed a novel
approach that uses the Gini coefficient to determine
coverage inequality. We found the SPAdes and Vel-
vet assemblies to be problematic, leading to misas-
semblies across low coverage, low complexity re-
gions leading to the creation of chimeric chromo-
somes: up to 15% of all genes were being placed
within these chimeric chromosomes. Although the as-
semblies generated by IDBA-UD did not suffer from
the problem of chimeric sequences, they were prob-
lematic due to a different assembly approach, lead-
ing to a large number of gaps, particularly in repeti-
tive regions. This is a significant issue because these
gaps often contained the VNTR sequences that are
important to us for developing new clinical genotyp-
ing strategies. However, the IMAGE gap closing tool
from the genome improvement pipeline, PAGIT, was
able to resolve these missing low complexity regions.
Using this strategy, of assembly with IDBA followed
by gap closing with IMAGE, we will be able to per-
form more in depth VNTR analysis with the intention
of identifying biomarkers that will facilitate the de-
velopment of novel prevention strategies in the fight
against this important disease.
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Figure 6: The misassembly interface between fragments from chromosomes 8 and 7 on the chimeric chromosome 7 of UKP3.
Single reads are shown, as is a colourised sequence track (A = Green, T = Red, C = Blue, G = Orange) at the bottom where
the repeat region implicated in the formation of this chimeric contig can be seen. Image produced using IGV.
Figure 7: A multiple alignment of a VNTR region within cgd5 350 in the C. parvum dataset utilised in this paper that was
resolved within IDBA-UD assemblies using IMAGE. Four alleles are seen within this alignment, defined by variation in the
number of ’ACC’ and ’ACT’ codons present within the region. Differences such as this within a VNTR region can be used to
define distinct genotypes, used for diagnostic evaluation.
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